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Abstract 
The presence of hypertension in middle-age is a major risk factor for later-life development of 
cognitive and cardiovascular disease. Exercise is widely recommended to combat vascular and 
brain aging in hypertension. We sought to compare the effects of a single bout of aerobic 
exercise on 1) arterial stiffness and cerebral hemodynamics and 2) cognitive function in middle-
aged adults with controlled-hypertension and without hypertension. Vascular and cognitive 
measures were assessed pre and post 30-min of aerobic exercise at ≈55% maximal oxygen 
consumption. Arterial stiffness and cerebral hemodynamics were measured non-invasively. 
Cognitive function was measured using a computerized testing battery that included executive 
function and memory tasks. Acute aerobic exercise resulted in similar 1) increases in arterial 
stiffness and cerebral hemodynamic pulsatility, and 2) accelerated executive function and 
memory reaction time post-exercise in adults with and without hypertension. Based on these 
results, we investigated if adults with hypertension had differential vascular contributions to 
cognitive activity. We measured cerebrovascular hemodynamics non-invasively during cognitive 
activity as a measure of neurovascular coupling. Adults with and without hypertension exhibit 
similar increases in large artery stiffness and decreases in extracranial hemodynamic pulsatility 
during cognitive activity, indicating similar neurovascular coupling between groups. In 
conclusion, these data indicate that middle-aged adults with controlled-hypertension experience 
similar 1) vascular responses to acute exercise and cognitive activity, and 2) beneficial changes 
in cognitive function following acute exercise as their counterparts without hypertension. Our 
results will be interpreted and explored in the context of hypertension severity and underscore 
the importance of optimal blood pressure control. 
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Key Concepts 
Hypertension (HTN): A clinical condition characterized by abnormally high pressure inside the 
blood vessels that carry blood away from the heart. HTN has been identified as a condition that 
increases the risk of developing further chronic disease (particularly of the heart, kidney, and 
brain). Controlled HTN refers to medically managed blood pressure via pharmaceutical 
medication prescribed by a physician alone and/or lifestyle modifications (diet/activity) 
Cognitive function: An umbrella term used to describe brain activities that contribute to 
acquiring and interpreting information and gaining knowledge. Cognitive function is comprised of 
domains (attention/concentration, language, visuospatial skills, psychomotor skills, executive 
functions, memory and orientation) that describe specific components required for adequate 
information acquisition/interpretation. Cognitive function is discussed in this document with a 
particular focus on the domains of executive function and memory.  
Arterial stiffness: A term referring to the material properties of the blood vessels that carry 
blood away from the heart (i.e. arteries). Arteries are naturally elastic and stretch when the heart 
ejects blood into the vessel. With aging and disease, 
the arteries lose elasticity (i.e. increase in stiffness) and 
this effects how blood flow and is delivered to tissues 
and organs transmitted throughout the body. This 
document focuses on large artery stiffness, particularly 
at the level of the carotid artery and aorta. 
Hemodynamics: Derived from heme, meaning blood, and dynamics, referring to the motion of 
objects under the action of external forces. Thus, hemodynamics is an encompassing term used 
to describe the movement of both blood pressure and blood flow throughout the body. Blood 
pressure and blood flow represent two separate forces. Blood pressure and blood flow travel at 
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different speeds throughout the body and are altered by different factors. When the heart 
contracts, the pressure created (energy) is what propels the liquid medium (blood) forward (i.e. 
downstream). A note for this study – blood pressure and blood flow do not travel in one 
direction. Blood pressure and blood flow can move backward. In some settings, backward 
traveling blood pressure and blood flow can be detrimental to health.  
Hemodynamic pulsatility: Refers to a specific pattern in which blood flow or pressure is 
delivered to the body. When the amount blood flow/pressure is somewhat constant from when 
the heart contracts to when the heart relaxes, it is considered non-pulsatile (i.e. continuous; 
there is not much difference between maximum and minimum flow/pressure). This continuous, 
non-pulsatile blood flow is ideal for working organs like the brain and kidney. When the amount 
of blood flow/pressure is highly variable from heart contraction to relaxation it is considered 
pulsatile (i.e. discontinuous; high amounts of blood flow/pressure after heart contraction, very 
low blood flow/pressure after heart relaxation). Discontinuous, pulsatile blood flow can damage 
fragile tissue and blood vessels in organs like the brain and kidney. See figure 2.3 for visual 
representation.  
Neurovascular coupling (NVC): Describes the increase in blood flow to the brain that is 
required to support neural activity during cognitive engagement (i.e. thinking). This increase in 
blood flow is required to deliver oxygen and fuel to, and remove waste from, the working brain 
cells.  
Vascular aging: A broad concept that describes the natural changes in vascular structure and 
function that accompany natural aging. This concept is often used to describe “accelerated 
vascular aging” that accompanies certain conditions/diseases (such as hypertension), whereby 
some individuals exhibit changes associated with “old age” but at a much younger age owing to 
the biological effects of a condition or chronic disease.   
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Non-Technical Summary 
What is known? 
High blood pressure (i.e. hypertension) is a key, treatable risk factor for the development 
of chronic diseases that impact the heart and brain. High blood pressure damages the brain 
over time, thereby contributing to cognitive decline (characterized by the loss of higher-order 
decision making and slowing of processing speed). Changes in artery structure and function can 
influence the development of hypertension and accelerate cognitive decline. The stiffening of 
large arteries is one underlying cause of high blood pressure and also contributes to detrimental 
changes in brain blood flow that impair brain health/function in adults with hypertension.  
Exercise is recommended to improve cardiovascular and brain health in adults with 
hypertension, however the effects of exercise on the arteries and brain in this population is 
somewhat unclear. Aerobic exercise may affect the stiffness of the arteries differently in adults 
with hypertension compared to those without. Moreover, it is unknown if aerobic exercise 
improves cognitive function in adults with hypertension. Thus, this study sought to examine the 
effect of a single bout of aerobic exercise on artery stiffness and brain blood flow (aim 1), and 
cognitive function (aim 2) in adults with controlled-hypertension and without hypertension.  
What is new and noteworthy from our results? 
Aim 1: Arterial stiffness and pulsatile (i.e. discontinuous) blood flow in the brain increased post-
exercise in middle-aged adults with, and without, hypertension. We additionally noted that the 
increases in pulsatile (i.e. discontinuous) blood flow were modest considering the increases in 
vascular contributors to pulsatile blood flow. That is, we would have theorized much larger 
increases in pulsatile blood flow in the brain given the changes in blood pressure and arterial 
stiffness. This may indicate that the brain is somewhat resilient to short-term changes in 
pulsatile blood flow in middle-aged adults, even in the presence of hypertension.  
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Aim 2: Cognitive function improved post-exercise in middle-aged adults with, and without, 
hypertension. Improvements in cognitive function manifested as accelerated processing speeds, 
where participants were able to respond to executive function and memory tasks significantly 
faster (measured by reaction time). We are the first to document that a single bout of exercise 
facilitates processing speed in adults with hypertension. This broadly suggests that the brain’s 
ability to respond to an exercise bout and improve processing speed is undisturbed by the 
presence of hypertension.  
The findings from Aim 1 and 2 indicated that adults with hypertension exhibited similar vascular 
and cognitive responses to exercise as those without hypertension. The similar responses to 
exercise may stem from groups having similar health status. Indeed, both adults with, and 
without hypertension were physically active, had similar age, body fat, sleep quality, and low 
levels of depression. Additionally, our adults with hypertension had well controlled blood 
pressure and cholesterol (i.e. no longer markedly elevated on average). Cumulatively, this data 
indicates that when well-matched for health status, adults with hypertension respond similarly to 
exercise.  
This led us to pursue an exploratory Aim 3 that examined if the vascular contributions to 
cognitive function differed between adults with hypertension to those without. Increases in brain 
activity (i.e. while thinking during a cognitive task) depend on complimentary changes in blood 
flow to deliver nutrients to working brain cells. Thus, the vascular system must deliver adequate 
blood flow and continuous (i.e. non-pulsatile) to support brain activity. The presence of 
hypertension may impair the vascular system’s ability to deliver adequate, and continuous (i.e. 
non-pulsatile), blood flow required to support brain activity. 
Aim 3: Blood flow and arterial stiffness increased, and pulsatile blood flow decreased, during 
cognitive activity in both adults with, and without, hypertension. Additionally, both groups 
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achieved similar oxygen delivery to working areas of the brain during cognitive activity. We 
noted that reductions in pulsatile blood flow (i.e. making blood flow more continuous) was 
associated with greater brain oxygenation during cognitive activity. This suggests that the 
presence of hypertension does not impair the vascular system’s ability to increase blood flow to 
the brain during times of increased brain activity, and that reducing pulsatile blood flow may be 
an important vascular response to ensure brain oxygenation during cognitive activity.  
Implications 
Our data largely suggest that proper use of physician-prescribed blood pressure medication and 
lifestyle factors (such as physical activity) may help attenuate detrimental vascular and cognitive 
changes that typically accompany hypertension. Moreover, adequate blood pressure control in 
hypertension may normalize vascular reactivity to perturbations such as acute exercise and 
cognitive activity such that they become similar to adults without hypertension. These data 
underscore the importance of hypertension management to slow vascular and cognitive decline 
in middle-aged adults.  
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Chapter I: Introduction 
Hypertension (HTN) is among the leading causes of death in the US, affecting one third 
of adults >20 yrs of age (≈80 million Americans) [1]. HTN is preceded and exacerbated by 
increases in arterial stiffness [2]. As such, adults with HTN routinely have higher arterial 
stiffness than their normotensive counterparts [3-7]. Increased arterial stiffness impairs the 
central vasculature’s ability to dampen fluctuations in pressure and flow, which affects blood 
flow delivery to target organs. Indeed, arterial stiffness affects cerebral blood flow to the brain [8] 
which ultimately governs cognitive function [9,10]. HTN with concomitant changes in arterial 
stiffness is recognized as a key risk factor in the vascular pathogenesis of cognitive decline, 
dementia, and Alzheimer’s disease [11]. Additionally, arterial stiffness in mid-life predicts 
cognitive decline later in life [10] and is a stronger predictor of cognitive decline than blood 
pressure in HTN [12].  
Aerobic exercise is recommended by the American College of Sports Medicine and 
American Heart Association to combat HTN [13,14] and is a potent and safe means to protect 
against age-related declines in cardiovascular health [15] and cognitive function [16,17]. Aerobic 
exercise reduces blood pressure, reduces arterial stiffness, improves cerebral perfusion, and 
enhances cognitive performance both acutely [18-21], and chronically [15,22-27] in most healthy 
and clinical populations. The favorable effects of exercise on vessel stiffness have been directly 
linked to improved cerebrovascular function [22,25,27],  and protection against age-related 
cognitive decline [16,17,28-30]. However, upon closer inspection of the literature, it becomes 
apparent that the hypertensive adult may not experience the same vascular benefits in 
response to exercise as other populations. A recent meta-analysis of 14 trials in 472 adults 
found that aerobic exercise training does not reduce arterial stiffness in adults with HTN [31]. 
That is, aerobic exercise may not be able to de-stiffen the large central arteries in HTN [32-34]. 
Moreover, hypertensives experience an increase in arterial elastance (a proxy of arterial 
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stiffness) during aerobic exercise [35] owing to underlying endothelial/autonomic dysfunction 
and an exaggerated pressor response [31]. This begs the question: is aerobic exercise an 
efficacious therapeutic strategy to improve cerebrovascular and cognitive health in those with 
HTN?  
The effect of exercise on cognitive function in HTN remains largely unexplored. We have 
also been unable to identify any studies investigating the acute effects of aerobic exercise on 
arterial stiffness, cerebral perfusion, or cognitive function in adults with HTN. Acute responses to 
exercise predict training responses [36], indicating that a detailed characterization of the acute 
response may provide insight into what may ultimately govern chronic adaptations.  
The specific aims of the proposed study are as follows:  
Specific Aim 1: Compare the effects of acute aerobic exercise on central artery stiffness and 
cerebral perfusion between middle-aged adults with and without hypertension. 
Hypothesis 1: Adults with hypertension will experience differential vascular responses to 
exercise compared to adults without hypertension, manifesting as decreased arterial stiffness 
and increased cerebral perfusion in adults without hypertension and unaltered arterial stiffness 
and reduced cerebral perfusion in adults with hypertension following acute aerobic exercise.  
Specific Aim 2: Compare the effects of acute aerobic exercise on cognitive function between 
middle-aged adults with and without hypertension. 
Hypothesis 2: Adults with hypertension will experience differential cognitive responses to 
exercise compared to adults without hypertension, manifesting as increased cognitive function 
(faster reaction time, higher accuracy on executive function and memory tasks) decreased 
cognitive function in adults with hypertension following acute aerobic exercise  
The results from this study will help elucidate if aerobic exercise is an effective stimulus 
to improve cerebrovascular and cognitive function in adults with hypertension. If aerobic 
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exercise does not improve cerebrovascular or cognitive function, other types of exercise (i.e. 
high-intensity interval) or exercise-lifestyle-pharmacological combinations may be needed to de-
stiffen the arteries and improve cerebrovascular/cognitive health in this at-risk population. Thus 
this initial study will set the groundwork for an important and exciting line of future investigations. 
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Chapter II: Review of Literature 
Hypertension (HTN) is a medical disorder marked by high arterial blood pressure 
(defined as systolic pressure ≥140 and/or diastolic pressure ≥90 mmHg) that effects roughly 
33% of adults >20 years of age [1]. The prevalence of HTN is expected to increase to 42% by 
the year 2030 and increase total cost of high blood pressure to $274 billion, nearly a 500% 
increase from the $46 billion spent in 2011 [1]. Aside from the financial burden of this condition, 
the persistent elevation of blood pressure and its long-term sequelae ultimately increase the risk 
of chronic diseases. In fact, HTN is one of the most pervasive modifiable-risk factors for 
cardiovascular disease (CVD) and stroke [37-39], making it a prime target for preventive 
treatment. Successful treatment of HTN, however, is often complex, owing to its multifaceted 
etiology.  
 
Pathogenesis of HTN 
HTN is a complex disease that may develop from multiple mechanisms. For this reason, 
the initiating factor may not be discernable, particularly as the disease advances and results in 
additional, compensatory pathological changes [40]. In its simplest model, blood pressure is 
dependent on the interaction between the heart and vasculature. Specifically, blood pressure is 
Figure 2.1: Prevalence 
of high blood pressure in 
adults ≥20 years of age 
by age and sex (National 
Health and Nutrition 
Examination 
Survey: 2007–2012). 
HTN defined as systolic 
blood pressure ≥140 mm 
Hg or diastolic blood 
pressure ≥90 mm Hg, if 
tak ing anti-HTN 
medication, or if told >2 
occasions that they had 
HTN. Source: 
Mozaffarian et al. 2015 
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the product of the amount of blood ejected by the heart (cardiac output, Q) and the resistance to 
blood flow that originates from the periphery (total peripheral resistance, TPR) [40]. Any 
alteration in factors impacting this relationship may alter blood pressure. The pathogenesis of 
HTN is further complicated by numerous contributing factors (i.e. genetics, diet/sodium intake, 
obesity, insulin resistance etc.) that can interact with one another and influence any of the major 
pathological pathways leading to HTN. A summary of the main arbiters of HTN is provided in 
Figure 2.2.  
Sympathoexcitation (1) 
Acute increases in blood pressure are typically sensed by stretch receptors located in 
the carotid and aortic bodies known as baroreceptors (BR). An increase arterial pressure 
stretches the vessel walls, stimulating the BR and resulting in afferent signals to the 
cardioregulatory center in the brain [41]. This results in activation of the parasympathetic (and 
Figure 2.2: Factors contributing to the pathogenesis of hypertension including: sympathoexcitation 
(1), k idney dysfunction (2), and systemic vascular structure and function (3). 
Q, cardiac output; TPR, total peripheral resistance; SV, stroke volume; HR, heart rate; Na, sodium; AT 
II, Angiotensin II; Aldo, aldosterone; SNS, sympathetic nervous system; BR, baroreceptor; BRS, 
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inhibition of the sympathetic) system, thereby increasing vagal tone, reducing heart rate, 
vascular resistance, and ultimately restoring blood pressure to normal levels [41]. If the 
elevation in blood pressure is sustained, however, the BR sensitivity is reset [42], leading to 
blunted cardio-vagal responses to elevated BP [43] and enhanced sympathoexcitaion. One 
hypothesis for the pathogensis of HTN is that increased sympathetic outflow (resulting from 
reduced BR sensitivity) perpetuates HTN through cardiac excitation and hyperkinetic circulation 
[40,44]. Alternatively, the increase in sympathetic outflow may be of neural origin and mediated 
through reduced BR sensitivity [45]. Ultimately, hyperkinetic circulation has been identified 
among pre-hypertensives, suggesting that sympathoexcitation may be an early factor in the 
development of HTN [44].  
Kidney dysfunction (2) 
Sympathoexcitation may also effect the kidneys which function as the long term 
regulators of blood pressure. Renal sympathetic nerves innervate the kidneys and can result in 
the release of renin, activating the renin-angiotensin-aldosterone system (RAS) [41]. Renin 
initiates the generation of angiotensin II which acts to increase blood pressure through 
peripheral vascular vasoconstriction, fluid resorption, and sodium resorption via adrenal 
aldosterone release [41,46]. Alternatively, kidney dysfunction may occur separate from 
sympathoexcitation. Disrupted renal hemodynamics may result in isolated ischemic nephrons in 
the kidney, resulting in chronic low-levels of renin release that activate the RAS pathway [40]. 
Additionally, impaired pressure natriuresis may play a role in maintaining long term elevations in 
blood pressure [40,47]. In a normally functioning kidney, pressure natriuresis occurs in response 
to elevated blood pressure, resulting in sodium and water excretion, thereby reducing blood 
volume, cardiac output, and blood pressure. Disrupted pressure natriuresis may result in 
blunted sodium excretion, preventing pressure from returning to normal levels and resulting in 
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long term elevated blood pressure [40]. Together, changes in kidney function likely play a role in 
the development and maintenance of HTN.  
Systemic vascular structure and function (3) 
The peripheral vasculature controls the resistance to blood flow. Any functional or 
structural factor that increases resistance will result in an equivalent increase in pressure. The 
vasculature modulates vessel diameter to alter resistance. Any decrease in peripheral vessel 
diameter will increase TPR and blood pressure since resistance is inversely related to vessel 
diameter. The ability of the vasculature to increase its diameter (vasodilate) is largely dependent 
on the endothelium. The endothelium functions to maintain vascular homeostasis and generate 
vasodilator substances such as nitric oxide [48]. The vascular etiology of HTN may be related to 
endothelial dysfunction, arising from increases in oxidative stress [49] that disrupts nitric oxide 
signaling [48]. Impaired nitric oxide generation in HTN [50] would render the vasculature prone 
to vasoconstriction, increasing TPR and contributing to elevated blood pressure.  
Vessel diameter and resistance may also be altered by vascular structure. Vessel 
remodeling can result in vascular hypertrophy. This type of remodeling is marked by a 
thickening of the arterial walls which may reduce the internal diameter of the vessel and 
increase resistance and blood pressure [51]. The Law of Laplace (tension = [pressure x 
radius]/wall thickness), states that increases in wall thickness can offset increases in pressure to 
normalize the forces exerted on the artery wall (tension) [52]. This mechanism is considered the 
primary biological signal governing vascular remodeling in HTN [53]. Importantly, HTN-mediated 
increases in wall thickness modify the structural and mechanical properties of the arterial wall 
and results in increased arterial stiffness [54]. Typically, changes in vascular structure 
(remodeling and increased stiffness) are viewed as consequences, rather than harbingers, of 
HTN that prevent long term reductions in blood pressure [40]. Recent data however, has begun 
to highlight a growing role of arterial stiffness in the pathogenesis of HTN.  
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Arterial stiffness and hypertension 
Arterial stiffness refers to the material properties of the artery wall and their functional 
ability to expand and recoil, dampening the amplitude of fluctuations in pressure and flow [55]. 
The buffering of the mechanical forces generated by cardiac pulsations is critical in converting 
pulsatile hemodynamics into continuous blood flow in the capillaries [56]. The stiffness of the 
vessel varies based on its wall composition which changes throughout the arterial tree. Central 
arteries (i.e. aorta, carotid) have greater elastic components (less stiff) compared to 
peripheral/muscular arteries (i.e. brachial) which contain less elastin and more vascular smooth 
muscle (more stiff) in order control blood flow distribution [57,58]. The elastic, central arteries 
are instrumental in converting pulsatile blood flow to more continuous, laminar (i.e. smooth) 
flow, thereby preventing transmission of excess energy into target organs [9]. The increase in 
pressure generated with each ventricular 
contraction is buffered by the elastin and 
collagen components of the arterial walls, with 
elastin and collagen engaging at low and high 
distention/pressure, respectively [55]. Elastin is 
progressively degraded and fragmented with 
increasing age due to the unrelenting pounding 
of arterial blood pressure that accumulates over 
time [59,60]. As elastin degrades, the buffering 
capacity of vessel shifts to the collagen fibers 
which is 100-1000 times stiffer than elastin [61]. 
This reliance on collagen fibers results in a stiffer 
artery and greater pulsatile hemodynamics (i.e. greater fluctuations in systolic pressure/flow vs 
diastolic pressure/flow; Figure 2.3) that are transferred downstream into end-organs [62]. 
Figure 2.3: Blood flow pulsatility in theory 
(A), and in practice (B)  
Adapted from Heffernan KS  
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Arterial stiffness, and thus hemodynamic 
pulsatility [56], increases across the life span 
(Figure 2.4), the progression of which, 
appears accelerated in those at-risk for, or 
diagnosed with HTN.  
Adults with HTN have been 
consistently documented to have higher 
arterial stiffness than their normotensive 
counterparts [3-7]. The widely held belief is 
that increased arterial stiffness is merely a 
manifestation of HTN [2,55,63]. Indeed, 
elevated arterial pressures alone will shift the 
pressure load burden to collagen, increasing arterial stiffness [64]. In this manner, HTN can 
give-way to stiffer central arteries. Recent data, however, challenges the assertion that stiffness 
is a consequence of HTN; reports now suggest that changes in central artery stiffness precede 
changes in blood pressure and predict the development of HTN later in life [6,7,65-69]. Thus, 
increased central artery stiffness has been proposed as a possible cause for the development of 
HTN [2]. Data from large, community-based longitudinal studies has been complimented by 
data from animal-models documenting changes in arterial stiffness prior to changes in blood 
pressure and the development of HTN [70-72]. The exact mechanism through which arterial 
stiffness contributes to the development of HTN has yet to be elucidated but it may occur 
through alterations in baroreceptor, kidney, and endothelial function.  
The role of arterial stiffness in the pathogensis of HTN may occur through multiple 
pathways (Figure 2.5). Elevated indices of arterial stiffness have been linked to impaired BR 
sensitivity [73-76] which may give-way to excessive sympathoexcitation and development of 
Figure 2.4: Arterial stiffness and pulsatile blood 
flow across the life-span. Red solid – pulsatile 
blood flow in the brain; Black  solid – arterial 
stiffness; Blue dashed – effects of aerobic 
exercise training. 
Adapted from McEniery et al. 2005, tarumi et al. 
2014, and Frank lin et al. 2013. 
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HTN. Increased arterial stiffness is also tightly 
linked to kidney damage [77-81] and chronic 
kidney disease [82,83]. Stiffness-mediated 
increases in pulsatile hemodynamics may disrupt 
kidney dysfunction by creating pockets of 
nephron ischemia which have been separately 
suggested to increase renin release and RAS 
activation [40]. Arterial stiffness and the 
concomitant increase in pulsatile hemodynamics is 
also associated with endothelial dysfunction 
[84,85]. In this manner, increased arterial stiffness may be the underlying cause of HTN through 
its effects on the baroreceptors, kidney, and endothelium.  
Consequences of hypertension  
HTN is unequivocally linked to increased cardiovascular disease risk [86] and 
widespread target organ damage (TOD), including the heart, kidney, and eye [87]. Indeed, 
elevated blood pressure is associated with left ventricular hypertrophy,[88,89] heart failure 
[90,91], kidney disease [92], and vascular retinopathy [93,94]. Although elevated blood pressure 
is unquestionably a major factor contributing to HTN-mediated TOD, evidence suggests other 
mediators, such as arterial stiffness, are likely involved. Arterial stiffness is strongly associated 
with left ventricular hypertrophy [95-97], heart failure [98-101], and kidney disease [77,82,83]. 
Additionally, arterial stiffness and its sequelae appear to play a large mechanistic role in the 
detrimental effects of HTN on one of the most important target-organs; the brain.  
Hypertension and the brain 
The brain is a high-flow target organ that is particularly vulnerable to HTN-mediated 
vascular dysfunction and arterial stiffening that accelerates cerebral aging. Vascular “function” is 
Figure 2.5: Role of arterial stiffness in the 
pathogenesis of hypertension. 
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a term used to describe if blood vessels have the ability to respond or “react” normally to a given 
perturbation [26]. In the case of the brain, cerebrovascular function often refers to whether or 
not the cerebral vessels provide adequate perfusion at rest and during periods of increased 
demand (such as neural activity). Any reduction in function (i.e dysfunction) may result from 
damage to the vascular endothelium (via inflammation, oxidative stress, etc.) or from changes in 
vessel wall structure (i.e. remodeling) [26]. The brain’s natural aging process alters both 
cerebrovascular structure and function. Reductions in cerebral capillarization and increased 
tortuosity of white matter vessels reduce resting cerebral blood flow (CBF), attenuate 
cerebrovascular reserve, and impairs the vessels ability to modulate diameter to prevent hyper- 
or hypo-perfusion (termed autoregulation) with normal aging [102-104]. The presence of HTN, 
however, potentiates these age-related changes and reduces the cerebrovascular blood flow 
response to a hyperemic stimulus [105], and impairs autoregulation [106]. Disturbed 
autoregulation may weaken the brain’s defenses against excessive arterial pressure and may 
render the brain more vulnerable to HTN-mediated damage [11]. 
Chronic exposure to high blood pressure is associated with wide-spread structural 
damage. HTN is associated with brain atrophy that occurs by both the potentiation of the natural 
aging processes and by independent, HTN-specific mechanisms [11]. A clear relationship exists 
between HTN and markers of cerebral damage, including microinfarcts [107] and white matter 
hyperintensities (WMH) [108,109], a manifestation of cerebral small vessel disease [110,111]. 
WMH progression is associated with HTN [112] and may mediate the relationship between HTN 
and cognitive decline [113]. The length of time that the cerebrovasculature is exposed to high 
blood pressure (BP) may be a key factor in determining the severity of damage [114] which 
appears strongly linked to arterial stiffness [115]. Increases in arterial stiffness reduce the 
arterial buffering capacity and alter cerebral hemodynamics. Indeed, increased arterial stiffness 
results in greater cerebral hemodynamic pulsatility [116,117] and hypoperfusion [8], 
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consequently altering brain structure and function. Greater arterial stiffness is associated with 
brain atrophy [118,119] and cerebral small vessel disease [120-124]. Ultimately, HTN and 
arterial stiffness-mediated cerebrovascular damage has functional consequences for the brain 
and results in accelerated cognitive decline.  
Hypertension and cognition 
Cognitive decline is regarded as one of the most important determinants of health, 
function, and quality of life with advancing age [125]. The medical, social and economic burden 
of cognitive decline is substantial. The worldwide cost of dementia was estimated at $421 billion 
in 2009 and the number of demented elderly is expected to increase to 63 million by 2030. 
Cognitive function is generally divided into 7 domains including: attention/concentration, 
language, visiospatial skills, psychomotor skills, executive functions, memory and orientation 
[126]. Executive function is an expansive term describing the high-level interrelated cognitive 
abilities, dependent on lower-level functions, which are necessary to complete goal-directed 
behavior [127,128]. There is some debate as to the specific components that comprise 
executive function, but information processing, attentional control, cognitive flexibility, and 
working memory have all been acknowledged as playing a role [126-128]. Description of the 
cognitive domains and tests that have been used to target them are displayed in Table 1.  
Although cognitive decline is one aspect of natural brain aging, the presence of HTN and 
its neurocognitive consequences accelerate brain aging [11], resulting in mild cognitive 
impairment, dementia, and Alzheimer’s disease [11], As such, HTN is recognized as an 
important modifiable risk factor for cognitive decline by AHA [129] and others [130-133] and 
disease [134,135]. HTN is associated with, and predicts, risk of cognitive impairment 
[133,134,136-138] and cognitive performance [12,132,139-143], particularly when coupled with 
additional co-morbidities [144-146]. These associations are detected as early as mid-life, as 
individuals with elevated mid-life systolic blood pressure have an increased likelihood of 
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developing mild cognitive impairment and dementia [131,147,148]. The majority of studies on 
cognition among hypertensives have focused on executive function and memory processing, 
documenting impaired performance in adults with HTN [3,114,140]. Ultimately, these negative 
effects of HTN on cognitive function reflect accelerated cerebral aging brought on by the 
vasculature [11].  
Arterial stiffness is associated with cognitive decline [149-152], dementia [149,153], and 
Alzheimer’s disease [154,155]. The effects of arterial stiffness on cognitive function appear to be 
mediated by cerebrovascular damage [115]. Cerebral pulsatility, stemming from arterial 
stiffness, is additionally associated with cognitive impairment and predictive of dementia in at 
risk individuals [156]. The association of arterial stiffening, subclinical brain injury, and cognition 
has been detected as early as middle-age [157], and independent from stroke or dementia 
[158], indicating that arterial stiffness may be an ideal target to slow the progression of 
neurovascular disease and cognitive decline. As such, recent reviews suggest arterial stiffness 
has the to be a potential indicator for clinicians to identify adults in need of treatment to 
prevent/delay dementia [152]. This is an area of burgeoning interest, as >20 studies, including 
meta-analyses, have been published in recent years linking stiffness to cognition 
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[10,22,30,118,149,151,158-176]. These data suggest that increased central artery stiffness may 
be one of the harbingers of cognitive decline among hypertensives. In fact, changes in arterial 
stiffness are a stronger predictor of cognitive decline among hypertensives than changes in 
blood pressure [12]. Therefore, arterial stiffness could be an important therapeutic target and 
vital missing link in the successful treatment of HTN and HTN-mediated cognitive decline. 
Treatment of hypertension 
Due to HTN’s complex etiology, there is no single, comprehensive treatment that 
addresses all causes of HTN. Medications often target the major components of blood pressure, 
targeting the kidneys (diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor 
blockers, renin inhibitors and mineralocorticoid receptor antagonists) and cardiac 
sympathoexcitation (β-adrenergic blockers, calcium channel blockers) [177]. Many of these anti-
hypertensive medications reduce overall blood pressure and improve cardiovascular outcomes, 
as seen with the 1970s efforts to control HTN, which has been cited as an important contributor 
to the recent reductions in strokes mortality [1]. Despite some success and recent advances in 
care, however, the medical community has been challenged by other secondary consequences 
of HTN, particularly cognitive decline [11].  
The length of time that the brain is exposed to elevated blood pressure likely dictates the 
degree of cognitive decline early and effective treatments are required. Thus, mid-life targeted 
interventions may serve as a “last chance” to intervene before long term exposure to high blood 
pressure causes irreversible target organ damage and cognitive impairment [157,178]. 
Unfortunately, the effect of anti-hypertensive therapy alone on cognitive decline is unclear 
[11,179,180] and may not consistently reduce the risk of cognitive decline [181-183], suggesting 
that contributing factors beyond blood pressure alone may be responsible for cognitive decline 
in this population. Indeed, although many anti-hypertensive drugs target successfully target 
some contributors to peripheral resistance and cardiac output, few anti-hypertensive drugs have 
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consistently and directly target central artery stiffness. Indeed, drug treatments that reduce 
brachial blood pressure in hypertensives do not consistently reduce vessel stiffness [13,14,184]. 
This may be of particular importance since inability to reduce vascular stiffness beyond the 
effects on brachial blood pressure predicts clinical outcome [185]. The null effect of HTN 
treatment on arterial stiffness may explain the inconsistent effectiveness of anti-hypertensive 
therapy on cognition, particularly since stiffness is more related to cognition than blood pressure 
among hypertensives [12]. For these reasons finding an additional means to target central 
artery stiffness, attenuate the burden of HTN, and prevent cognitive decline is of the utmost 
importance. 
Exercise as a preventive intervention  
Prevention is a core concept in to reduce the burden of CVD and its co-morbidities like 
cognitive decline. Governing bodies like the American Heart Association (AHA) recommend that 
interventional studies beginning as early as midlife are necessary to prevent or postpone the 
onset of cognitive impairment [16]. Mid-life interventions aimed to prevent late-life cognitive 
decline and preserve independence are therefore imperative to reduce the burden of cognitive 
diseases in an ever-growing sect of the US population [11]. Regular aerobic exercise is 
recognized as the most pluripotent and effective means to maintain cardiovascular health [15] 
and mental longevity [186-188]. Exercise is as effective, if not more effective, than most drug 
interventions across a variety of disease treatments (i.e. heart failure, diabetes, stroke) [189], 
thereby supporting the idea that exercise is medicine [190,191]. For these reasons, aerobic 
exercise is highly recommended by the American College of Sports Medicine (ACSM) and AHA 
to maintain cardiovascular and brain health and prevent vascular-cognitive impairment [192-
194].  
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Exercise and the brain 
Numerous investigations have examined the acute effects of aerobic exercise on 
cognition, across a variety of domains. The findings of any individual study appear variable, 
likely stemming from methodological differences in cognitive domains examined, tasks used, 
metrics of cognitive performance (reaction time, accuracy, sum score), exercise 
duration/intensity, and participant population [20,195]. Interpretation of exercise-cognitive data is 
further complicated by research design regarding the timing of cognitive testing since cognitive 
responses to exercise are different if measured during exercise, immediately following, or 
delayed-following exercise [20,195]. Meta-analytical investigations, however, have found that 
acute exercise does improve executive function [20,195-198], and may impact memory 
[20,195], particularly following moderate to vigorous exercise.  
With regards to chronic exercise (i.e. training), both epidemiological and experimental 
studies have consistently shown that physical activity and regular aerobic exercise improves 
brain health and may act as a primary prevention for cognitive decline [28]. Data from meta-
analyses, clinical trials, and cohort-based studies all indicate physical activity reduces the risk of 
dementia and preserves cognitive function with age [199-202]. Similar patterns are observed 
with regards to exercise training specifically, rather than global physical activity. Cross-
sectionally, higher levels of regular exercise are associated with reduced risk of cognitive 
decline and Alzheimer’s disease [203]. Prospectively, higher cardiorespiratory fitness in early 
life predicts better cognitive function 25 years later [204]. Cognition is also improved among 
elderly populations with and without dementia who undergo exercise training interventions 
[17,205-208].  
The exact mechanism behind the beneficial effects of exercise on the brain are yet to be 
fully understood. Improvements are likely related to changes in neural function, brain structure, 
and vascular adaptations [26,209,210]. Exercise may improve neural function through direct 
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modulation of neurotrophic factors such as brain-derived neurotrophic factor, nerve growth 
factor, and insulin-like growth factor-1 which increase following exercise training [210-214]. 
These neurotrophic factors have been linked to improved neural plasticity [215], neuroprotection 
[216], and neuronal growth [213], and likely play a role in improving cognitive function [210,213]. 
Additionally, exercise alters brain structure, evident by attenuations of age-related brain atrophy. 
Higher levels of physical activity and aerobic exercise training are associated with greater brain 
volume [217,218] and lower plaque deposits in the brain (a marker of Alzheimer’s disease) 
[219]. Aerobic exercise training has been shown to reduce risk of age-related atrophy and 
increase brain volume [220]. Changes in brain volume must be accompanied by improvements 
in cerebrovascular perfusion if these changes are expected to facilitate function. Thus, while a 
myriad of adaptations accompany exercise training and may impact the brain [28], there is 
growing body of literature linking vascular to brain function, suggesting the vasculature may be 
an emerging moderator of exercise’s effects on the brain.  
Exercise and arterial stiffness 
Although arterial stiffness increases with age [221-223], aerobic exercise consistently 
elicits beneficial effects on the vasculature, including reductions in both blood pressure and 
central artery stiffness [18,19,224]. Similar reductions in stiffness and blood pressure are noted 
following aerobic exercise training [15,24,225-227]. Given the growing connection between the 
vasculature and brain it would be expected that exercise-mediated reductions in arterial 
stiffness would elicit improvements in cerebrovascular hemodynamics. Aerobic exercise is 
cross-sectionally associated with improved cerebral blood flow [25] and cerebrovascular 
reactivity [25,27]. Moreover endurance-trained adults have lower central artery stiffness, greater 
cerebral perfusion, and greater cognitive performance compared to their sedentary counterparts 
[22]. Changes in cerebrovascular hemodynamics likely support changes in brain structure and 
function. Exercise training increases region-specific cerebral blood volume, which is further 
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associated with improvements in cognitive performance [228]. Additionally, exercise training 
increases neural and cerebral hemodynamic (i.e. neurovascular) connectivity at rest [229] and 
during periods of increased neural activation (i.e. cognitive tasks) [230]. Taken together, these 
data suggest that exercise-induced improvements in arterial stiffness may favorably impact 
cerebrovascular hemodynamics at rest, and during neural activity, thereby improving cognition.  
Exercise and hypertension 
AHA [13] and ACSM [14] recommend 
aerobic exercise for adults with HTN to lower 
blood pressure and maintain cognitive health [16]. 
Despite the established body of literature linking 
elevated blood pressure to diminished cognitive 
function, exercise to improved cognitive function, 
and exercise to reduced blood pressure /stiffness 
(Figure 2.6), there is a paucity of data on the 
effect of exercise on cognitive function in adults 
with HTN. In fact, a recent review article on exercise 
and cognitive function in human HTN relied primarily on rodent-model research [231]. Moreover, 
this review did not include the only studies conducted in humans on the topic, which noted no 
beneficial effects of aerobic training on cognition in HTN [232,233]. Other data in adults with 
type II diabetes reported reductions in cognitive performance following an exercise/lifestyle 
intervention that were only shown in participants with co-morbid HTN [234]. Although limited by 
a small number of studies, the ineffectiveness of exercise in improving cognition may be related 
to differential vascular responses to exercise.  
Unlike normotensive individuals, acute exercise in hypertensives elicits increases in 
arterial elastance (a proxy measure of arterial stiffness) during exercise [35], and does not alter 
Figure 2.6: Publications related to cognitive 
function indexed by PubMed. 
 
19 
 
arterial stiffness following acute exercise [235]. Chronically, aerobic exercise training does not 
de-stiffen the arteries of hypertensives, as recently described by a recent meta-analysis of 14 
trials in 472 adults [31]. Additionally, cross sectional investigations note that cardiorespiratory 
fitness is not associated with lower stiffness among hypertensives [236]. It is possible that 
chronic exposure to high blood pressure may reduce the arteries ability to adapt to exercise 
training, rendering the vessels unable to de-stiffen [237]. This has particular significance for 
cognitive function since arterial stiffness is a stronger predictor of cognition than blood pressure 
among hypertensives [12]. While some of these data are limited by indirect proxies of stiffness 
(i.e. elastance), which is insensitive to hemodynamic load [238], these data suggest that the 
effects of aerobic exercise on vascular and cognitive function likely differ for adults with HTN 
compared to healthy or other clinical populations. Since acute exercise responses predict 
chronic responses to training [36] we wish to investigate the acute cerebrovascular and 
cognitive responses to aerobic exercise in adults with HTN. 
Proposed study 
The aim of the proposed 
study is to compare the effects 
of acute aerobic exercise 
between middle-aged adults 
with and without HTN on 1) 
central artery stiffness and 
cerebral perfusion and 2) 
cognitive function. It is 
hypothesized that acute 
exercise will result in differential 
vascular and cognitive responses in 
Figure 2.7: Theoretical model and anticipated responses to 
acute exercise between adults with hypertension (red arrows) 
and adults without hypertension (green arrows). 
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adults with compared to without HTN. Specifically, we posit that acute exercise will reduce 
artery stiffness and increase cerebral perfusion in adults without HTN, while arterial stiffness will 
be unaltered and cerebral perfusion reduced in adults with HTN. Further, we believe that 
compared to adults without HTN, adults with HTN will have decreased cognitive function 
following acute aerobic exercise, manifesting as slower reaction times and reduced accuracy on 
executive function and memory tasks (Figure 2.7). 
Significance/Relevance 
Prevention is key if we hope to achieve improve the long-term cardiovascular health of 
Americans and reduce the burden of cognitive decline. Adults aged >65 years represent the 
fastest growing demographic in the US [239] (accounting for >20% of the US population by 
2020) [240] and this growing population will change the demographic landscape to that of an 
aging society where chronic disease prevention is critical. Roughly 70% of middle-age adults 
already enter their sixth decade with ≥1 chronic condition that will impair overall quality of life, 
increase healthcare costs, and pose additional burden on society [241,242]. As such, mid-life 
interventional studies aimed to prevent late-life cognitive decline and preserve independence 
are imperative to reduce the burden of cognitive diseases in an ever-growing sect of the US 
population [11]. Aerobic exercise is recommended by governing bodies [13,14] for adults with 
HTN to lower blood pressure and to maintain cognitive health [16]. Aerobic exercise, however, 
does not reduce large artery stiffness in hypertensives [34], which is a stronger predictor of 
cognitive decline than blood pressure in this population [12]. This phenomena, coupled with the 
virtual dearth of studies investigating the effects of exercise on cognition in adults with HTN, 
requires further scrutiny. Understanding how acute aerobic exercise effects the large central 
arteries, cerebrovasculature and subsequently cognitive function in middle-aged adults with 
HTN may equip us with better tools to prevent stroke, neurovascular disease, and attenuate 
cognitive decline as these at-risk adults enter their golden years.  
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Innovation 
Traditional investigations of cognition in this field assess function for a given cognitive 
task by using simple pen-and-paper tasks or by interpreting any combination computerized 
data, including; 1) accuracy (correct stimuli divided by total stimuli), 2) number of stimuli correct 
(sum score) or 3) processing speed/RT for correct trials. While these methods provides some 
insight into cognition, it can lead to mixed conclusions where change in one parameter (i.e. 
slower RT) may indicate a processing deficit, whereas preservation of accuracy may suggest 
the contrary. While pen-and-paper tasks do not account for behavioral aspects of decision-
making like RT, assessing only accuracy and RT still leaves many questions unanswered. This 
is because various cognitive processes may contribute to RT and the ability to correctly respond 
to a task.  
Drift-diffusion modeling (DDM) is a descriptive mathematical approach which can be 
used to decompose observational data (hits, misses, RTs) into latent processes [243-246] (for 
theoretical basis of mathematical modeling in decision-making and cognitive neuroscience see) 
[247]. In essence, DDM describes what changes in the underlying decision-making process 
elicit a given observed response. DDM utilizes all available behavioral data (accuracy, 
correct/error RTs, shape of correct/error RT distributions) rather than focusing solely on RT for 
correct trials and accuracy in attempts to describe the observed data. This modeling technique 
can provide insight into whether changes in cognition (observed through accuracy and RT) are 
due to neurological (i.e. encoding, motor response) or behavioral (i.e. caution, response bias) 
changes in the underlying decision-making process. Although this technique has not been 
previously used to interrogate cognition in hypertensives or in the exercise literature at-large, it 
has been successful in explaining the slowing of RT with advancing age [248,249] and effects of 
hypoxia on cognition during exercise [250]. Thus, DDM holds significant potential to provide 
insight into changes in cognition with hypertension and exercise. 
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Chapter III: Preliminary Data 
The student PI has lead multiple projects (as PI) examining racial differences [251], and 
underlying contributors to arterial stiffness [252]. Additionally, the PI has investigated arterial 
stiffness, and cognitive/cerebrovascular function at the population level [253] and following a 
variety of perturbations (including exercise [254,255], environmental stress [256,257], and 
dietary nitrate supplementation [257,258]). The PI has been involved in research in the Human 
Performance Laboratory throughout his MS/PhD and is familiar with all physiological and 
behavioral measures described in the methodology and preliminary data section. In acquiring 
these measurement skills the PI has personally collected data in 680 of the estimated 760 
participants (age range, 9-89 yrs old) that have participated in HPL studies over the past 6 
years. 
The vascular response to acute high-intensity (aerobic or resistance) exercise is 
markedly different than that of aerobic exercise. Vessels stiffness tends to transiently 
increase following high-intensity exercise and it is debated 
whether this is a beneficial or detrimental response. We 
have documented acute increases in arterial stiffness and 
hemodynamic pulsatility following acute resistance 
[254,255] (and high intensity cycling exercise) [259] that is 
buffered prior to reaching cerebral arteries (ophthalmic 
artery [Figure 3.1], and 
MCA [Figure 3.2]) in 
healthy, young adults. 
Additionally, we found 
exercise-induced 
increases in central load 
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Figure 3.2: Carotid stiffness and MCA pulsatility at baseline (BL) and post 
resistance exercise. *p<0.05 vs BL. Lefferts et al. 2014 
Figure 3.1: Ophthalmic artery pulsatility at 
baseline (BL), control, and post resistance 
exercise. Lefferts et al. 2015 
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(exercise-induced ∆carotid stiffness) was associated with lower resting left ventricular function 
(assessed as left ventricular fractional shortening, r=-0.437, p=0.045) in healthy men, which was 
undetected by traditional peripheral hemodynamics (∆brachial systolic pressure vs fractional 
shortening, r=-0.256, p=0.169) [260]. 
 There is a growing link between vascular 
hemodynamics and cognitive function. Our laboratory 
has investigated this relationship under normal 
physiological conditions [261-263] as well as during acute 
hypoxia, an environmental stimulus similar to what may 
occur locally in the brain secondary to HTN and arterial 
stiffening. We investigated whether nitrate ingestion could 
improve vascular and cerebral function, and attenuate decrements in cognitive function in 
hypoxia. We found that hypoxia alone unloaded the heart and was not further effected by nitrate 
supplementation [258]. With regards to cerebrovascular and cognitive function, acute hypoxia 
reduced memory performance, but did not alter the change in middle cerebral artery (MCA) 
blood flow during cognitive activity (i.e. preserved neurovascular coupling; Figure 3.3) [257]. 
Nitrate ingestion in our study did not further impact the cerebrovascular or cognitive responses 
to hypoxia. 
After initial investigations into the relationship between cerebrovascular and cognitive 
function at rest in hypoxia, my recent doctoral work has expanded to incorporate exercise in 
such an environment. We then sought to investigate whether changes in cerebral perfusion 
during cognitive activity were preserved during exercise in hypoxia among 30 healthy men and 
women [250]. Although MCA flow increased with exercise, there were no further changes with 
additional cognitive activity (Figure 4). Pfc oxygenation was reduced during hypoxic vs normoxic 
exercise, but increased during cognitive activity in both conditions (Figure 3.4), indicating 
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specific increases in oxygenation in areas involved in 
executive function. Cognitive function was tested using 
Flanker, N-back and memory recognition tasks (as 
described previously in Methods). No changes in N-back 
performance or response speed were observed. 
Cognitive performance (accuracy) was maintained for 
Flanker and memory tasks during hypoxic exercise 
despite slower reaction times (RT; memory data 
depicted in Figure 3.5A,B). We further interrogated our 
behavioral data using DDM (as described previously). 
We noted the slowing of RT observed during exercise 
was related to significant increases in caution in hypoxia 
compared to normoxia (Figure 3.5D), rather than 
changes in the other components of RT (such as 
encoding/motor response, assessed by non-decision 
time; Figure 3.5C). Taken together, our data support 
the extracranial vasculature’s role in modulating 
cerebral hemodynamics, which may impact cognitive 
function. 
  
  
Figure 3.5: Memory performance during 
normoxic and hypoxic aerobic exercise. 
*p<0.05 vs normoxia 
Figure 3.4: Cerebral perfusion during 
normoxic/hypoxic exercise (mean±SE).  
*p<0.05 vs normoxia; ǂp<0.05 vs previous 
time-point 
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Chapter IV: Effects of Acute Aerobic Exercise on Arterial Stiffness and Cerebrovascular 
Pulsatility in Adults With and Without Hypertension 
 
 
Abstract 
Stiffer central arteries, as seen in hypertension (HTN), foster transmission of pulsatile 
hemodynamics into fragile cerebral vessels. Aerobic exercise is recommended for adults with 
HTN, but its effects on arterial stiffness and pulsatility in this group are unclear. Objectives: 
This study sought to investigate the effect of acute aerobic exercise on arterial stiffness and 
cerebrovascular pulsatility in 30 adults with treated HTN and 30 age, sex, and body mass index 
(BMI)-matched adults without HTN (56±6 yrs, BMI 28.2±2.9 kg/m2; 28 women). Methods: 
Subjects underwent hemodynamic measures pre/post 30-min cycling (≈55% peak oxygen 
consumption). Aortic stiffness was measured using carotid-femoral pulse wave velocity (cf 
PWV) and carotid artery stiffness was assessed with β-stiffness via Ultrasound. Aortic/carotid 
pulse pressure (PP; aortic via radial generalized transfer function) was measured by tonometry 
and calibrated to brachial mean (MP) and diastolic pressure. Carotid/middle cerebral artery 
(MCA) blood velocity pulsatility index (PI) were measured using Doppler. Carotid wave intensity 
analysis was used to derive forward wave intensity (W1). Results: Exercise impacted 
hemodynamics similarly in HTN compared to no-HTN. cf PWV, MCA PI, carotid PI, and W1 
increased similarly post exercise in both groups (p<0.05). Carotid PP and β-stiffness were 
unaltered post-exercise. Post-exercise changes in W1 were positively associated with carotid PI, 
which was further associated with MCA PI. Conclusions: These data suggest adults with 
treated HTN experience similar increases in aortic stiffness and cerebrovascular hemodynamic 
pulsatility during early recovery from acute aerobic exercise as their counterparts without HTN.  
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Introduction 
Nearly 20% of the US population is between the ages of 50 and 64; a group considered 
middle-aged adults by the Center of Disease Control, AARP, and American Medical 
Association. As recognized by the National Institutes of Health, this growing population will 
change the demographic landscape to that of an aging society where chronic disease 
prevention is critical. Roughly 70% of middle-age adults already enter their sixth decade with ≥1 
chronic condition that will impair overall quality of life, increase healthcare costs, and pose 
additional burden on society [241,242]. Hypertension (HTN) is one such chronic condition that 
represents a leading cause of disability and death in the US, affecting ≈33% of adults >20 yrs of 
age (≈80 million Americans) [1].  
Although the etiology of HTN is multi-factorial, HTN is preceded and exacerbated by 
increases in arterial stiffness [2,69]. As such, adults with HTN individuals routinely have higher 
arterial stiffness than their normotensive counterparts [4]. Increased arterial stiffness impairs the 
central vasculature’s ability to dampen fluctuations in pressure and flow, affecting perfusion of 
target organs [9,55,264]. Indeed, arterial stiffness increases pulsatile hemodynamics in the brain 
[8] which ultimately damages brain structures. Specifically, cerebrovascular pulsatility is 
associated with greater prevalence of subcortical infarct [9], and white matter volume [9], 
integrity [265] and lesions [56]. As such, HTN, with concomitant changes in arterial stiffness and 
pulsatile hemodynamics, is recognized as a key risk factor in the vascular pathogenesis of 
dementia and Alzheimer’s disease [11].  
 Aerobic exercise is recommended by the American Heart Association and American 
College of Sports Medicine to combat hypertension [13,14] and is a potent and safe means to 
protect against age-related declines in cardiovascular health and brain function. Aerobic 
exercise reduces blood pressure, reduces arterial stiffness, and improves cerebral perfusion 
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both acutely [18,19,21], and chronically [22,25,27] in most healthy and clinical populations. The 
favorable effects of exercise on vessel stiffness have been directly linked to improved 
cerebrovascular function [22,25,27]. However, upon closer inspection of the literature, it 
becomes apparent that adults with HTN may not experience the same vascular benefits in 
response to exercise as other populations. A recent meta-analysis of 14 trials in 472 adults 
found that aerobic exercise training may not reduce arterial stiffness in adults with HTN 
independent of substantial changes in blood pressure [31]. That is, aerobic exercise may not be 
able to de-stiffen the large central arteries in hypertension [32-34]. Indeed, acute aerobic 
exercise has been shown to have no effect [235] or possibly increase large artery stiffness in 
HTN [35,266]. How large artery responses to acute exercise impact cerebral hemodynamic 
pulsatility in HTN is currently unknown. Understanding how modulation of large artery stiffness 
alters intracranial hemodynamics following an acute stress such as aerobic exercise is 
important considering that 1) HTN are widely recommended to engage in aerobic exercise 
[13,14], 2) intracranial pulsatility may be of extracranial origin whereby pulsatile energy 
originating from the heart is transmitted into downstream cerebrovascular beds [8,9], and 3) 
recent literature suggests that large extracranial arteries may be resistant to modification by 
aerobic exercise [34]. 
 The purpose of this study was two-fold: 1) to investigate the effects of acute aerobic 
exercise on large artery stiffness and cerebrovascular pulsatility in adults with HTN and adults 
without HTN (no-HTN), and 2) to examine extracranial contributions to intracranial 
hemodynamic pulsatility following acute aerobic exercise. It was hypothesized that 1) large 
artery stiffness and pulsatility would respond differently to exercise in adults with versus without 
HTN, evident by reductions post-exercise in adults without HTN but increases in adults with 
HTN and 2) exaggerated extracranial pulsatility would contribute to post-exercise intracranial 
pulsatility regardless of HTN status.  
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Materials and Methods 
Participants 
30 middle-aged adults with HTN (56 ± 6 yrs; 14 women) and 30 age-, sex-, and body 
mass index (BMI)-matched adults without HTN (56 ± 6 yrs; 14 women) were recruited for this 
study. This age range was selected because large artery stiffness and cerebral pulsatility 
increases precipitously after ≈50 years of age [221,264], making this age range a prime target 
for preventive research. Exclusion criteria included self-reported smoking, stroke, dementia, 
diabetes mellitus, previous cardiovascular events, pulmonary/renal/neurological disease, or 
recent head trauma (concussion). Additionally, participants were free from dementia (Montreal 
Cognitive assessment score ≤21), and depression (assessed using the Center for 
Epidemiologic Studies Depression [CESD] questionnaire). Hyperlipidemic, overweight (BMI 25-
30 kg/m2), and obese (BMI 30-35 kg/m2) individuals were not excluded due to the high 
prevalence of these risk factors within middle-aged adults (with and without HTN). Menopausal 
phase (pre-, peri-, post-menopausal) for female participants was documented according to 
STRAW+10 guidelines [267]. This study was approved by the Syracuse University Institutional 
Review Board and conformed to the standards outlined in the Declaration of Helsinki. All 
participants provided written informed consent prior to study initiation.  
All participants with HTN were previously diagnosed by a physician and undergoing 
treatment for HTN. Participants did not refrain from anti-HTN medication during testing owing to 
1) concern of rebound HTN, and 2) the medicated state is the “natural state” in which most 
adults with HTN exercise.  
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Study design 
Participants were tested over 3 separate visits: 1) an initial health screening, followed by 
7 days of at-home blood pressure measurement, 2) a familiarization visit and aerobic fitness 
test, and 3) an acute exercise visit.  
Health screening 
 Height and weight were measured using an electronic scale and stadiometer, 
respectively, and used to derive BMI. Body fat was determined using air displacement 
plethysmography (Bod Pod, Cosmed, Concord CA). Serum lipoproteins (total cholesterol, 
triglycerides, low- and high-density lipoproteins) and fasting plasma glucose were assessed 
using a validated point-of-care device via finger stick (Cholestech, Alere Medical) following an 
overnight, 12-hour fast and abstinence from caffeine, alcohol, and exercise.  
At-home measurements 
 Participants underwent 7 days of at-home blood pressure measures to confirm blood 
pressure status, in-line with American Heart Association recommendations [268], using an 
oscillometric device (BP786N, Omron Healthcare Inc., Lakeforest, IL). Participants were 
instructed to measure their blood pressure in duplicate twice per day (once in the morning, and 
once in the evening). Participants were excluded if they were not on blood pressure medication 
but had an average 7-day blood pressure suggestive of undiagnosed HTN (systolic pressure 
(SP) ≥135 mmHg and diastolic pressure (DP) ≥85 mmHg) [268].  
Familiarization and aerobic fitness test 
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 All participants were familiarized with all vascular measures to be used in the acute 
exercise visit prior to undergoing a cardiorespiratory fitness assessment. Cardiorespiratory 
fitness was assessed as peak oxygen intake (VO2peak) during a progressive exercise test on a 
cycle ergometer (Excalibur, Lode B.V., Gronigen, Netherlands) to volitional fatigue (cadence 
<40 RPM, or voluntary exercise cessation). VO2peak was measured via indirect calorimetry 
(TrueOne 2400, Parvo Medics) and determined by the highest 15-sec average obtained during 
exercise. VO2peak was considered achieved if 2 of the 3 following criterion were achieved: a) 
heart rate peak >85% age-predicted maximal heart rate (HR; 220-age), b) respiratory exchange 
ratio (RER) ≥1.10, c) plateau in HR and/or oxygen consumption with increasing intensity.  
Acute exercise visit 
 Participants were instructed to arrive >4-hours fasted, and abstain from non-essential 
medication (i.e. medication not prescribed for chronic conditions; allergy medication, nutritional 
supplements, NSAIDS), caffeine, alcohol, and exercise the day of the acute exercise visit. Time 
of day (morning) was standardized for all acute exercise visits. The acute exercise visit was 
conducted during the early follicular phase for pre- (n=2) and peri-menopausal (n=6) 
participants. Measurement periods were not standardized for amenorrheic (no menses for >3 
months; n=3) or post-menopausal participants (n=17).  
Participants underwent arterial stiffness and cerebrovascular hemodynamic measures 
pre and post a 30-min bout of moderate aerobic exercise. Pre-exercise cerebrovascular and 
cognitive testing occurred following 15 min of supine rest. Post-exercise measures were 
assessed approximately 10 min post in order to allow for instrumentation and avoid immediate 
recovery from exercise when hemodynamics are subject to rapid changes. This time point was 
chosen because we wished to understand the effect of exercise on large artery stiffness and 
pulsatility independent of blood pressure (i.e. after initial hemodynamic recovery but prior to 
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substantial post-exercise hypotension which may be altered by anti-hypertensive medication) 
[269]. All pre- and post-measures were assessed in the supine position.  
 
Acute exercise protocol  
Acute aerobic exercise consisted of 30 min of moderate-intensity cycling (≈55% 
VO2peak). This dose/intensity of exercise is recommended by governing bodies to promote and 
maintain health in adults <65 years of age [270], and lower blood pressure in HTN [14]. Oxygen 
consumption was assessed during two separate 5-min increments of the exercise period (min 5-
10, 20-25) in order to confirm that the exercise intensity was being optimally maintained. 
Measures 
Arterial stiffness  
Aortic stiffness was assessed using the “gold standard” carotid-femoral (c-f) pulse wave 
velocity (PWV). Blood pressure waveforms from the carotid and the femoral artery were 
captured with applanation tonometry (AtCor Medical, Sydney, Australia) over a 10-s epoch 
along with ECG for simultaneous R-wave gating. PWV was calculated using the time delay 
between the carotid/femoral waveforms and the transit distance between the carotid and 
femoral arteries. The time delay was assessed as the time from peak R-wave from 
simultaneous ECG gating to the foot of the corresponding pressure waveform. Distances from 
the carotid sampling site to the femoral artery were measured as straight lines with a tape 
measure to the nearest mm (and properly adjusted for the bi-directional nature of pressure 
propagation via subtracting the suprasternal notch – carotid distance from the suprasternal 
notch – femoral distance).  
Common carotid artery stiffness was measured using eTracking. The carotid artery was 
imaged below the carotid bulb using ultrasound (ProSound α7, Aloka, Tokyo, Japan) and a 7.5-
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10.0 MHz linear-array probe. The distance from the near wall to far wall lumen-intima interface 
is continuously traced using eTracking to create a distension waveform analogous to pressure 
waveforms [271,272]. Carotid distension waveforms were calibrated against carotid systolic and 
diastolic pressures obtained from applanation tonometry. At least 8 carotid waveforms were 
averaged to gain a representative average waveform. Regional β-stiffness was calculated as 
ln(PMax/PMin)/[(DMax - DMin)/DMin], where P and D correspond to pressure and diameter 
respectively, and Max and Min refer to maximum (systolic) and minimum (diastolic) values 
during the cardiac cycle.  
Cerebrovascular pulsatility 
Pressure pulsatility 
Brachial SP and DP were measured in duplicate via an automatic device on the 
participant’s non-dominant arm (BP786N, Omron Healthcare Inc., Lakeforest, IL). Pressures 
were taken in duplicate and averaged. If values differed by more than 5 mmHg, a third measure 
was obtained and the average of the 2 closest measures was used for subsequent analyses. 
Central pressures (aortic and carotid) were obtained via applanation tonometry. Aortic 
waveforms (estimated from radial waves using a validated generalized transfer function) and 
carotid pressure waveforms (obtained during the measurement of PWV, described above) were 
ensemble averaged to a single waveform for determination of aortic and carotid SP. Central 
pressure waveforms were calibrated to brachial mean pressure (MP) and DP. MP and pulse 
pressure (PP) were calculated as 1/3 SP + 2/3 DP and SP – DP, respectively. Augmentation 
index was calculated from central pressure waveforms as the difference between the early (P1) 
and late (P2) systolic peaks of the pressure waveforms to the total PP expressed as a 
percentage (P2 − P1/PP × 100) and standardized to a heart rate of 75 beats per min (AIx75). 
The rate of systolic pressure rise in the radial pulse (assessed as maximum dP/dt) was used as 
a surrogate measure of left ventricular contractility. 
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Blood velocity pulsatility 
Carotid artery hemodynamics were assessed using ultrasound and techniques 
described previously for carotid artery stiffness. Blood velocity pulsatility was measured using 
Doppler ultrasound with an insonation angle < 60° for all measures and sample volume 
manually adjusted to encompass the entire vessel. Carotid artery mean velocity was calculated 
with a semi-automated flow tracing software as: MnV = ∫ V(t) dt/FT, where ∫ V(t) dt is the 
velocity-time integral of the velocity waveform and FT is flow time. Carotid artery blood velocity 
pulsatility index (PI) was calculated as PI = (Vs-Vd)/ MnV, where Vs is peak systolic, Vd is 
diastolic, and MnV is mean velocity. All images were stored for later offline analysis by a single, 
un-blinded trained investigator. 
Middle cerebral artery (MCA) blood velocity was measured using Transcranial Doppler 
(TCD) using a 2-MHz transcranial probe applied to the left temporal window at a depth of 50-
65mm (as is commonly reported for MCA measurements) and secured using a headset in order 
to ensure optimal insonation angle/position during the testing period. All measurements were 
taken by a single, trained investigator at the same probe depth and position to ensure recapture 
of the same cerebral artery. MCA PI and MnV were calculated over a 6-s epoch in the same 
manner as previously described for the carotid artery PI and by a standard algorithm 
implemented on the device with use of a fast Fourier transform, respectively MCA 
hemodynamics were captured as 4 separate 6-s epochs that were subsequently averaged. 
Cerebrovascular resistance was calculated as MP / MCA MnV. End-tidal CO2 and respiration 
rate were assessed via capnography in order to account for the effects of respiration on cerebral 
hemodynamics.  
Contributors to cerebrovascular pulsatility 
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Additional novel measures of carotid artery hemodynamics were obtained to provide 
insight into contributors to cerebrovascular pulsatile energetics. Extracranial pulsatile energy 
transmission was measured via wave-intensity analysis combined with eTracking. Flow 
waveforms were assessed using range gated color Doppler signals averaged along the Doppler 
beam and combined with eTracking distension waveforms described previously for carotid 
artery stiffness. Wave intensity was calculated using time derivatives of blood pressure (P) and 
velocity (U), such that wave intensity = (dP/dt x dU/dt); the area under the dP/dt x dU/dt curve 
represents the energy transfer of the wave [273]. W1 is a forward travelling energy wave 
generated by the heart during early systole, accelerating flow and increasing pressure; the 
negative area (NA) occurring immediately following W1 is a backward travelling compression 
wave stemming from reflected waves from the periphery that decelerate flow but increase 
pressure. NA measured in the carotid has been suggested as a measure of cerebrovascular 
tone [274]. The reflection index was calculated as NA/W1. Time from ventricular depolarization 
(R-wave from concurrent ECG-gating) to arrival of W1 is akin to pre-ejection period and was 
used as an estimate of cardiac sympathetic modulation.  
Statistical analyses 
 All data are reported as mean ± standard deviation and statistical significance was 
established a priori as p < 0.05. Normality of distribution for variables was assessed qualitatively 
using histograms and Q-Q plots as well as quantitatively using the Shapiro-Wilk test. Non-
normally distributed variables were transformed to meet normality assumptions. Descriptive 
characteristics were compared using independent T-tests for continues variables and χ2 tests for 
categorical data. We examined vascular-hemodynamic parameters in no-HTN versus HTN 
groups across pre- and post-exercise time points using a 2x2 [2 group x 2 time] repeated 
measures ANOVA. Main effects of HTN status, exercise, and group x time interactions were 
further explored with Bonferroni corrected post-hoc tests. Repeated measures ANOVA’s were 
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repeated for cf PWV and Carotid/MCA PI while covarying for changes in variables known to 
effect outcome variables (MAP/heart rate, and ET-CO2, respectively). Associations between 
changes in arterial stiffness and hemodynamic pulsatility were examined using Pearson 
correlation coefficients.  
 Based on univariate associations, we used path analysis (SPSS, AMOS) to interrogate 
the theoretical model that changes in carotid diameter and forward wave intensity (W1) 
contributed to carotid blood velocity pulsatility, which further contributed to MCA blood velocity 
pulsatility. Model fit was quantified using the standard metrics of normal fit index (NFI), the 
comparative fit index (CFI), and the root mean square error of approximation (RMSEA). All 
analyses were performed using Statistical Package for the Social Sciences (SPSS, Version 24, 
IBM, Chicago IL).  
Results 
Group characteristics and baseline hemodynamics 
 Groups were well-matched for sex, age, anthropometrics, body composition, and lipid 
profile (Table 4.1). Groups primarily self-identified as white/Caucasian (No-HTN n=29; HTN 
n=26), with remaining subjects identifying as Black/African (No-HTN n=1; HTN n=4). Mean 
glucose was higher in HTN vs No-HTN (p<0.05), however this difference was not present when 
accounting for HTN participants on beta-blockers. No-HTN had higher mean cardiorespiratory 
fitness than the HTN group (p<0.05). Non-anti-hypertensive medication use was similar in both 
groups, with the exception of statin use, which was greater in HTN vs No-HTN (p<0.05).  
 HTN participants had been diagnosed with hypertension for an average of 10.8 ± 8.1 
years. The time of day that HTN participants took their anti-hypertensive medication (63.3% AM 
vs 33.0% PM) was not different within the group (p=0.095), with one participant taking 
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medication at both times of day. Combination therapy was used among 20% of the HTN group 
(n=7). Anti-hypertensive medication use is reported in Table 4.1. At-home blood pressure 
monitoring confirmed that 7-day average SP and DP were significantly higher in the HTN vs No-
HTN group (p<0.05; Table 4.2).  
 
Acute exercise 
 The mean intensity of the aerobic exercise bout was similar between groups for 
%VO2peak (No-HTN 57.6 ± 3.6% vs HTN 56.5 ± 3.5%, p>0.05) and %maximum heart rate (No-
HTN 69.7 ± 5.5% vs HTN 71.4 ± 7.3%, p>0.05). The mean absolute workload, however, was 
higher for No-HTN vs HTN (No-HTN 82 ± 43W vs HTN 63 ± 22W, p<0.05). Participants returned 
to the supine position to begin recovery within 27 ± 6 and 26 ± 6 sec following cessation from 
exercise for No-HTN and HTN groups, respectively. Post-exercise measures were initiated (No-
HTN 7.16 ± 0.42 min vs HTN 7.12 ± 0.39 min) and completed (No-HTN 12.12 ± 1.25 min vs 
HTN 11.96 ± 1.10 min) at similar times between groups (p>0.05).  
Effect of exercise on arterial stiffness 
 Significant time effects were detected for mean aortic, but not carotid, stiffness post-
exercise (Figure 4.1a, 4.1b). Aortic stiffness increased significantly from pre (no-HTN 7.9 ± 1.1 
m/s; HTN 8.2 ± 1.3 m/s) to post-exercise in both groups (no-HTN 8.1 ± 0.9 m/s; HTN 8.7 ± 1.5 
m/s). Increases in aortic stiffness remained after covarying for changes in MP (p<0.05), but 
were no longer significant after covarying for changes in heart rate. There was no change in 
carotid artery stiffness from pre (no-HTN 8.4 ± 2.4; HTN 8.4 ± 2.2) to post-exercise in either 
group (no-HTN 8.4 ± 2.2; HTN 8.9 ± 2.4). No other significant group or interaction effects were 
detected. 
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Effect of exercise on cerebrovascular pulsatility 
 Blood pressure, regardless of measurement site, was not different post-exercise 
compared to baseline for mean SP, DP, MP (Table 4.3; p>0.05). Time effects were detected for 
mean aortic PP which significantly decreased post-exercise (p<0.05) although no such effects 
were observed for brachial or carotid PP. DP was higher throughout testing in HTN vs no-HTN 
groups (p<0.05). Significant time effects were detected for mean carotid and aortic 
augmentation indices which decreased post-exercise (p<0.05).  
 MCA Blood velocities were not obtained for 1 individual due to a poor temporal window, 
thus results for MCA hemodynamics are presented for 30 no-HTN and 29 HTN. Time effects 
were detected for both mean carotid and MCA blood velocity PI which increased post-exercise 
in both groups (Figure 1c, 1d; p<0.05). Both groups experienced increases in carotid blood 
velocity PI from pre (no-HTN 1.43 ± 0.34; HTN 1.34 ± 0.26) to post-exercise (no-HTN 1.49 ± 
0.34; HTN 1.42 ± 0.26). MCA blood velocity PI increased from pre (no-HTN 0.78 ± 0.12; HTN 
0.76 ± 0.11) to post-exercise in both groups (no-HTN 0.82 ± 0.12; HTN 0.78 ± 0.11). Changes in 
carotid and MCA PI remained after covarying for changes in ET-CO2 (p<0.05).  
 Significant time effects were detected for mean HR, W1, NA, carotid mean diameter, ET-
CO2, and respiration rate (Table 4.4). Heart rate, W1 and NA increased, while carotid mean 
diameter decreased post-exercise in both groups (p<0.05). Minor, but significant, increases in 
mean respiration rate post-exercise were coupled with similar reductions in ET-CO2 in both 
groups (p<0.05). A significant interaction effect was observed for MCA MnV however, the minor 
changes in MnV were not significant after post-hoc Bonferroni adjustment for multiple 
comparisons. No other significant group or interaction effects were observed.  
Associations between arterial stiffness and hemodynamic pulsatility 
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 Correlation matrices for exercise-induced change in hemodynamics are displayed in 
Table 4.5. Of note, we observed significant positive associations between post-exercise 
changes in carotid stiffness and both aortic and carotid PP. Exercise-induced changes in PP 
were positively associated with changes in carotid forward wave intensity (W1). Post-exercise 
change in W1 and aortic/carotid PP were positively associated with change in radial dP/dt, while 
change in W1 and carotid PP were positively associated with carotid blood velocity PI. Post-
exercise change carotid blood velocity PI was further positively associated with changes in 
downstream MCA blood velocity PI. We noted significant negative correlations between 1) 
change in aortic/carotid AIx and change in carotid and MCA blood velocity PI; and 2) change in 
carotid mean diameter and carotid blood velocity PI.  
 Path analysis was used to explore the contribution of carotid hemodynamics to 
extracranial, and in-turn intracranial, pulsatile hemodynamics (Figure 4.2). Changes in carotid 
diameter and W1 significantly contributed to carotid blood velocity PI, which further contributed 
to downstream MCA PI. Our model was significantly better than the saturated model (Chi-
square=2.44, p=0.49) and fit the data well (NIF=0.92, CFI=1.00, RMSEA=0.00).  
Discussion 
 This investigation was designed to examine the effects of acute aerobic exercise on 
large artery stiffness and cerebrovascular pulsatility in middle-aged, adults with and without 
HTN. Our data suggest that acute moderate-intensity aerobic exercise increases aortic stiffness 
and cerebrovascular (carotid/MCA) blood velocity pulsatility during early recovery. Additionally, 
wave-intensity analysis indicates increases in forward wave energy, transmitted from a stiffened 
aorta into a constricted carotid artery, may be a primary contributor to post-exercise 
cerebrovascular pulsatility. These observations were not different between adults with and 
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without HTN, indicating that middle-age adults with HTN respond similarly to acute aerobic 
exercise as their age-matched counterparts without HTN.  
 Contrary to our hypothesis, middle-aged, adults with HTN had a similar hemodynamic 
response following exercise compared to their counterparts without HTN. The similar acute 
response may be related to similar health status between our groups. Despite a 5 ml/kg/min 
difference in VO2peak, groups had comparable traditional cardiovascular disease profiles, and 
body composition. Moreover, blood pressure of our adults with HTN was well-controlled 
according to at-home blood pressure values, a notable observation as controlling blood 
pressure has a favorable effect on the progression of arterial stiffening in the setting of HTN 
[275]. Our HTN group had a mean cf PWV (8.2 ± 1.3 m/s) comparable to that of normotensive 
adults in the Framingham Heart Study (mean age 58.2 ± 8.9 yrs, cf PWV 7.9 ± 1.4 m/s) [276]. 
Additionally, participants did not refrain from use of anti-HTN medication during testing, and this 
may modify how individuals respond to the physiological stress of acute exercise [269]. Whether 
vascular responses to acute exercise differ in a less healthy or untreated/uncontrolled cohort of 
adults with HTN remains unknown and an area of future interest.  
 We noted increased aortic stiffness during early recovery from acute aerobic exercise in 
HTN and No-HTN groups. This post-exercise aortic stiffening occurred without any change in 
distension pressure (i.e. MP) and remained following covariate adjustment for MP. Independent 
of changes in distension pressure, acute increases in aortic stiffness following submaximal 
exercise may be related to residual effects of exercise on heart rate. Indeed, the significant 
increase in aortic stiffness was attenuated when covarying for changes in heart rate post-
exercise, indicating that elevations in heart rate contributed to aortic stiffening post-exercise. 
Heart rate may exert a direct mechanical effect on the vessel wall. Increases in heart rate would 
shorten diastole, preventing complete wall recoil and thus stiffening the vessel [277]. Separate 
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from the direct mechanical effects, heart rate is an index of sympathetic activity which may 
directly modulate aortic stiffness [278].  
 There were no changes in carotid stiffness following exercise. Our observations of 
increases in aortic stiffness in the absence of change in carotid stiffness are in-line with previous 
studies in older adults with controlled HTN [235,266]. The disparate changes in carotid stiffness 
versus aortic stiffness post-exercise indicates that large arteries may recover from the 
hemodynamic insult of exercise differently. The exact mechanism underlying this observation is 
beyond the scope of this study, but may be due to differing wall composition (i.e. elastin, smooth 
muscle, collagen), or differential effects of sympathetic activation, myogenic tone, or hormonal 
modulation on the aorta versus carotid artery. Ultimately, differential changes in aortic versus 
carotid stiffness during early recovery from exercise may have altered pulsatile energy 
transmission.  
 Disproportionate increases in aortic compared to carotid stiffness during early recovery 
from exercise may alter input/characteristic impedance at the aorta-carotid interface, affecting 
transmission of pulsatile energy into cerebral vessels [9,222]. Using wave-intensity analysis, a 
novel method of appraising pulse wave dynamics [279], we were able to interrogate potential 
origins of post-exercise cerebrovascular hemodynamic pulsatility. We documented significant 
increases in carotid forward wave intensity (W1) post-exercise. The change in forward wave 
intensity is likely related to post-exercise elevations in left ventricular contractility [280] as we 
saw a significant positive relationship between radial dP/dt (a proxy of left ventricular inotropic 
function) and W1. Transmission of this forward wave energy may be further amplified in the 
presence of carotid vasoconstriction [281,282]. Ultimately, left ventricular-generation of 
forward wave energy [65] has been identified as a primary contributor to hemodynamic 
pulsatility [283,284]. Indeed, as the forward travelling wave increases in intensity, it augments 
systolic blood flow velocity [285] and increases blood velocity pulsatility. Indeed, we noted 
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increased extracranial blood velocity pulsatility at the level of the carotid artery which was likely 
propagated downstream, increasing MCA pulsatility post-exercise. The contribution of forward 
wave energy to extra- and intra-cranial pulsatility was corroborated by significant linear 
associations between the post-exercise change in forward wave intensity (W1) and carotid 
blood pressure/blood velocity pulsatility, which was in-turn associated with middle cerebral 
artery blood velocity pulsatility.  
 Forward traveling pulse waves are partially reflected by regions of impedance mismatch 
as they travel downstream. Pressure from wave reflections augment pressure but subtract from 
flow and may thus play an important role as modulators of hemodynamic pulsatility. Following 
exercise we noted that reductions in global wave reflections, as assessed via the augmentation 
index, were inversely associated with carotid and MCA flow pulsatility index. Consistent with 
previous suggestions by Mitchell, substantial reductions in extracranial pressure from wave 
reflections may reduce their contribution to PP while concomitantly allowing greater forward 
wave energy to enter the intracranial circulation and augment flow pulsatility [9,286]. 
Conversely, we noted increases in regional reflected wave intensity in the carotid artery as 
indicated by an increase in NA from wave-intensity analysis. Increased carotid wave reflection 
may stem from downstream changes in cerebrovascular tone [274] and serve to protect the 
brain from pulsatile hemodynamics. Thus, at any given moment, intracranial flow pulsatility may 
be influenced by the net balance between regional and global wave reflections.  
 Regular aerobic exercise is generally known to have beneficial effects on systemic 
vascular structure and function [15,22]. However, the data presented herein are somewhat 
counterintuitive. Increases in hemodynamic pulsatility after each bout of exercise would be 
inferred to harm the cerebral microvascular bed and increase cerebrovascular risk over time. 
First, we wish to underscore that with only modest increases in intracranial hemodynamic 
pulsatility following acute exercise, our data may indicate cerebrovascular “resilience” to 
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pulsatile forces incurred from acute exercise even among HTN, a group typically considered 
vulnerable to pulsatile burden [287]. Second, habitual exercise training is known to cause 
vascular remodeling [288,289]. Increased vessel diameter from exercise training may serve to 
offset impedance mismatches at the aorta-carotid interface, thereby minimizing transmission of 
pulsatile hemodynamic energy [290].  
Limitations and considerations 
 Our study is the first to examine the effects of acute submaximal exercise, at a dose 
typically recommended for adults with HTN, on gold-standard measures of arterial stiffness and 
cerebrovascular pulsatility in adults with well-controlled HTN and well-matched adults without 
HTN. We purposefully selected adults with controlled-HTN since this is their “free-living” state in 
which they would typically engage in exercise as a therapeutic intervention. As such, acute 
responses to submaximal exercise may differ in untreated HTN considering anti-HTN 
medications’ effect on blood pressure (and thus aortic stiffness) and cerebral arterial pulsatility 
[291,292]. It is possible that higher intensity exercise may elicit different effects although 
exercise intensity may not elicit greater changes in blood pressure in adults with HTN [293]. A 
recent meta-analysis suggests that post-exercise hypotension may be attenuated with anti-HTN 
medication [269] complicating interpretation of post-exercise changes in large artery stiffness 
between individuals with controlled-HTN and those without HTN. As such, we chose to 
interrogate the effect of acute exercise on arterial stiffness and hemodynamic pulsatility during 
early recovery, permitting us to identify potential group differences independent of differential 
alterations in blood pressure during prolonged recovery. Nonetheless, understanding post-
exercise hemodynamic recovery kinetics in HTN is of importance and future research is needed 
to identify the interactions between anti-HTN medication, post-exercise hypotension, and 
delayed effects of exercise on large artery stiffness and hemodynamic pulsatility. The 
contribution of early versus delayed recovery dynamics in governing chronic adaptations is 
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unclear, and requires additional research to fully elucidate the long-term implications of these 
acute responses. 
 In summary, our data indicate that acute, moderate-intensity aerobic exercise increases 
aortic stiffness and cerebrovascular hemodynamic pulsatility during early recovery from exercise 
in middle-aged adults with and without HTN. The increases in cerebrovascular pulsatility may be 
related to increases in forward wave propagation, coupled with carotid vasoconstriction and 
disparate changes in aortic and carotid stiffness and wave reflections. These data indicate that 
extracranial hemodynamic responses to a recommended dose/intensity of aerobic exercise 
contribute to intracranial hemodynamic pulsatility during early recovery from acute exercise. The 
increase in post-exercise intracranial pulsatility was modest despite exposure to an extracranial 
hemodynamic milieu that appeared primed to substantially increase intracranial pulsatility, 
potentially indicative of an apparent cerebrovascular “resilience” to pulsatile hemodynamics in 
our sample of middle-aged adults with well-controlled HTN and their counterparts without HTN. 
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Table 4.1: Descriptive characteristics for no-HTN and HTN groups (mean ± SD 
unless otherwise noted). 
  No-HTN HTN p-value 
Sex (male/female) 16/14 16/14 - 
Age (yrs) 56 ± 6 56 ± 6 0.93 
Anthropometrics    
Height (cm) 169.8 ± 11.3 171.3 ± 9.6 0.57 
Weight (kg) 82.0 ± 13.3 82.4 ± 12.5 0.91 
Body fat (%) 32.2 ± 8.4 31.4 ± 6.9 0.69 
Body mass index (kg/m2) 28.3 ± 2.6 28.0 ± 3.3 0.71 
Medications, %(n)    
Statin 6.7 (2) 40.0 (12) 0.005 
Birth control 3.3 (1) 0.0 (0) - 
Hormone replacement therapy 3.3 (1) 3.3 (1) - 
Hypothyroid 3.3 (1) 3.3 (1) - 
ACE inhibitor - 43.3 (13) - 
ARB - 33.3 (10) - 
Diuretic - 20 (6) - 
β-Blocker - 13.3 (4) - 
CCB - 13.3 (4) - 
Lipid profile    
Hemoglobin (g/dL) 14.2 ± 0.9 13.8 ± 1.3 0.12 
Total cholesterol (mg/dL) 202 ± 39 192 ± 36 0.28 
HDL (mg/dL) 58 ± 17 56 ± 20 0.56 
Triglycerides (mg/dL) 103 ± 61 116 ± 56 0.28 
LDL (mg/dL) 128 ± 41 114 ± 30 0.17 
Non-HDL (mg/dL) 144 ± 44 136 ± 32 0.43 
Total cholesterol:HDL  4 ± 2 4 ± 1 0.89 
Glucose (mg/dL) 94 ± 9 102 ± 16 0.03 
Fitness    
VO2max (mL/kg/min) 32.4 ± 8.8 27.2 ± 5.6 0.008 
ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; CCB, 
calcium-channel blocker; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
VO2max, maximal oxgyen consumption; MVPA, minutes of moderate-vigorous 
physical activity.  
 
 
  
45 
 
Table 4.2: 7-day average at-home brachial blood pressure measures in No-HTN 
and HTN groups (mean ± SD). 
  No-HTN HTN p-value 
SP (mmHg) 116 ± 9 126 ± 12 0.001 
DP (mmHg) 73 ± 6 79 ± 8 0.004 
PP (mmHg) 43 ± 8 47 ± 8 0.06 
Heart rate (b/min) 64 ± 8 68 ± 9 0.06 
SP, systolic pressure; DP, diastolic pressure; PP, pulse pressure.  
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Table 4.3: Effect of exercise on blood pressure and wave reflections in no-HTN and HTN groups (mean ± SD). 
  No-HTN HTN    
Measure Pre Post Pre Post G T GxT 
Brachial artery        
SP (mmHg) 122 ± 14 123 ± 10 127 ± 13 126 ± 13 0.23 0.54 0.19 
DP (mmHg) 76 ± 8 76 ± 6 81 ± 9† 81 ± 8 0.03 0.72 0.22 
MP (mmHg) 91 ± 9 92 ± 7 96 ± 10 95 ± 9 0.053 0.92 0.14 
PP (mmHg) 47 ± 11 47 ± 9 46 ± 8 45 ± 8 0.70 0.36 0.51 
Aorta        
SP (mmHg) 110 ± 12 110 ± 8 115 ± 12 112 ± 11 0.18 0.07 0.08 
PP (mmHg) 33 ± 9 32 ± 7 33 ± 7 30 ± 7 0.18 0.005 0.60 
AIx (%) 25 ± 12 20 ± 13 27 ± 9 21 ± 11 0.55 0.001 0.60 
AIx75 (%) 18 ± 12 16 ± 12 21 ± 10 19 ± 10 0.24 0.001 0.79 
Carotid artery        
SP (mmHg) 113 ± 13 113 ± 9 118 ± 13 116 ± 12 0.17 0.19 0.38 
PP (mmHg) 37 ± 10 36 ± 8 37 ± 8 35 ± 8 0.82 0.07 0.89 
AIx (%) 15 ± 20 0 ± 19 22 ± 15 5 ± 21 0.17 0.001 0.77 
AIx75 (%) 7 ± 20 -4 ± 18 15 ± 15 3 ± 21 0.10 0.001 0.94 
G, group effect; T, time effect; GxT, group-by-time interaction; SP, systolic pressure; DP, diastolic pressure; MP, 
mean pressure; PP, pulse pressure.  
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Table 4.4: Effect of exercise on vascular hemodynamics in no-HTN and HTN groups (mean ± SD). 
  No-HTN HTN    
Measure Pre Post Pre Post G T GxT 
Heart rate (b/min) 59 ± 10 68 ± 9 61 ± 8 71 ± 11 0.26 0.001 0.25 
Pre-ejection period (ms) 102 ± 15 99 ± 15 99 ± 11 96 ± 11 0.30 0.001 0.76 
ET-CO2 (mmHg) 35 ± 3 34 ± 3 35 ± 3 34 ± 3 0.93 0.007 0.76 
Respiration rate (br/min) 14 ± 4 16 ± 4 14 ± 3 15 ± 4 0.39 0.001 0.89 
dP/dt (mmHg/s) 643 ± 230 687 ± 214 630 ± 170 652 ± 182 0.62 0.06 0.51 
Carotid artery        
Mean diameter (mm) 5.67 ± 0.54 5.62 ± 0.56 5.55 ± 0.66 5.47 ± 0.65 0.35 0.008 0.62 
Mean velocity (cm/s) 35.2 ± 5.2 36.1 ± 4.9 37.5 ± 5.8 38.3 ± 7.0 0.11 0.10 0.99 
W1 (mmHg/m/s3) 7.4 ± 6.5 9.2 ± 5.4 6.8 ± 3.0 8.8 ± 4.8 0.68 0.001 0.82 
NA (mmHg/m/s2) 30.4 ± 26.5 34.5 ± 21.5 23.2 ± 10.4 26.6 ± 14.6 0.28 0.005 0.51 
NA/W1 (%) 4.35 ± 2.52 4.18 ± 2.43 3.59 ± 1.35 3.30 ± 1.34 0.17 0.29 0.67 
Middle cerebral artery        
Mean velocity (cm/s) 61 ± 15 62 ± 15 63 ± 11 62 ± 11 0.76 0.98 0.02 
Resistance (mmHg/cm/s) 1.58 ± 0.35 1.56 ± 0.39 1.58 ± 0.36 1.60 ± 0.36 0.71 0.99 0.27 
G, group effect; T, time effect; GxT, group-by-time interaction; ET, end-tidal; W1, forward wave intensity; NA, negative 
area; NA/W1; reflection index.  
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Table 4.5: Linear associations between change in hemodynamics pre to post exercise.  
  
Δcf 
PWV 
ΔCCA 
β 
ΔAO 
PP 
ΔCCA 
PP 
ΔAO 
AIx 
ΔCCA 
PI 
ΔMCA 
PI 
ΔCCA 
W1 
ΔCCA 
NA 
ΔCCA 
NA/W1 
ΔCCA 
AIx 
ΔCCA 
Diam 
ΔCCA β -0.110 
        
   
ΔAO PP -0.133 0.386 
       
   
ΔCCA PP -0.034 0.554 0.777 
      
   
ΔAO AIx -0.068 0.232 0.066 0.130 
     
   
ΔCCA PI -0.250 0.159 0.238 0.289 -0.294 
    
   
ΔMCA PI -0.240 0.164 0.259 0.171 -0.442 0.494 
   
   
ΔCCA W1 -0.136 0.008 0.295 0.322 -0.161 0.444 0.202 
  
   
ΔCCA NA 0.047 0.032 0.225 0.330 -0.013 0.285 0.050 0.550 
 
   
ΔCCA NA/W1 -0.104 0.049 0.092 0.063 -0.013 0.020 0.178 0.524 -0.372    
ΔCCA AIx -0.161 0.043 0.198 0.044 0.350 -0.180 -0.348 -0.112 -0.096 -0.246   
ΔCCA Diam 0.045 -0.091 0.071 -0.075 -0.102 -0.268 0.008 0.079 -0.082 0.001 0.106  
ΔdP/dt -0.076 0.210 0.789 0.501 -0.152 0.128 0.097 0.292 0.156 0.149 0.084 0.165 
 CCA, common carotid artery; AO, aortic; PWV, pulse-wave velocity; PP, pulse pressure; AIx, augmentation index; PI, 
pulsatility index; W1, forward wave intensity; NA, negative area; NA/W1, reflection index; Diam, diameter. Bold denotes 
p<0.05 
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Figure 4.1: Effect of acute exercise on a) Carotid and b) aortic PWV, and c) carotid and d) MCA 
blood velocity PI in no-HTN and HTN groups.  
PWV, pulse wave velocity; MCA, middle cerebral artery; PI, pulsatility index.  
a) Group, 0.44; Time, 0.26; Group-by-time, 0.38.  
b) Group, 0.08; Time, 0.001; Group-by-time, 0.22. 
c) Group, 0.36; Time, 0.001; Group-by-time, 0.53. 
d) Group, 0.31; Time, 0.003; Group-by-time, 0.51. 
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Figure 4.2: Path analysis demonstrating relationships between post-exercise changes in 
extracranial hemodynamics and intracranial pulsatility. 
W1, forward wave intensity; PI, pulsatility index. Values presented as unstandardized 
(standardized) coefficients, bold denotes p<0.05. 
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Chapter V: Effects of Acute Aerobic Exercise on Cognition and Constructs of Decision-making 
in Adults with and without Hypertension 
 
Abstract 
Hypertension (HTN) is associated with accelerated cognitive decline and dysfunction. Exercise 
is widely recommended for adults with HTN to slow cognitive decline, yet little data exists on 
exercise and cognition in HTN. Whether acute exercise improves cognitive function in this at-
risk population is unknown. The purpose of this study was to compare the effects of acute 
aerobic exercise on cognitive function in 30 middle-aged adults with HTN and 30 age, sex, and 
body mass index (BMI)-matched adults without HTN (no-HTN; 56±6 yrs, BMI 28.2±2.9 kg/m2; 
32 men). Subjects underwent cognitive testing pre/post 30-min cycling (≈55% peak oxygen 
consumption). Cognition was assessed using standard metrics of accuracy and reaction time 
(RT) across memory recognition, 2-Back and Flanker tasks. Behavioral data was further 
analyzed using drift-diffusion modeling to examine underlying components of decision-making 
(strength of evidence, caution, bias) and RT (non-decision time). Exercise elicited similar 
changes in cognitive function in both HTN and no-HTN groups (p>0.05). Accuracy was 
unaltered for Flanker and 2-back tasks, while hits and false alarms increased for memory 
recognition post-exercise (p<0.05). Modeling results indicated changes in memory hits/false 
alarms were due to significant changes in stimulus bias post-exercise. RT decreased for Flanker 
and memory recognition tasks and was driven by reductions in post-exercise non-decision time 
(p<0.05). Our data indicate acute exercise resulted in unaltered task accuracy and accelerated 
RT post-exercise in both middle-age adults with and without HTN. Additionally, drift-diffusion 
modeling revealed that beneficial acceleration of cognitive processing post-exercise (RT) is 
driven by changes in non-decision components (encoding/motor response) rather than the 
decision-making process itself. 
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Introduction 
Cognitive decline is regarded as one of the most important determinants of health, 
function, and quality of life with advancing age [125]. Hypertension (HTN) and its neurocognitive 
consequences accelerate brain aging [11], resulting in mild cognitive impairment, dementia, and 
Alzheimer’s disease [11]. HTN is associated with, and predicts, risk of cognitive impairment 
[133,134,136-138] and overall cognitive performance [12,132,139-142]. The cognitive domains 
of executive function (high-level interrelated cognitive abilities that integrate lower-level 
functions to complete goal-directed behavior [127,128]) and memory appear to be most 
vulnerable to HTN [3,114,140]. Associations between high blood pressure and cognitive 
dysfunction can be detected as early as mid-life, as individuals with elevated mid-life systolic 
blood pressure have an increased likelihood of developing mild cognitive impairment and 
dementia [131,147,148]. The length of time that the brain is exposed to elevated blood pressure 
likely dictates the degree of cognitive decline. Thus, mid-life targeted interventions may serve as 
a “last chance” to intervene before long term exposure to high blood pressure causes 
irreversible target organ damage and cognitive impairment [157,178].  
Regular aerobic exercise is recognized as the most pluripotent and effective means to 
maintain brain health and mental longevity [186-188]. As such, aerobic exercise is highly 
recommended by governing bodies [13,14] for adults with HTN to maintain cognitive health [16] 
and prevent cognitive impairment with advancing age [192-194]. Despite the established body 
of literature linking HTN to cognitive function, and exercise recommendations to improve 
cognitive function in HTN, there is a paucity of data on the effect of exercise on cognitive 
function in adults with HTN. Meta-analytical investigations in populations without HTN have 
shown that acute exercise improves executive function [20,195-197] and may positively impact 
memory [20,195]. Moderate to vigorous exercise appears to produce the most pronounced, 
beneficial changes in both executive function and memory [294]. Whether adults with HTN 
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experience acute improvements in executive function and memory performance following a bout 
of exercise has not been directly investigated but is of particular interest since these domains 
are sensitive to the detrimental effects of HTN [3,114,140]. 
  Traditional investigations of cognition and exercise assess function in a given cognitive 
domain by using simple pen-and-paper tasks or by interpreting a combination of computerized 
data metrics such as accuracy or processing speed/reaction time (RT) for correct trials. Greater 
accuracy is believed to reflect better functioning of the cognitive domain of interest (i.e. 
executive function, memory). Faster RT is posited to indicate improved functioning in the 
cognitive domain of interest since less time is required for the individual to respond correctly to 
the stimulus. This traditional analytical approach to studying cognition relies on reverse 
inference. For example, observing slower RT on an executive function task would be assumed 
to reflect a change in the cognitive process of interest (i.e. impaired executive function). 
Reverse inference in this setting is valid only if the changes in behavior (RT) are driven solely by 
executive function. There is substantial evidence, however, that factors independent of the 
cognitive process of interest, such as caution and bias, impact both RT and accuracy [295]. As 
such, observing slower executive function RT may actually reflect changes in caution (i.e. 
slower responses intended to preserve accuracy), rather than impaired executive function itself.   
Drift-diffusion modeling (DDM) is a mathematical approach that helps navigate this 
obstacle in cognitive testing (the theoretical basis of mathematical modeling in decision-making 
and cognitive neuroscience is described elsewhere [247]). In brief, DDM decomposes 
observational data (hits, misses, RT) into latent processes underlying decision-making, 
including caution, encoding and motor response duration, the strength and quality of evidence 
presented by the stimulus, and response bias (i.e. implicit or explicit preference for one 
response over another) [243-246,295]. Thus, DDM attempts to describe what changes in the 
latent decision-making process are responsible for the observed responses. DDM incorporates 
54 
 
all available behavioral data (accuracy, correct/error RT, shape of RT distributions) rather than 
solely relying on RT for correct trials and accuracy to describe changes in behavioral data. This 
modeling technique can provide novel insight into whether changes in cognition stemming from 
acute exercise (observed through accuracy and RT) are due to neurological (i.e. encoding, 
motor response) or behavioral changes (i.e. caution, bias) in the latent constructs of decision-
making. Although DDM has not been previously used to interrogate cognition in HTN or in the 
acute exercise literature at-large, it has provided insight into 1) the slowing of RT with advancing 
age [248,249], and 2) the effect of hypoxia on cognition during exercise [250], and holds 
significant potential to provide insight into changes in cognition with HTN and exercise.  
As such, the purpose of this investigation was to 1) compare the effect of acute aerobic 
exercise on cognitive function (using memory and executive function tasks) in middle-aged 
adults with (HTN) and without HTN (no-HTN), and 2) examine the effect of acute exercise on 
underlying constructs of decision making using DDM. It was hypothesized that acute exercise 
would differentially effect cognition in adults with versus without HTN, manifesting as improved 
cognition (manifesting as improved accuracy and accelerated RT post-exercise on executive 
function and memory tasks) in adults without HTN, while cognition would be unaltered by 
exercise in HTN. 
Methodology 
Participants 
30 middle-aged adults with HTN (56 ± 6 yrs; 14 women) and 30 age-, sex-, and body 
mass index (BMI)-matched adults without HTN (56 ± 6 yrs; 14 women) were recruited for this 
study. We targeted middle-aged adults because 1) cognitive decline can be detected as early as 
middle-age [296-298], making this age range a prime target for preventive research and 2) 
recent meta-analyses indicate this is an understudied group regarding acute exercise and 
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cognition [198]. Exclusion criteria included self-reported smoking, stroke, dementia, diabetes 
mellitus, obesity (BMI ≥30 kg/m2), previous cardiovascular events, pulmonary/ renal/neurological 
disease, or recent head trauma (concussion). Additionally, participants were free from dementia 
(Montreal Cognitive assessment score ≤21), and depression (assessed using the Center for 
Epidemiologic Studies Depression (CESD) questionnaire). Hyperlipidemic and overweight 
participants (BMI 25-30 kg/m2), were not excluded due to the high prevalence of these risk 
factors within middle-aged adults (with and without HTN). Menopausal phase (pre-, peri-, post-
menopausal) was documented according to STRAW+10 guidelines [267]. This study was 
approved by the Syracuse University Institutional Review Board and all participants provided 
written informed consent prior to study initiation.  
All participants with HTN were diagnosed and undergoing treatment for HTN. 
Participants did not refrain from HTN medication during testing owing to 1) concern of rebound 
HTN [299], and 2) the medicated state is the “natural state” in which most adults with HTN 
exercise.  
Height and weight were measured using an electronic scale and stadiometer, 
respectively, and used to derive BMI. Body fat was determined using air displacement 
plethysmography (Bod Pod, Life Measurement Inc., Concord CA). Serum lipoproteins (total 
cholesterol, triglycerides, low-density lipoprotein and high-density lipoprotein), and fasting 
plasma glucose were assessed using a validated point-of-care device via finger stick 
(Cholestech, Alere Medical) following an overnight, 12-hour fast and abstinence from caffeine, 
alcohol, and exercise.  
 Cardiorespiratory fitness was assessed as maximal oxygen intake (VO2max) during a 
progressive exercise test on a cycle ergometer to volitional fatigue (cadence <40 RPM). 
VO2max was measured via indirect calorimetry (TrueOne 2400, Parvo Medics) and determined 
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by the highest 15-sec average obtained during exercise. VO2max was considered achieved if 2 
of the 3 the following criterion were achieved: a) heart rate peak >85% age-predicted heart rate 
(HR) max, b) respiratory exchange ratio (RER) ≥1.10, c) plateau in HR or oxygen consumption 
with increasing intensity.   
Acute Exercise Design: 
Participants were instructed to arrive >4-hours fasted, and abstain from non-essential 
medication, caffeine, alcohol, and exercise the day of the visit. Time of day (morning) was 
standardized for the all acute exercise visits. Participants underwent cognitive measures pre 
and post a 30-min bout of aerobic exercise. Pre-exercise cognitive testing occurred following 
15-minutes of supine rest. Post-exercise measures were assessed approximately 10-min post 
because cognition may be negatively affected within the first 10 min post exercise [20]. All pre 
and post measures were assessed in the supine position.  
Acute exercise protocol:  
Acute aerobic exercise consisted of 30-min of moderate-intensity cycling (≈55-60% 
VO2max). This dose/intensity of exercise is recommended by the American Heart Association 
and American College of Sports Medicine to promote and maintain health in adults <65 years of 
age [270], and elicits positive effects on cognition post-exercise [20] in healthy adults. Oxygen 
consumption was assessed during two separate 5-minute increments of the exercise period 
(minutes 5-10, 20-25) in order to confirm and titrate the exercise intensity. 
Cognitive measures 
Cognitive function was assessed using a 15-min, 3-task computerized (Matlab, The 
MathWorks, Natick, MA; and PsychToolbox) cognitive battery (with a hand-held response 
clicker) that interrogates the attention (Flanker task) and working memory (N-back task) 
components of executive function, and memory (word recognition task). This battery of tasks 
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has been used by our group previously [250]. These domains were selected because they have 
implications for later-life cognitive function and are effected by HTN and acute exercise [20]. 
The battery always began with the word study list, followed by the working memory and 
executive function tasks in a randomized, counter-balanced order, followed by the memory 
recognition task. Each trial was preceded by verbal instructions and a visual reminder of each 
task and its respective goals, in addition to brief on-screen instructions prior to beginning each 
task once testing had begun. This multi-stage instruction process was designed to ensure 
participants recalled the goal of each task prior to initiation.  
Participants were familiarized with all cognitive tasks prior to the acute exercise visit to 
account for learning effects. Familiarization included point-by-point written and verbal 
instructions for each task, followed by a complete practice session of the cognitive battery. If 
participants did not adequately understand a task they were permitted to repeat the task until 
they were comfortable with the goals and procedures of the task.  
Executive function  
 The attention component of executive function was assessed using the standard Eriksen 
Flanker task. Participants were presented with 5 arrows (standard Eriksen Flanker task) and 
instructed to respond to which direction the middle arrow was pointing. This task contained 64 
congruent (i.e. all arrows facing the same direction; <<<<<) and 64 incongruent (i.e. flanking 
arrows facing different direction from middle arrow; <<><<) 1.5-s long trials (totaling 
approximately 5-minutes). Accuracy was expressed as percent hits and processing speed was 
assessed as mean hit RT for hit incongruent/congruent trials.  
 The working memory component of executive function was assessed using a 2-back 
number task. This task included 160 trials, lasting approximately 4 min. After fixating on 3 
crosses, participants were presented with a series of digits (1-9) at a rate of 1/s, with 
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consecutive numbers separated by 0.25 seconds. They were instructed to press the right 
response button if the number presented matched the number that was presented 2 numbers 
before (i.e. 4-7-4; this is the 2-back version of the N-back task) and press the left response 
button for all non-match stimuli. Accuracy was expressed as percent hits and commission errors 
(falsely identifying a number as a match), and processing speed was assessed as mean hit RT.  
Memory  
 Memory recognition was assessed by presenting participants with 36 words for 
memorization and later recognition from memory. The list contained 36 concrete words from the 
English language that are displayed for 1 s each. Participants then completed two cognitive 
tasks (flanker and N-back, randomized order) before beginning the memory recognition portion 
of the test (approximately 10 min later). To assess memory recognition performance, 
participants were presented with 72 words (36 distracters), at a rate of 1 every 2 s, and 
instructed to identify the words as “old” if they remembered the word from the study list or “new” 
if the word being presented was not on the study list. Accuracy was expressed as percent hits 
(correctly recalled items) and false alarms (old/studied items incorrectly identified as 
new/distractors). Mean reaction time (RT) for hits was calculated to assess processing speed.  
Drift-diffusion modeling  
 Drift-diffusion modeling (DDM) was conducted post-hoc on all cognitive performance 
data. This modeling technique can provide insight into whether changes in cognition are due to 
neurological (i.e. encoding) or behavioral (i.e. caution, bias) changes. DDM has been validated 
[300] and described in detail previously [243-245]. In short, the model assumes that decisions 
start at a point (z) and noisy evidence is sampled until a boundary (a/0) is reached, initiating a 
response (Figure 5.1). Wider distances between boundaries (a) indicate slower but more 
accurate responses (caution). Drift rate (v) indicates the strength of evidence (higher drift rate 
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means stronger evidence), and non-decision time estimates the duration of encoding/motor 
response. DDM parameters are summarized in Table 5.1.  
Statistical Analyses 
 All data is reported as mean ± standard deviation and statistical significance was 
established a priori as p < 0.05. Normality of distribution for variables was assessed qualitatively 
using histograms and Q-Q plots as well as quantitatively using the Shapiro-Wilk test. Non-
normally distributed RT and DDM metrics were transformed to meet normality assumptions. 
Descriptive characteristics were compared using independent T-tests for continues variables 
and χ2 tests for categorical data. We examined cognitive RT and DDM parameters in no-HTN 
versus HTN groups across pre- and post-exercise time points using a 2x2 [2 group x 2 time] 
repeated measures ANOVA. Group x time interactions were further explored with Bonferroni 
corrected post-hoc tests. All accuracy metrics (hit rates) were unable to be successfully 
transformed to meet assumptions, and were therefore analyzed using Mann-Whitney U-tests 
run to test the effect of time (pre- vs post-exercise), group (HTN vs no-HTN), and group by time 
interaction (change in accuracy post-pre for HTN vs no-HTN) with Bonferroni correction for 
multiple comparisons.  
Results 
Group characteristics 
 Groups were well-matched for sex, age, anthropometics, body composition, lipid profile, 
CESD score, and menstrual status (Table 5.2). Glucose was significantly higher in HTN vs no-
HTN (p<0.05), however this difference was abolished when accounting for HTN participants on 
beta-blockers. No-HTN had significantly higher cardiorespiratory fitness, accumulated minutes 
of MVPA (p<0.05), and tended to have greater total number of steps over 6 days (p=0.058). 
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Medication use was similar in both groups, with the exception of statin use which was greater in 
HTN vs no-HTN (p<0.05).  
Blood pressure status 
 Participants with HTN had been diagnosed with HTN for an average of 129 ± 97 months. 
The time of day that participants with HTN took their BP medication (63.3%, AM vs 33.0%, PM) 
was not different within the group (p=0.095), with one participant taking BP medication at both 
times of day.  
Acute exercise 
 The intensity of the aerobic exercise bout was similar between groups for %relative 
VO2max (no-HTN, 57.6 ± 3.6% vs HTN, 56.5 ± 3.5% p>0.05) and %maximum heart rate (no-
HTN, 69.7 ± 5.5 vs HTN, 71.4 ± 7.3 p>0.05). The absolute workload, however, was higher for 
no-HTN vs HTN (no-HTN, 82 ± 43W vs HTN, 63 ± 22W p<0.05).  
Post-exercise testing 
 Participants returned to the supine position within 27 ± 6 and 26 ± 6 seconds following 
cessation of exercise for no-HTN and HTN groups, respectively. Post-exercise cognitive testing 
was initiated at similar times between groups (memory study list, no-HTN, 12.12 ± 1.25 min vs 
HTN, 11.96 ± 1.10 min; Flanker, no-HTN, 16.14 ± 2.67 min vs HTN, 16.78 ± 4.00 min; 2-back, 
no-HTN, 17.05 ± 3.26 min vs HTN 16.74 ± 3.4 min; Memory, no-HTN, 24.27 ± 1.23 min vs HTN 
23.57 ± 2.34 min; p>0.05). The higher variability for post-exercise timing of Flanker and 2-back 
is related to the randomized, counter-balance design.  
Effect of exercise on accuracy and RT 
 Hand-held clicker malfunctions resulted in lost data for 2 no-HTN individuals on the 
Flanker task and 1 no-HTN individual on the 2-Back. Thus data are presented for n=28 and 29 
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for Flanker and 2-Back respectively among no-HTN. No significant group, time, or group-by-time 
effects were detected for accuracy as measured by hit rates on congruent/incongruent Flanker 
or 2-back (p>0.05; Table 5.3). Post-exercise commission errors on the 2-back were not 
statistically different compared to pre. A significant time effect was detected for memory hit rate, 
which significantly increased post-exercise in both groups (p<0.05; Table 5.4). This was 
accompanied by a significant time effect for false alarm rate, which also increased post-exercise 
(p<0.05). Significant time effects were detected for Flanker and Memory hit RT, which 
decreased post-exercise (p<0.05). There was a tendency for hit RT to decrease post-exercise 
on the 2-back although this did not reach statistical significance (p=0.06). No statistical effects 
for discriminability were detected. No group or group by time interactions were observed, 
indicating that 1) there were no inherent group differences in cognitive performance and 2) the 
effect of acute exercise on accuracy and processing speed were similar between HTN and no-
HTN individuals.  
Effect of exercise on constructs of decision-making 
 Significant time effects were detected for memory stimulus bias, and 2-back and 
memory non-decision time, all of which decreased post-exercise compared to pre (p<0.05). 
Similar effects were noted for the Flanker non-decision time post-exercise but this did not reach 
statistical significance (p=0.066). No significant group or group by time interactions were 
detected for DDM metrics, indicating that 1) there were no underlying group differences in latent 
processes of decision-making, and 2) the effect of acute exercise on latent processes of 
decision making were similar between HTN and no-HTN groups.  
Discussion 
 The first aim of this study was to compare the effects of acute exercise on cognitive 
function in middle-aged adults with and without HTN. Acute exercise did not alter accuracy, but 
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increased processing speed (decreased RT), on executive function and memory tasks post-
exercise in both HTN and no-HTN groups. The second aim of this investigation was to 
interrogate the effects of exercise on underlying constructs of decision-making (encoding and 
motor response duration [i.e. non-decision time], strength/quality of stimulus evidence, and 
response bias) via DDM. Our results indicate that non-decision time significantly decreased 
post-exercise during executive function and memory tasks, and that a significant change in 
stimulus bias occurred post-exercise during the memory task. Our data cumulatively suggest 
that middle-age adults with HTN experience similar beneficial increases in executive function 
and memory processing speed following acute exercise as their counterparts without HTN, and 
that post-exercise increases in processing speed are driven by changes outside of the decision-
making process.  
Hypertension and cognition  
 HTN is associated with accelerated brain aging [11] and impaired cognitive performance 
[12,132,139-142]. Surprisingly, we noted no differences in baseline cognitive function between 
adults with and without HTN in our cohort of middle-aged adults. Indeed, task accuracy and 
processing speeds (RT) were similar across executive function (Flanker, 2-Back) and memory 
recognition tasks between groups at baseline. The lack of baseline differences in cognitive 
function contrasts with previous data, indicating lower executive function and memory 
performance [142], and slower RT in HTN [301]. These conflicting data may relate to our 
middle-aged sample of adults with HTN since age independently contributes to cognition among 
hypertension [302]. As such, middle-aged individuals with HTN may not experience notable 
differences in cognitive function since the duration the brain is exposed to HTN likely contributes 
to the degree of dysfunction (or lack thereof) [142]. This suggests that our cohort of middle-aged 
adults with HTN had similar cognitive health as their counterparts without HTN, and were not 
exhibiting signs of cognitive dysfunction from accelerated brain aging. 
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 The similar cognitive health between our groups may relate to the use of anti-HTN 
therapy. Indeed, our cohort of adults with HTN relied on anti-HTN medication to control their 
blood pressure to within normal levels. This is of importance since well-controlled HTN appears 
to attenuate differences in cognition [302]. Additionally, our HTN group did not refrain from 
taking their anti-HTN medication during our study which may have influenced our findings. 
Whether anti-HTN therapy independently impacts cognition is of debate and may depend on 
age, drug type, and cognitive assessment strategy [11,179,180]. The American Heart 
Association and American Stroke association have recommended anti-HTN therapy for adults in 
mid-life and early old age as an effective means to attenuate late-life dementia [16]. Among 
older adults (>80 years of age), however, the utility of such therapy is unclear and requires 
additional scrutiny [16]. Additionally, some drug types (angiotensin II receptor blockers [ARB], 
angiotensin converting enzyme inhibitors [ACE-I], and calcium-channel blockers [CCB]) and 
combination therapies appear more effective in combating cognitive decline in HTN than other 
monotherapy drugs [180]. While the long-term implications of anti-HTN therapy 
delaying/preventing cognitive disease have received the most attention [11,179,180], it is 
unclear if acute ingestion of anti-HTN medication directly impacts cognitive function. Cognition 
could improve acutely following drug ingestion if the beneficial effects of anti-HTN therapy on 
the brain results from the direct blood-pressure lowering, or neuroprotective effects of the drug. 
Indeed, acute doses of an ARB have been reported to enhance prospective memory in young 
normotensive adults [303], however this remains to be replicated in a clinically relevant 
population (i.e. HTN). Ultimately, roughly a fifth (20%) of our adults with HTN were on a 
combination therapy (i.e. >1 anti-hypertensive drug) and 90% used either an ARB, ACE-I, or 
CCB, which may have contributed to the similar cognitive health between our HTN and no-HTN 
groups. Taken together, these data indicate that our sample of medicated, well-controlled, 
middle-aged adults with HTN had similar baseline cognitive function as their counterparts 
without HTN, which may have contributed to their similar cognitive responses to acute exercise.  
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Hypertension, exercise, and cognition 
 To our knowledge, this is the first study to investigate the acute effects of exercise on 
cognition in adults with HTN, a population at-risk for cognitive decline. Accuracy on executive 
function tasks was unaltered by acute exercise in both HTN and no-HTN groups. Indeed, hit 
rates were not significantly different pre compared to post exercise on either Flanker or 2-Back 
tasks in our sample. With respect to memory recognition, however, we noted a significant effect 
of exercise on metrics of task performance. Specifically, we observed significant increases in 
memory recognition hits and false alarms post-exercise in both HTN and no-HTN individuals. 
Although the number of correctly identified “studied” words (i.e. hits) increased post-exercise, 
this is not indicative of improved memory recognition performance or accuracy per se since it 
was accompanied by an increase in the number of false alarms (incorrect responses where 
distractor words were classified as “studied”). This seems to suggest that acute exercise altered 
how individuals categorized memory stimuli and will be discussed further below with insight from 
DDM.  
 The null effects of acute exercise on cognitive task accuracy observed herein concurs 
with previous experimental data [294,304,305]. Meta-analytical investigations suggest there 
may be a small effect on non-time dependent cognitive task performance (i.e. accuracy) [198], 
although this is not universal [197]. Improvements in cognitive task accuracy post-exercise may 
be difficult to observe as many studies rely on tasks vulnerable to ceiling effects (i.e. task 
difficulty is not sufficient that improvements in cognitive processing or decision-making can alter 
hit rates). Indeed, this may impact our findings with the Flanker task (hit rate ≈99%), although 
ceiling effects likely did not impact the effect of exercise on 2-back or memory recognition tasks 
based on the lower mean hit rates (≈70% and ≈53%, respectively). These data indicate that 
acute aerobic exercise does not improve accuracy on executive function or memory tasks in 
middle-aged adults with and without HTN.    
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While task accuracy did not improve following acute aerobic exercise, we noted faster 
executive function and memory processing speed post-exercise in both adults with and without 
HTN. Accelerated processing speed post-exercise manifested as significantly reduced RT for 
Flanker/memory recognition tasks, with trends for 2-back. This facilitation of RT is in-line with 
recent literature [294,304,305], as well as meta-analyses of the literature at-large that indicate 
RT is sensitive to changes with acute exercise [195,198]. Previous findings suggest larger 
benefits of exercise on RT are seen in children and older adults, with attenuated benefits in 
young healthy adults [198]. While the effect of acute exercise on cognition is under-investigated 
among middle-aged adults [198], our observation of accelerated RT post-exercise suggests 
middle-aged adults exhibit similar facilitation of post-exercise RT as children and older adults. 
Taken together, these data suggest that middle-aged, adults with medicated HTN experience 
similar facilitation of cognitive processing speed, manifesting as reduced RT, on executive 
function and memory tasks following acute exercise as their counterparts without HTN. 
Exercise, cognition, and insight from drift-diffusion modeling 
 Previous studies have provided limited insight into psychological factors underlying 
exercise-induced changes in cognition.  A reason for this may be due to reliance on standard 
metrics of cognitive performance (task accuracy and processing speed (i.e. RT) [198]. Any 
change in cognitive function could stem from multiple components of the decision-making 
process including stimulus classification, stimulus evaluation, response selection, and motor 
execution [306], all of which, influence RT. Mathematical modeling via DDM is a novel means of 
dissecting the entire decision-making process contained in the behavioral data into its 
underlying components of visual encoding, evidence accumulation and decision, and motor 
response. As such, DDM may offer insight into mechanisms behind changes in cognitive 
performance (hits and false alarms) and mechanisms of accelerated RT following exercise by 
quantifying the changes in the decision-making process that elicited the observed responses.  
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 We noted no effect of acute exercise on executive function task accuracy, as assessed 
by hit rate on the Flanker and 2-back. The ability to correctly identify stimuli in a given task is 
strongly dependent on the strength of evidence extracted from the stimuli itself [295]. An 
increase in the strength of evidence extracted from the stimuli would be expected to increase 
the hit rate and potentially decrease RT (since it would take less time to make a decision when 
interpreting stronger evidence). Seeing as Flanker and 2-Back hit rates were unaltered by 
exercise, it is not surprising that the strength of evidence (drift rate) did not significantly change 
post-exercise for either executive function task.  
 We did, however, observe increases in hit and false alarm rates during the memory 
recognition task post-exercise. This change in hit and false alarm rates suggests a change in 
how evidence was extracted from the stimuli (quantified as drift rate by DDM). Indeed, DDM 
revealed that drift rates for both old/studied and new/distractor words tended to increase post-
exercise, although this was not statistically significant. According to the model, more positive 
drift rate values indicate stronger perceived evidence for stimuli to be an “old/studied” word. In 
the case of new/distractor word, more positive (i.e. less negative) drift rates indicate weaker 
perceived evidence as a new/distractor word and thus, stronger evidence for being an 
old/studied stimuli. The drift rates of old/studied and new/distractor words were summed to 
create an index of stimulus evaluation bias, which significantly increased post-exercise. An 
increase in stimulus evaluation bias (and thus, a more positive value) suggests all items 
seemed to provide more evidence as old/studied even when they were new/distractor stimuli. A 
change in stimulus evaluation bias signifies a shift in how the stimulus is processed and what 
evidence is extracted from the stimuli under consideration [244]. This differs from response 
expectancy bias which alters the amount of evidence required for a given response and would 
manifest as faster and more probable responses for one response over another [244]. Whether 
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the post-exercise changes in stimulus evaluation bias are a direct result of exercise or the 
experimental design itself is unclear and requires further scrutiny.  
The significant reductions in post-exercise executive function (Flanker, trend for 2-Back) 
and memory RT could stem from changes in encoding, the decision process itself, and motor 
execution. For the first time, DDM was able to provide insight into the components of RT that 
are altered by acute exercise. Indeed, we noted significant reductions in non-decision time 
during the 2-Back and memory recognition tasks, with trends for reductions during the Flanker 
task. As such, DDM proposes that the reductions in executive function and memory recognition 
RT observed herein were likely related to significant reductions in non-decision time (the sum of 
encoding and motor response phases that occur immediately prior to, and directly following, the 
actual decision making process). Previously, it was unclear if changes in RT post-exercise 
stemmed from alterations in stimulus evaluation (encoding), response selection (decision), or 
motor execution [305]. Our finding is corroborated by electroencephalographic data that suggest 
P3 latency (a neuroelectric proxy of stimulus evaluation duration, likely analogous to the 
decision component of DDM) may not be altered by exercise [307] although this is not universal 
[308]. This may indicate that improved executive function and memory processing speed post-
exercise is largely independent from changes in the decision-making process itself (evidence 
strength, caution, bias) and is isolated to the encoding and motor response.  
While we are unable to directly comment on whether exercise increases cognitive 
processing speed via accelerated visual encoding, motor response, or a combination of both, 
there is evidence that each may be altered post-exercise. Limited data suggest there are minor 
changes in the time required for a motor response post-exercise (approximately 10 ms faster 
immediately post-exercise) [309]. Even a relatively small reduction in motor response time (i.e. 
10 ms) may account for 25%-40% of the mean change in non-decision time (-Δ40-25ms) 
documented herein for memory and executive function domains respectively. This suggests that 
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the remaining reductions may stem from accelerated encoding during post-exercise memory 
recognition and executive function tasks. Residual effects of exercise on sensory cortex 
excitability [310] may reduce the time required for visual encoding of cognitive stimuli, thereby 
reducing non-decision time. Alternatively, reductions in non-decision time may be isolated to the 
motor response component since exercise does not alter the N1 component derived from EEG 
(potentially reflective of initial sensory extraction from stimulus) [307]. Additional contributors to 
post-exercise facilitation of non-decision time may include acute elevation of brain-derived 
neurotrophic factor and acute catecholamine/endorphin-mediated increases in arousal 
[311,312]. Ultimately, the mechanisms behind the contributions of visual encoding and motor 
response to post-exercise changes in non-decision time, and in turn to RT, require further 
research and the use of additional experimental measures.  
Implications 
 Aerobic exercise is recommended as an important lifestyle strategy to attenuate 
cognitive decline in HTN. To date, however, there is a paucity of data on the effects of aerobic 
exercise on cognition in HTN. In fact, recent reviews on exercise and cognitive function in 
human HTN rely primarily on rodent-model research [231]. We examined the effects of acute 
aerobic exercise on cognitive function and components of decision-making in middle-aged 
adults with and without HTN, an understudied age group that is ideal for preventive research. 
We observed similar improvements in executive function and memory processing speeds 
following acute exercise in no-HTN and HTN groups. Our data cautiously suggest that the 
brain’s ability to respond to an aerobic exercise stimulus and improve processing speed is 
undisturbed by the presence of HTN, at least in our sample of middle-aged adults with well-
controlled HTN. This may provide insight into the brain’s ability to reap the touted benefits of 
chronic exercise and suggest that adults with well-controlled HTN may respond similarly to an 
exercise training program, however this is speculative at this time. Limited data currently 
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indicates no beneficial effect of exercise training on cognition in middle-aged adults with un-
treated HTN [313], older adults with resistant HTN [233], and adults with HTN and co-morbid 
diabetes mellitus [234]. Whether exercise training results in beneficial changes in cognition 
among a healthier or well-controlled group of adults with HTN (as studied herein) remains 
unknown and requires further scrutiny.  
Limitations 
 Our study is the first to examine the effects of acute submaximal exercise, at a dose 
typically recommended for adults with HTN, on cognitive function and underlying components of 
decision-making in adults with controlled HTN and well-matched adults without HTN. We 
purposefully selected controlled-HTN since this is the “free-living” state in which adults with HTN 
would typically engage in exercise as a lifestyle strategy to improve cognitive health and brain 
aging. As such, acute cognitive responses to exercise may differ in adults with untreated HTN. 
Whether responses are different among a group of older adults with HTN is additionally unclear 
and requires further research. We purposefully chose to interrogate the effect of exercise on 
cognition from minutes 10-30 post-exercise since we wished to identify if individuals with HTN 
experienced the same benefits of exercise on cognition as those without HTN and meta-
analyses indicate this time period is sensitive to the acute effects of exercise [20]. It is possible 
that further or differential changes in cognition could occur in these groups during prolonged 
recovery (i.e. >30 min) from a single bout of exercise.  
Conclusions 
We sought to investigate the effects of exercise on cognitive function in middle-aged 
adults with and without HTN, and examine the effect of exercise on underlying processes of 
decision-making (via DDM). Both individuals with and without HTN had similar cognitive 
responses following a single exercise bout of a recommended dose/intensity. While acute 
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exercise did not alter task accuracy, there were significant reductions in post-exercise RT for 
both executive function and memory domains in both groups. DDM revealed that changes in RT 
may largely stem from significant reductions in non-decision time which encompasses the early 
(visual encoding) and late (motor response) portions of the decision-making process.  
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Table 5.1: Diffusion modeling outcome parameters. 
Variable Description Interpretation Tasks 
Caution Metric of speed/ accuracy trade-off 
Higher value indicates more cautious (i.e. 
accuracy over speed), represented as greater 
distance between criterion boundaries in the 
latent decision-making processes. 
Flanker 
 
2-Back 
  Memory 
Non-decision 
time 
(Encoding + motor 
execution) 
Higher value represents slower encoding/motor 
processing. 
Flanker 
2-Back 
Memory 
Drift rate Metric for strength of 
evidence accumulation 
for a given response. 
Calculated for old/new 
words (memory) and 
match/non-match (2-
Back) 
Positive values represent evidence to reject new 
word/non-match. Greater value indicates 
stronger evidence. 
2-Back 
Memory 
 
Negative values represent evidence to reject new 
word/non-match. More negative value indicates 
stronger evidence. 
 
  
Greater absolute value indicates stronger 
evidence. 
  
Stimulus bias Memory = (Drift old + 
drift new) 
Value <0 indicates strict criterion for recognizing 
correct response (i.e. unless very sure, they do 
not endorse it as a "studied" word/match). 
2-Back 
Memory 
  2-Back = (Drift match 
+ drift non-match) 
Value >0 indicates lenient criterion for 
recognizing correct response (i.e. endorse 
"studied" words or matches with less evidence). 
 
Response bias (Stimulus bias / 
caution) 
Value <0.5 indicates bias for "new/non-match." 2-Back 
    Value >0.5 indicates bias for "old/match." Memory 
Discriminability Memory = (Drift new - 
drift old) 
Higher value represents better ability to 
discriminate between correct (old 
words/matches) vs incorrect (new words/non-
matches) (i.e. better task performance). 
2-Back 
  2-Back = (Drift match - 
drift non-match) 
Memory 
Perceptual 
strength 
Strength of evidence 
from displayed arrows 
More negative values represent better perceptual 
ability.  Comparable to drift rate from 2-Back, 
memory tasks. 
Flanker 
Attention 
interference 
(Attention/selective 
attention) 
Indicates duration required to narrow attention 
completely. Lower values indicative of better 
selective attention. 
Flanker 
Metric of selective 
attention capacity 
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Table 5.2: Descriptive characteristics for no-HTN and HTN groups (mean ± SD 
unless otherwise noted). 
  No-HTN HTN p-value 
Sex (male/female) 16/14 16/14 - 
Age (yrs) 56 ± 6 56 ± 6 0.93 
Anthropometrics    
Height (cm) 169.8 ± 11.3 171.3 ± 9.6 0.57 
Weight (kg) 82.0 ± 13.3 82.4 ± 12.5 0.91 
Body fat (%) 32.2 ± 8.4 31.4 ± 6.9 0.69 
Body mass index (kg/m2) 28.3 ± 2.6 28.0 ± 3.3 0.71 
Medications, %(n)    
Statin 6.7 (2) 40.0 (12) 0.005 
Birth control 3.3 (1) 0.0 (0) - 
Hormone replacement therapy 3.3 (1) 3.3 (1) - 
Hypothyroid 3.3 (1) 3.3 (1) - 
ACE inhibitor - 43.3 (13) - 
ARB - 33.3 (10) - 
Diuretic - 20 (6) - 
β-Blocker - 13.3 (4) - 
CCB - 13.3 (4) - 
Lipid profile    
Hemoglobin (g/dL) 14.2 ± 0.9 13.8 ± 1.3 0.12 
Total cholesterol (mg/dL) 202 ± 39 192 ± 36 0.28 
HDL (mg/dL) 58 ± 17 56 ± 20 0.56 
Triglycerides (mg/dL) 103 ± 61 116 ± 56 0.28 
LDL (mg/dL) 128 ± 41 114 ± 30 0.17 
Non-HDL (mg/dL) 144 ± 44 136 ± 32 0.43 
Total cholesterol:HDL  4 ± 2 4 ± 1 0.89 
Glucose (mg/dL) 94 ± 9 102 ± 16 0.03 
Questionnaires    
CESD 6 ± 5 7 ± 4 0.71 
Fitness    
VO2max (mL/kg/min) 32.4 ± 8.8 27.2 ± 5.6 0.008 
ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; CCB, 
calcium-channel blocker; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
CESD, Center for Epidemiologic Studies Depression questionnaire; VO2max, 
maximal oxygen consumption.  
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Table 5.3: Executive function parameters pre and post-exercise in HTN and No-HTN individuals (mean ± SD). 
  No-HTN HTN    
Task Parameter Pre Post Pre Post Group Time GxT 
Flanker        
 Hits, congruent (%) 99.9 ± 0.3 99.8 ± 0.7 99.9 ± 0.6 99.8 ± 0.6 0.93 0.58 0.94 
 Hit RT, congruent (ms) 513 ± 76 493 ± 66 510 ± 64 478 ± 63 0.63 0.01 0.15 
 Hits, incongruent (%) 97.8 ± 3.0 98.0 ± 2.5 96.8 ± 4.5 95.5 ± 4.9 0.54 0.80 0.83 
 Hit RT, incongruent (ms) 606 ± 87 578 ± 82 590  ± 68 562 ± 72 0.46 0.01 0.89 
DDM Caution 0.22 ± 0.14 0.21 ± 0.12 0.24 ± 0.24 0.24 ± 0.20 0.77 0.97 0.80 
 Non-decision time (ms) 309 ± 121 296 ± 117 320 ± 83 273 ± 112 0.81 0.07 0.28 
 Attention interference (ms) 190 ± 171 152 ± 103 198 ±176 158 ± 108 0.55 0.26 0.78 
 Perceptual strength 0.53 ± 0.19 0.55 ± 0.17 0.58 ± 0.19 0.59 ± 0.18 0.26 0.35 0.69 
         
2-Back  Hits (%) 67.0 ± 22.2 67.2 ± 21.5 73.5 ± 15.6 74.1 ± 17.0 0.26 0.96 0.69 
 Commission errors (%) 6.4 ± 4.9 5.6 ± 5.2 7.3 ± 6.6 6.2 ± 5.5 0.67 0.07 0.98 
 Discriminability 0.61 ± 0.22 0.62 ± 0.20 0.66 ± 0.15 0.679 ± 0.168 0.16 0.56 0.86 
 Hit RT (ms) 666 ± 106 651 ± 94 633 ± 89 613 ± 88 0.13 0.06 0.83 
DDM Caution 0.14 ± 0.02 0.15 ± 0.02 0.15 ± 0.02 0.14 ± 0.02 0.44 0.28 0.06 
 Non-decision time (ms) 402 ± 108 370 ± 95 353 ± 94 344 ± 91 0.11 0.048 0.27 
 Response bias 0.39 ± 0.11 0.39 ± 0.12 0.40 ± 0.11 0.39 ± 0.10 0.66 0.53 0.52 
 Drift rate-match 0.16 ± 0.03 0.17 ± 0.04 0.17 ± 0.04 0.17 ± 0.03 0.23 0.84 0.94 
 Drift rate-non-match -0.13 ± 0.04 -0.13 ± 0.03 -0.13 ± 0.04 -0.14 ± 0.03 0.65 0.36 0.61 
 Drift rate-discriminability 0.29 ± 0.06 0.30 ± 0.04 0.31 ± 0.05 0.31 ± 0.03 0.20 0.43 0.90 
  Stimulus bias 0.03 ± 0.05 0.03 ± 0.06 0.04 ± 0.60 0.03 ± 0.04 0.70 0.62 0.56 
HTN, Hypertension; DDM, Drift-diffusion modeling; GxT, Group-by-time interaction; RT, reaction time. 
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Table 5.4: Memory recognition parameters pre and post-exercise in HTN and Non-HTN individuals (mean ± SD).  
  No-HTN HTN    
Task Parameter Pre Post Pre Post Group Time GxT 
Memory Hits, studied (%) 51.8 ± 21.0 57.7 ± 20.2 53.5 ± 17.7 57.8 ± 20.7 0.71 0.02 0.85 
 False alarms (%) 22.6 ± 17.7 27.2 ± 19.9 24.6 ± 17.7 30.2 ± 20.9 0.64 0.01 0.88 
 Discriminability 0.29 ± 0.18 0.30 ± 0.14 0.29 ± 0.16 0.28 ± 0.19 0.68 0.98 0.55 
 Hit RT (ms) 941 ± 181 897 ± 148 894 ± 149 853 ± 145 0.24 0.02 0.91 
DDM Caution 0.14 ± 0.02 0.13 ± 0.03 0.12 ± 0.02 0.13 ± 0.02 0.27 0.74 0.07 
 Non-decision time (ms) 579 ± 126 531 ± 104 564 ± 101 532 ± 136 0.79 0.01 0.53 
 Response bias 0.06 ± 0.02 0.07 ± 0.02 0.06 ± 0.01 0.06 ± 0.02 0.45 0.93 0.68 
 Drift rate-studied 0.01 ± 0.07 0.04 ± 0.07 0.02 ± 0.06 0.02 ± 0.11 0.95 0.12 0.26 
 Drift rate-distractor -0.11 ± 0.08 -0.09 ± 0.07 -0.10 ± 0.09 -0.08 ± 0.10 0.75 0.11 0.87 
 Drift rate-discriminability 0.11 ± 0.08 0.12 ± 0.06 0.11 ± 0.07 0.10 ± 0.07 0.66 0.94 0.24 
  Stimulus bias -0.10 ± 0.12 -0.05 ± 0.12 -0.08 ± 0.133 0.04 ± 0.14 0.44 0.02 0.76 
HTN, Hypertension; DDM, Drift-diffusion modeling; GxT, Group-by-time interaction; RT, reaction time. 
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Figure 5.1: Components of the drift diffusion model for a 2-choice decision task. Noisy evidence 
(dotted line) accumulates over time from the starting point, z, to one of the two boundaries, a or 
0. The total response time includes the decision time plus the time taken for non-decision 
processes like visual encoding and motor response.  
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Chapter VI: Summary and Exploratory Aim 3 
Contrary to our hypotheses, findings from aim 1 and 2 largely indicated our cohort of 
middle-aged adults with controlled-HTN had similar vascular and cognitive responses to acute 
exercise as their counterparts without HTN. This contrasts with previous literature and likely 
stems from the generally healthy nature of our middle-aged adults with well-controlled HTN. 
Based on our findings from aim 1 and 2 we pursed an exploratory aim 3 that sought to explore if 
the vascular contributions to cognitive function differed in our cohort of middle-aged adults with 
HTN to those without HTN.  
The vasculature has been recognized as a major contributor to cognitive function, 
cognitive decline, and dementia [16,314]. The brain is dependent on continuous blood flow that 
must react acutely to changes in metabolic demand stemming from neural activity. Neuronal 
activity increases metabolic demand and must be supported by compensatory increases in 
blood flow to support the active neural circuitry. This process is known as neurovascular 
coupling (NVC) [315,316]. Optimal NVC determines cognitive performance [179,317] and is a 
factor in cognitive impairment and dementia [314].  
Our lab has previously examined NVC in healthy young/middle-aged adults [261], and in 
older adults [263].  Our previous findings indicate older adults experience increases in 
extracranial large artery (i.e. carotid, aorta) stiffness and intracranial pulsatility during cognitive 
activity, acutely influencing NVC and reducing cognitive performance [263]. Conversely, our 
observations in younger/middle-age adults indicate they are able to effectively buffer pulsatile 
hemodynamics by reducing extracranial pulsatility at the level of the carotid artery, leaving 
intracranial pulsatility unaltered [261]. By including measures of extra-cranial large artery 
stiffness and hemodynamic pulsatility we can gain further insight into contributors to NVC. 
Despite the similar resting vascular and cognitive function observed in Aims 1 and 2, it is 
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possible that examining vascular contributions to cognition during cognitive activity (i.e. NVC) 
will reveal differences not seen at rest or following an exercise bout. As such, it is possible 
adults with HTN may mimic responses seen in older adults, characterized by excessive 
transmission of pulsatile cerebrovascular hemodynamics and NVC disruption during cognitive 
activity. 
Exploratory Aim 3: Examine vascular contributions to cognitive function by comparing vascular 
hemodynamic responses during cognitive activity (i.e. NVC) in middle-aged adults with, and 
without, HTN.  
Hypothesis 3: Adults with HTN will exhibit different vascular responses during cognitive activity. 
Specifically that compared to adults without HTN, adults with HTN will exhibit impaired NVC, 
manifesting as insufficient changes in cerebral oxygenation accompanied by disproportionate 
increases in arterial stiffness and hemodynamic pulsatility. 
Innovation 
Our lab utilizes an innovative means 
of assessing the vascular contributions to 
cognitive engagement described by NVC. We 
project a computerized-cognitive task 
horizontally over the participant (Figure 6.1). 
Participants lie supine and perform cognitive 
tasks while simultaneous measures of 
arterial stiffness and cerebral perfusion 
(Transcranial Doppler [TCD] and prefrontal 
cortex (Pfc) tissue oxygenation using 
functional near-infrared spectroscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Concurrent vascular & cognitive assessment 
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[fNIRS]) are obtained. We will use a cognitive task specific to executive function, a domain 
mediated by the Pfc, which appear particularly sensitive to HTN-mediated dysfunction 
[12,318,319]. We can then correlate functional and spatial changes in arterial stiffness and 
cerebral/Pfc hemodynamics with cognitive performance at the time of measurement. Thus we 
are targeting cerebral hemodynamics in a susceptible region of the brain relevant to HTN while 
concurrently activating that region using domain-specific tasks.  
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Chapter VII: Neurovascular Coupling during Cognitive Activity in Adults With and Without 
Hypertension 
Abstract 
Hypertension accelerates vascular aging, which may impair the ability of the cerebrovasculature 
to increase blood flow to support neural activity (neurovascular coupling [NVC]). Optimal NVC 
depends on continuous, non-pulsatile flow, which is partially determined by extra- and intra-
cranial vessel function. We sought to compare extra- and intra-cranial hemodynamics during 
cognitive activity (Stroop task) in 30 middle-aged adults with, well-controlled medicated 
hypertension and 30 age-, sex-, and body mass index (BMI)-matched adults without 
hypertension (56±6 yrs, BMI 28.2±2.9 kg/m2; 32 men). Aortic and carotid (single-point) pulse 
wave velocity (PWV) were assessed via tonometry and ultrasound respectively. Carotid and 
middle cerebral artery (MCA) blood velocity pulsatility were measured via ultrasound and 
Doppler. Prefrontal cortex oxy- and deoxy-hemoglobin, and tissue saturation index (TSI) were 
measured using near-infrared spectroscopy. Accuracy and reaction times were computed to 
assess cognitive performance. Stroop performance was similar between groups (p>0.05). Aortic 
and carotid PWV increased, carotid pulsatility decreased (p<0.05), and MCA pulsatility was 
unaltered during the Stroop in both groups. Groups achieved similar cortical TSI during Stroop, 
although hypertensives did so with greater increases in oxyhemoglobin (p<0.05). Reduced CCA 
pulsatility during the Stroop was associated with increased cortical TSI in the combined sample. 
Our findings suggest that intra- and extra-cranial cerebrovascular reactivity in middle-age adults 
with medically-controlled hypertension is largely similar to adults without hypertension. 
Additionally, reductions in extracranial pulsatility during NVC may minimize intracranial 
pulsatility and enhance downstream cerebral oxygenation in adults with and without 
hypertension. Our data suggest extracranial hemodynamics may play an important role in 
optimizing intracranial NVC.  
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Introduction 
Hypertension (HTN) and its neurocognitive consequences potentiate the development of 
cognitive dysfunction [12] and disease [11]. The link between HTN and cognitive dysfunction 
may reflect accelerated vascular aging [11] and underlying changes in cerebrovascular 
structure/function that disrupt cerebral blood flow regulation. Cerebral blood flow is tightly 
regulated to 1) prevent pressure-mediated hyper- or hypo-perfusion episodes and 2) ensure 
blood flow reacts appropriately to changes in metabolic demand (assessed as cerebrovascular 
reactivity) [320]. Cerebrovascular reactivity to carbon dioxide (CO2) and exogenous vasodilators 
may be attenuated in adults with HTN compared to without [105,106,321,322]. Of particular 
concern for HTN, cerebrovascular reactivity is associated with stroke and white-matter 
hyperintensities [323], lower cognitive function [321], and may precede cognitive dysfunction 
[316].  
The vast majority of investigations into cerebrovascular reactivity in HTN have relied on 
measuring cerebrovascular responses to changes in CO2 [105,106,321,324]. The processes 
governing cerebrovascular reactivity to CO2, however, likely differs from those dictating 
cerebrovascular responses during cognitive engagement known as neurovascular coupling 
(NVC) [320]. The brain is an obligate high-flow target organ that is dependent on acute changes 
in blood flow to meet metabolic demands. NVC describes the compensatory increases in 
regional blood flow and oxygen delivery required to support metabolic need during neuronal 
activation [315,316]. NVC is a significant determinant of cognitive performance [179] and key 
contributor to cognitive impairment and dementia [314]. Despite extensive insight into molecular 
factors that contribute to NVC from in vivo animal studies, knowledge of contributors to optimal 
NVC in humans is limited and underexplored [320,325]. 
 Increases in intracranial blood flow necessary for optimal NVC may partially depend on 
extracranial vessels. Large extracranial vessels are active regulators of intracranial blood flow, 
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accounting for nearly 25-50% of total cerebrovascular resistance [320]. As such, extracranial 
changes in diameter may contribute to intracranial flow by modulating blood pressure, a key 
component of NVC [326]. Moreover, increases in intracranial flow may result in a conducted 
vasodilation of extracranial feed arteries stemming from regional changes in transluminal 
pressure and shear stress [327]. Thus, changes in extracranial shear, diameter, and flow may 
provide greater insight into intracranial NVC.   
 Optimal NVC is dependent not only on increases in mean blood flow to maintain a 
steady supply of oxygen, but also on the manner in which that blood flow is delivered. Tissue 
perfusion at the capillary level relies on continuous blood flow for optimal oxygen extraction, 
whereas pulsatile blood flow can cause epochs of hypo-perfusion and alter red blood cell transit 
time, resulting in reduced oxygen extraction, ischemia and microvascular damage, [9,328]. The 
dampening of hemodynamic pulsatility in the cerebral microvasculature is highly dependent on 
large extracranial artery elastic function (i.e aorta, carotid) [9]. Acute changes in extracranial 
vessel stiffness transmits pulsatile hemodynamic energy into downstream vascular beds, 
possibly influencing NVC and cognitive function [263]. Indeed, during cognitive engagement, 
older adults experience increases in extracranial large artery stiffness and intracranial pulsatility, 
acutely impacting NVC and reducing cognitive performance [263]. Conversely, normotensive 
younger/middle-age adults are able to effectively buffer pulsatile hemodynamics with reductions 
in extracranial pulsatility and unaltered intracranial pulsatility [261]. As such, incorporating 
measures of extracranial large artery stiffness and intracranial hemodynamic pulsatility may 
provide additional insight into contributors to NVC.  
 Considering HTN is associated with accelerated vascular aging [329], adults with HTN 
may mimic responses seen in older adults, characterized by pulsatile hemodynamics disrupting 
NVC. Thus, the first aim of this study was to compare extra- and intra-cranial vascular-
hemodynamic reactivity during cognitive activity in middle-aged adults with and without HTN. 
The second aim was to examine the relationships between extracranial changes in stiffness, 
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transmission of pulsatile hemodynamics, and cortical oxygenation during cognitive activity in this 
sample. It was hypothesized that adults with HTN would exhibit different vascular reactivity 
during cognitive activity versus those without HTN, manifesting as exaggerated increases in 
extracranial vessel stiffness and hemodynamic pulsatility during cognitive activity compared to 
their counterparts without HTN. We additionally hypothesized that excessive hemodynamic 
pulsatility during cognitive activity would be associated with reduced cortical oxygenation and 
thus impaired NVC.    
Methodology 
Participants 
Thirty middle-aged adults with HTN (56 ± 6 yrs; 16 men) and 30 age-, sex-, and body 
mass index (BMI)-matched adults without HTN (no-HTN; 56 ± 6 yrs; 16 men) were recruited for 
this cross-sectional study. Participants were excluded if they reported smoking, stroke, 
dementia, diabetes mellitus, severe obesity (BMI ≥35 kg/m2), depression, previous 
cardiovascular events, pulmonary/renal/neurological disease, or recent head trauma 
(concussion). Additionally, participants were screened for dementia (Montreal Cognitive 
assessment score ≤21) and depression (assessed using the Center for Epidemiologic Studies 
Depression questionnaire). Overweight/obese (BMI 25-35 kg/m2) and hyperlipidemic individuals 
were included in the sample since these risk factors are highly prevalent within middle-aged 
adults (regardless of HTN status). Menopausal status (pre-, peri-, post-menopausal) was 
documented according to STRAW+10 guidelines [267]. This study was approved by the 
Syracuse University Institutional Review Board and conformed to the standards outlined in the 
Declaration of Helsinki. All participants provided written informed consent prior to study 
initiation.  
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Participants with HTN had been previously diagnosed by a physician and were 
undergoing anti-HTN therapy based on the previous HTN management guidelines [37]. 
Participants did not abstain from their anti-HTN medication during testing because 1) of concern 
of rebound HTN, and 2) the medicated state is the “natural state” in which nearly three-quarters 
of individuals with HTN live.  
Study design 
Testing was conducted over 3 separate visits: 1) health screening, followed by 7 days of 
at-home blood pressure measurement and physical activity monitoring, 2) a familiarization visit, 
and 3) NVC assessment (vascular measures during cognitive engagement).  
Health screening 
 An electronic scale and stadiometer were used to assess height and weight for BMI 
calculations. Body fat was estimated via air displacement plethysmography (Bod Pod, Cosmed, 
Concord CA). Fasting plasma glucose and serum lipoproteins (total cholesterol, triglycerides, 
low- and high-density lipoproteins) were assessed using a validated point-of-care device via 
finger stick (Cholestech, Alere Medical) following an overnight fast (12-hr) and abstinence from 
alcohol, caffeine, and exercise. Participants filled out the Pittsburgh Sleep Quality Index, 
Montreal Cognitive Assessment, and Centers for Epidemiologic Studies Depression 
questionnaire to assess subjective sleep quality, dementia, and depressive symptomology, 
respectively. 
At-home measures 
 Blood pressure status was confirmed via 7 days of at-home blood pressure 
measurement, as recommended by the American Heart Association [268], using an 
oscillometric blood pressure device (BP786N, Omron Healthcare Inc., Lakeforest, IL). 
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Participants were asked to take duplicate measures of blood pressure twice per day (morning 
and evening). Participants not on anti-HTN therapy were excluded if they exhibited an average 
7-day blood pressure suggestive of undiagnosed HTN (systolic pressure (SP) ≥135 mmHg and 
diastolic pressure (DP) ≥85 mmHg) [268].  
Physical activity was assessed using a tri-axial accelerometer (activPAL3tmmicro, PAL 
Technologies Ltd, Glasgow, Scotland) secured to the middle of the thigh over a 7-day period. 
Measures of physical activity included average steps and min of moderate-to-vigorous physical 
activity (MVPA; number of min with ≥100 steps/min [330]) from 6 full-days of data.  
Familiarization  
All participants were familiarized with all vascular/cerebral measures and the cognitive 
task to be used in the NVC protocol. Participants were familiarized with the cognitive task to 
account for learning effects. Familiarization included point-by-point written and verbal 
instructions for the task followed by a complete practice session. If participants did not 
adequately understand the task they were permitted to repeat the task until they were 
comfortable with the goals of the task.  
Neurovascular coupling protocol 
 Participants were instructed to arrive following a >4-hour fast, and abstinence from non-
essential medication (i.e. NSAIDS, nutritional/dietary supplements, allergy medication), alcohol, 
caffeine, and exercise the day of the NVC assessment. The NVC protocol was standardized to 
the morning for all participants. NVC was assessed during the early follicular phase for pre- 
(n=2) and peri-menopausal (n=6) participants. The NVC visit was not standardized for 
amenorrheic (no menses for >3 months; n=3) or post-menopausal participants (n=17).  
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The hemodynamic response to cognitive activity (i.e. NVC) was measured as the 
change in cerebrovascular hemodynamics from rest to each 3-min task. Participants underwent 
cerebrovascular measures at rest, and during each iteration of the cognitive task (Stroop). NVC 
testing occurred following 15 min of supine rest. All testing was conducted in the supine 
position. Cerebrovascular measures included 1) blood pressure; 2) extracranial hemodynamics 
(common carotid artery [CCA]); and 3) intracranial hemodynamics (middle cerebral artery [MCA] 
and pre-frontal cortex [PFC] oxygenation). PFC oxygenation was measured continuously, while 
remaining cerebrovascular measures were initiated after the first 30-seconds of each task to 
allow adequate time for the hemodynamic lag that follows neural activation.  
Cognitive task 
 Cerebrovascular NVC was assessed during two computerized 3-min modified Stroop 
color-word tasks (congruent and incongruent tasks, presented in a randomized-counterbalanced 
order; E-Prime, Psychology Software Tools Inc., Sharpsburg, PA) that participants completed 
using a hand-held response clicker. The Stroop task interrogates the executive function domain 
of cognition, which has implications for later-life cognitive function and is affected by HTN [12]. 
Additionally, the Stroop task has been shown to elicit significant cerebrovascular hemodynamic 
responses in the PFC [331] and MCA [261,263].  
 This experimental manipulation and cognitive perturbation has been described in detail 
previously by our lab [261,263]. In brief, the tasks were displayed above the supine participant 
using a wall-mounted flat screen television. A target word was displayed in congruous (i.e. the 
word “red” written in red) or incongruous colors (i.e the word “blue” written in the color red). 
Participants selected one of the four response items (presented below the target word in similar 
color scheme [congruous/incongruous] as the target word) that described the color of the target 
word as quickly and as accurately as possible. Participant’s accuracy was titrated by 
manipulating the intertrial timing intervals in order to produce similar hemodynamic responses. 
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The intertrial interval would decrease by 300 ms for every 3 consecutive trials answered 
correctly and vice versa for incorrect responses (minimum and maximum interval of 400 and 
5,000 ms, respectively). If the participant did not respond in time, a large “TOO LATE!” prompt 
was displayed before the next trial began. Accuracy (hits/[hits+incorrect]) and mean hit reaction 
times (RT) were recorded for analysis.  
Cerebrovascular Measures: 
Blood pressure  
Brachial SP and DP were taken in duplicate and subsequently averaged using an 
oscillometric device on the non-dominant arm (BP786N, Omron Healthcare Inc., Lakeforest, IL). 
If baseline values differed by >5 mmHg, a third measure was obtained and the average of the 
two closest measures was used for analyses. Carotid pressure waveforms were measured over 
a 10-s epoch via applanation tonometry (AtCor Medical, Sydney, Australia), ensemble averaged 
to a single waveform, calibrated to brachial mean pressure (MP) and DP, and used to derive 
carotid SP. MP and pulse pressure (PP) were calculated as 1/3 SP + 2/3 DP and SP – DP, 
respectively. Augmentation index (AIx) was derived from central pressure waveforms as the 
difference between the early (P1) and late (P2) systolic peaks of the pressure waveform to the 
total PP expressed as a percentage ([P2 − P1]/PP × 100) and standardized to a heart rate of 75 
b/min (AIx75). 
Extracranial Hemodynamics 
Aortic stiffness was measured using “gold standard” carotid-femoral (cf) pulse wave 
velocity (PWV). Applanation tonometry (described for carotid blood pressure) was used to 
capture pressure waveforms from the carotid and the femoral artery over a 10-s epoch along 
with ECG for simultaneous R-wave gating. PWV was calculated using the time delay between 
the carotid/femoral waveforms and the transit distance between the carotid and femoral arteries. 
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The time delay was calculated as the time from peak R-wave from simultaneous ECG gating to 
the foot of the corresponding pressure waveform. The distance between the carotid-femoral 
pulse sites was measured in mm using a tape measure and adjusted for the bi-directional 
nature of pressure propagation via subtracting the suprasternal notch – carotid distance from 
the suprasternal notch – femoral distance.  
The left CCA was imaged below the carotid bulb using ultrasound (ProSound α7, Aloka, 
Tokyo, Japan) and a 7.5-10.0 MHz linear-array probe simultaneously with carotid tonometry 
performed on the contralateral side. CCA diameters were measured from inside the near-wall 
intima-media to far-wall intima-media across a 5 mm region of interest via semi-automated 
digital calipers during systole and diastole (indicated by the T-wave and R-wave from 
simultaneous ECG gating, respectively). Mean diameter was calculated as (1/3 systolic 
diameter + 2/3 diastolic diameter). Mean blood velocity (Vm) was measured using Doppler- 
ultrasound with an insonation angle < 60° for all measures and sample volume manually 
adjusted to encompass the entire vessel. CCA Vm was calculated from an average of 6 ± 1 
consecutive waves as: Vm = ∫ V(t) dt/FT, where ∫ V(t) dt is the velocity-time integral of the 
velocity waveform and FT is flow time. CCA pulsatility index (PI) was derived via semi-
automated flow tracing software and the following equation: (Vs-Vd)/ Vm, where Vs is peak 
systolic velocity and Vd diastolic velocity. Mean blood flow was calculated as π x (1/3 systolic 
radius + 2/3 diastolic radius)2 x Vm x 60. Systolic, diastolic, and mean shear rates were 
calculated as 4 x velocity/diameter using their respective velocities and diameters. Pulsatile 
shear rate was calculated in the same manner as blood velocity PI. All images were stored for 
later offline analysis by a single investigator. 
Carotid stiffness was measured using eTracking software that continuously traced the 
distance from the near wall to far wall lumen-intima interface, creating a distension waveform 
analogous to pressure waveforms [272]. Distension waveforms were calibrated against CCA 
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systolic and diastolic pressures estimated via tonometry (described above). Carotid stiffness 
was calculated using a regional single-point PWV as PWV = �𝛽𝛽 𝑥𝑥 𝑃𝑃𝑀𝑀𝑀𝑀𝑀𝑀/2𝜌𝜌 , where β = 
ln(PMax/PMin)/[(DMax - DMin)/DMin] where P and D correspond to pressure and diameter 
respectively, and Max and Min refer to maximum (systolic) and minimum (diastolic) values 
during the cardiac cycle.  
Wave intensity analysis (WIA) was combined with eTracking to assess novel measures 
related to genesis of extracranial pulsatile hemodynamics that may influence intracranial NVC. 
Flow waveforms were measured using range gated color Doppler signals averaged along the 
Doppler beam. Wave intensity was calculated using time derivatives of blood pressure (P) and 
velocity (U), where wave intensity = (dP/dt x dU/dt); the area under the dP/dt x dU/dt curve 
represents the energy transfer of the wave. W1 is a forward-traveling compression wave 
produced by the left ventricle during early systole that increases pressure and accelerates flow 
as it travels downstream. Forward traveling energy waves in the CCA would be expected to 
increase hemodynamic pulsatility. The negative area (NA) occurring immediately following W1 is 
a backward-travelling compression wave caused by downstream wave reflections that increases 
pressure but decelerates flow. Wave reflections measured in the CCA are of cerebral origin, and 
as such, NA has been proposed as a measure of cerebrovascular tone [274]. The reflection 
index (RIx) was calculated as wave reflection intensity relative to forward wave intensity 
(NA/W1) and provides insight into pulsatile energy transmission into intracranial circulation. W2 
is a forward travelling expansion wave generated by the cessation of left ventricle contraction 
and initial untwist and relaxation. This suction wave creates a “braking” force, decreasing 
pressure while concomitantly decelerating the column of blood from behind [285,332,333] that 
could alter extracranial (i.e. CCA) pulsatility.  
Middle Cerebral Artery Hemodynamics  
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 MCA hemodynamics were measured via Transcranial Doppler (TCD) and a 2-MHz 
transcranial probe applied to the left temporal window at a depth of 50-65mm and secured using 
a headset to ensure optimal insonation angle/position throughout testing. The MCA was 
selected because it is the most commonly interrogated vessel in functional TCD studies, has a 
substantial body of literature linking it to clinical outcomes (reviewed in [334]), and responds to 
the Stroop task [263]. MCA hemodynamics were captured across 4 separate 6-second epochs 
distributed throughout each cognitive task (approximately every 30 s) that were subsequently 
averaged. The MCA Vm was calculated by a standard algorithm implemented on the device 
over a 6-s epoch with use of a fast Fourier transform. MCA PI was calculated using the same 
equation as CCA PI described above via an automated waveform tracking function. MCA 
conductance and pulsatile dampening factor were calculated as MCA Vm/MP and proximal PI 
(CCA)/distal PI (MCA), respectively. All measurements were taken by a single, trained 
investigator. 
Prefrontal cortex (PFC) oxygenation  
While transcranial Doppler provides a direct measure of blood flow velocity and potential 
oxygen supply, functional near infrared spectroscopy (NIRS) provides activation-dependent 
information on cortical hemodynamics related to oxygen extraction and tissue saturation. Thus, 
the combination of NIRS and TCD provides a more comprehensive appraisal of NVC. A small 
sensor containing transmitting/receiving optodes (Artinis, Portalite) was placed on the left side of 
the forehead (Broadman area Fp1 according to the international 10-20 System) with the 
receiving optode located 2 cm from the midline. The NIRS device was secured in position using 
a headband and headset to minimize ambient light interference and potential movement 
artifacts. Changes in oxygenated (O2Hb) and deoxygenated hemoglobin (HHb) were measured 
via NIRS at 25 Hz using a modified Lambert-Beer law algorithm from the transmitter with the 
deepest tissue penetration to ensure assessment of brain oxygenation while attempting to avoid 
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direct influence of changes in skin blood flow. Tissue saturation index (TSI) was calculated 
(TSI=O2Hb/tHb) x 100) by the NIRS system (via spatially resolved spectroscopy) from the light 
attenuation slope between emitting and detection probes. Total hemoglobin (THb) was 
calculated as the sum of O2Hb and HHb. An age-dependent path length factor was used to 
correct for light scattering in the tissue in participants <50 years of age. The path length was 
assumed constant at 6.61 for all participants >50 years of age. All NIRS data were measured 
continuously, binned, averaged for each task, and expressed as change from baseline.  
Respiration and skin temperature 
 We assessed end-tidal PCO2 and respiration rate using capnography and a nasal 
cannula to account for the effects of respiration on cerebral hemodynamics during NVC. To 
account for the effects of skin blood flow on the NIRS signal, forehead skin temperature (as a 
proxy of skin blood flow) was measured on the contralateral aspect of the forehead using a 
single thermocouple (4600 series, Measurement Specialties, Hampton, VA). Both end-tidal 
PCO2, respiration rate, and forehead skin temperature were assessed at the same time as 
blood pressure measures.  
Statistical Analyses 
 All data are reported as mean ± standard deviation and statistical significance was 
established a priori as p<0.05. Normality of distribution for variables was assessed using 
histograms, Q-Q plots, and Shapiro-Wilk tests. Non-normally distributed variables were 
transformed to meet normality assumptions prior to analyses. Mean differences in descriptive 
characteristics and resting hemodynamics were compared using t-tests. Differences in 
categorical descriptive variables were tested using χ2 tests. Accuracy and Stroop task RT were 
analyzed via t-test to assess differences in cognitive performance. The effects of task, HTN 
status, and interactions between task and HTN status were tested using a 2x3 (2 group [HTN, 
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no-HTN] x 3 task [baseline, congruent, incongruent]) repeated measures ANOVAs with 
Bonferroni correction for all cerebrovascular hemodynamics. PFC oxygenation (via NIRS) is 
expressed as change from baseline to each task. PFC oxygenation analyses were also tested 
while covarying for mean changes in skin temperature, and when expressed relative to MP 
(NIRS signal/MP). Pearson correlation coefficients were used to explore associations between 
cognitive performance, PFC oxygenation, and upstream hemodynamic pulsatility and extra-
cranial vessel stiffness.  
Results 
Group characteristics 
 Groups were well-matched for sex, age, anthropometics, body composition, lipid profile, 
depression symptomology, and menstrual status (Table 1). Glucose was significantly higher in 
HTN vs no-HTN (p<0.05); however, this difference was abolished when accounting for HTN 
participants on beta-blockers. The no-HTN group had higher mean minutes of moderate-to-
vigorous physical activity per day compared to HTN (p<0.05). Non-HTN medication use was 
similar in both groups, with the exception of statin use which was greater in HTN vs no-HTN 
(p<0.05).  
Blood pressure status and baseline hemodynamics 
 HTN participants had been diagnosed for an average of 129 ± 97 months. The time of 
day that HTN participants took their anti-HTN medication (63.3%, AM vs 33.0%, PM) was not 
different within the group (p=0.095), with one participant taking anti-HTN at both times of day. 
At-home blood pressure measurement confirmed HTN had higher SP (no-HTN 116 ± 9 mmHg; 
HTN 126 ± 12 mmHg), DP (no-HTN 73 ± 6 mmHg; HTN 79 ± 8 mmHg), and MP (no-HTN 88 ± 6 
mmHg; HTN 95 ± 9 mmHg; p<0.05) than no-HTN. Group differences in resting hemodynamics 
as assessed by t-tests are denoted in the baseline column of Tables 2-5. The only differences in 
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baseline vascular and cerebral hemodynamics between groups were brachial DP and MP which 
were higher in HTN than no-HTN (p<0.05).  
 
Cerebrovascular reactivity to cognitive activity 
Task performance 
 Mean hit RT was similar between groups for congruent (no-HTN 996 ± 143 ms; HTN 971 
± 92 ms) and incongruent tasks (no-HTN 1507 ± 295 ms; HTN 1543 ± 267 ms; p>0.05). 
Accuracy was not different between groups for congruent (no-HTN 95.3 ± 3.6%; HTN 95.5 ± 
3.1%) or incongruent (no-HTN 76.7 ± 11.4%; HTN 74.3 ± 10.2%; p>0.05).  
Heart rate, respiration, and blood pressure 
 Significant task effects were observed for heart rate, skin temperature, and respiration 
rate, which each increased from rest to both cognitive tasks (Table 2). Post-hoc analyses within 
the task effect indicated that heart rate was slightly, albeit significantly, higher during the 
incongruent compared to congruent tasks. A significant task effect was detected for end-tidal 
CO2, which decreased slightly from rest to each cognitive task. Significant task effects were also 
observed for brachial and carotid SP and PP and augmentation indices (AIx, AIx75) which 
increased from baseline to each cognitive perturbation (p<0.05; Table 3). Significant group and 
task effects were detected for brachial DP and MP. Brachial DP and MP was higher in the HTN 
versus no-HTN group and increased similarly from baseline to NVC perturbation (p<0.05). Post-
hoc analyses indicated brachial SP, DP, and MP were slightly but significantly higher during 
incongruent compared to congruent tasks. No significant group-by-task interactions were 
observed, indicating adults with and without HTN responded similarly to the cognitive 
perturbation.  
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Extracranial hemodynamics 
Significant task effects were observed for Vs, velocity PI, mean diameter, carotid mean 
blood flow, and systolic, diastolic and pulsatile shear rates (p<0.05; Table 4).  Carotid mean 
diameter, and mean blood flow increased, while Vs, and systolic, diastolic and pulsatile shear 
rates decreased from baseline to both cognitive tasks (p<0.05).  No significant effects of the 
NVC perturbation were detected for carotid conductance, MnV, Vd, or mean shear rate. 
Significant task effects were detected for cf PWV, carotid PWV-β, W1, NA and W2 (p<0.05; 
Table 5). Cf PWV, PWV-β, W1, and NA increased significantly from baseline to each cognitive 
task. Increases in carotid W2 from baseline were only significant during the congruent task 
(p<0.05). No significant group-by-task interactions were observed, indicating HTN and no-HTN 
groups had similar extracranial reactivity to the cognitive perturbation. 
Intracranial hemodynamics 
 A significant task effect was revealed for MCA MnV and pulsatile dampening factor, 
while MCA PI, RI, and conductance were not different during cognitive activity (Table 5). MCA 
MnV increased in both groups from baseline to cognitive activation (p<0.05). The pulsatile 
dampening factor decreased during the cognitive tasks (p<0.05). No significant group-by-task 
interactions were observed, indicating HTN and no-HTN groups responded similarly to the 
cognitive perturbation at the level of the MCA.  
 Significant group differences emerged with respect to prefrontal cortex oxygenation 
during the NVC perturbation. The change in O2Hb was greater in HTN vs no-HTN (p<0.05; 
Figure 1), as HTN increased significantly from baseline to each cognitive task, but no-HTN did 
not. HHb decreased similarly from baseline to NVC perturbation in both HTN and no-HTN 
(p<0.05). Group differences in prefrontal cortex O2Hb responses to the cognitive tasks remained 
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significant after covarying for changes in mean skin temperature (as an estimate of change in 
skin blood flow), and when expressed relative to MP.  
 
 
Vascular and cognitive associations 
 Exploratory associations between cerebrovascular hemodynamics and cognitive 
performance were performed separately for each iteration of the Stroop task (congruent vs 
incongruent) and are displayed in Tables 6-7. HTN and no-HTN groups were combined for 
exploratory analyses because of similar extra- and intra-cranial NVC. Of note, during the 
congruent task changes in PFC TSI were positively associated with Stroop accuracy and 
negatively associated with CCA PI. Changes in congruent CCA PI and PP were positively 
associated with MCA PI and CCA PWVβ, respectively. CCA pulsatile shear rate during the 
congruent task was positively associated with CCA and MCA PI. During the incongruent task, 
RT was positively associated with changes in PWVβ. Incongruent CCA PI and pulsatile shear 
rate were positively associated with MCA PI and inversely related to PFC TSI. Incongruent CCA 
PP was positively associated with MCA PI, mean CCA shear rate, and CCA PWVβ.  
Discussion 
 While select studies have interrogated the effect of HTN on cerebrovascular reactivity in 
response to CO2 manipulation, we sought to investigate extra- and intra-cranial cerebrovascular 
reactivity during a cognitive perturbation (i.e. NVC). Understanding this NVC in response to 
cognitive activity may have broader implications for cognitive function, particularly in the setting 
of HTN since this population is at a greater risk of dementia and cognitive decline [11]. Our data 
indicates that individuals with and without HTN had similar extra- and intra-cranial responses to 
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sustained neural activity to achieve NVC; however, HTN achieved PFC oxygenation with 
greater reliance on changes in O2Hb. A secondary aim of this investigation was to identify the 
contributions of extracranial stiffness and hemodynamic pulsatility to intracranial hemodynamics 
during NVC. We noted significant increases in extracranial vessel stiffness and disparate 
changes in extra- (decreased) vs intra-cranial hemodynamic pulsatility (unaltered) in both 
groups. Exploratory analyses indicated that extracranial pulsatility was associated with PFC 
oxygenation in the combined sample, suggesting that extracranial modulation of hemodynamic 
pulsatility may play a role in ensuring optimal NVC in middle-age adults with and without HTN.  
Hypertension, vascular stiffness and neurovascular coupling 
Although HTN is typically associated with accelerated vascular aging [329], we observed 
little evidence of early vascular aging in our cohort of middle-aged HTN. While brachial MP and 
DP were higher in HTN than no-HTN, average values were controlled to within normal ranges. 
Additionally, there were no significant group differences in large artery stiffness, a hallmark of 
vascular aging. These similarities in arterial stiffness are likely related to adequate blood 
pressure control in HTN, which may help slow the progression of arterial stiffening [275]. Heart 
rate, a contributor to aortic stiffness [277], was additionally similar between groups. Greater 
physical activity and less sedentary time is associated with slowing the progression of age-
related aortic stiffening [335]. Although no-HTN achieved ≈2,000 more steps/day and averaged 
≈10 more MVPA/day compared to HTN individuals, our data indicate both groups on average 
were physically active and achieved the recommended dose of 150 min/week of MVPA. Our 
groups also had similar blood lipids [336], body composition [337], subjective sleep quality [338], 
and depression symptomology [339], all of which can contribute to accelerated vascular aging. 
Additionally, statin use was higher in our adults with versus without HTN, which may have 
improved the arterial stiffness profile among our HTN group [340]. Taken together, these data 
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suggest our cohort of middle-aged adults with HTN was generally healthy, had well-controlled 
blood pressure and a low vascular risk factor burden.  
The use of anti-HTN medication in our HTN sample may have contributed to the similar 
NVC responses observed herein by influencing vascular health. While the direct effects of anti-
HTN medication on brain function is unclear [11,179,180], halting the progression of arterial 
stiffness (via anti-HTN therapy/blood pressure control) may indirectly benefit the brain by 
slowing pulsatility-mediated cerebrovascular damage secondary to vascular stiffness [9,158]. 
Indeed, aortic stiffness may not be associated with cerebral small vessel disease in adults with 
controlled HTN [123]. With regards to NVC specifically, animal-model research suggests anti-
HTN therapy may exert protective effects on the neurovascular unit [341] but may not restore 
NVC [342]. Overly aggressive blood pressure lowering may impair NVC in HTN [343] since NVC 
depends on adequate blood/perfusion pressure [326]. However higher MP, and thus perfusion 
pressure, in adults with HTN may overcome early changes in HTN-mediated intracranial 
remodeling to ensure adequate absolute flow during NVC. Ultimately it is currently unknown if 
acute or chronic use of anti-HTN medication can preserve NVC in humans and future research 
is needed to identify these effects.  
Contributions of vascular stiffness and pulsatility to neurovascular coupling 
 We noted significant increases in carotid and aortic stiffness during the Stroop 
irrespective of HTN status. This indicates middle-aged adults with and without HTN experience 
similar increases in large artery stiffness during the Stroop task as older adults, whereas large 
artery stiffness is unaltered in healthy young/middle-aged adults [261,263]. Increases in vessel 
stiffness during cognitive activity may stem from changes in blood pressure. Carotid and 
brachial systolic, diastolic, and MP increased during the Stroop task in both HTN and no-HTN 
groups. Adequate changes in intracranial flow during NVC is dependent on blood pressure 
[326].  Increases in pressure during cognitive activity would increase distension pressure within 
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the vessel and shift the pressure load burden to collagen fibers within the wall, thereby acutely 
stiffening the vessel [64]. Increases in blood pressure are an integral part of NVC [325] and may 
reflect the sympathetic response to the cognitive load (i.e. task difficulty/effort required) [344]. 
Ultimately, concomitant changes in carotid and aortic stiffness herein may help maintain 
impedance mismatch at the aortic-carotid interface, potentially protecting the 
cerebrovasculature from excessive transmission of pulsatile energy [9] during cognitive activity. 
These pressure-mediated changes in extracranial vessel stiffness during cognitive activity may 
alter the generation and transmission of extracranial pulsatility.  
 Despite increases in carotid pressure pulsatility (CCA PP), we noted decreases in 
carotid blood velocity pulsatility (PI) regardless of HTN status. These disparate changes in 
pulsatile hemodynamics during the Stroop may reflect changes in wave-transmission and 
reflection during cognitive activity. Carotid WIA is a novel means of appraising pulse wave 
contributions to extracranial pulsatility [279]. Left ventricular contraction generates a forward 
traveling compression wave (measured by WIA as W1) [285] that, when encountering cerebral 
vessels with increased vasomotor tone, can be reflected  toward the heart, creating a backward-
traveling expansion wave (measured as NA) [274]. Subsequent left ventricular relaxation 
creates a forward-traveling expansion wave that decelerates blood flow from behind as it moves 
downstream [285,332,333]. We observed increases in forward wave energy (W1) in both HTN 
and no-HTN during the Stroop task concomitant with equivalent increases in carotid reflected 
wave energy (NA), resulting in no net change in the amount of forward wave energy 
penetrating into the downstream cerebrovasculature. Increases in CCA reflected wave energy 
would be posited to 1) dampen pulsatile blood velocity by braking and slowing forward blood 
flow, and 2) augment pulsatile pressure (i.e. CCA PP) [345]. Additionally, we noted increases in 
W2 during cognitive activity and this is a novel observation. Small increases in this suction wave 
creates a “braking” force that may additionally contribute to attenuation of CCA blood velocity 
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pulsatility during cognitive activity. Ultimately, WIA suggests that these hemodynamic forces 
may work in concert to extinguish flow pulsatility in the large extracranial vessels, potentially 
minimizing pulsatile transmission into intracranial circulation.  
 MCA blood velocity PI was not significantly altered during the Stroop task in either HTN 
or no-HTN groups, similar to observations in healthy younger/middle-age adults [263]. 
Additionally, we noted reductions in the dampening of hemodynamic pulsatility in the MCA 
(assessed as pulsatile dampening factor; proximal/distal PI) during the Stroop task, largely 
driven by reductions in proximal (i.e. CCA) PI. This finding suggests that more pulsatility was 
buffered in the large extracranial vessels, thereby reducing reliance on intracranial pulsatile 
dampening during sustained cognitive activity. The exact reason for this response is unknown. 
Considering CCA and MCA PI were associated, this highlights the importance of reducing 
pulsatile hemodynamics in the extracranial vessels prior to entering the intracranial circulation 
where hemodynamic pulsatility could interfere with microvascular oxygenation during NVC.  
Contribution of flow to neurovascular coupling  
 We noted increased CCA diameter during the Stroop tasks in both HTN and no-HTN 
groups, consistent with our previous observations in healthy young/middle-aged adults [261]. 
Recent data suggests shear may influence extracranial dilation at the level of the internal but 
not common carotid artery [327,346,347], and our data support this. We noted no change in 
CCA mean shear rate during Stroop, accompanied by reductions in systolic, diastolic, and 
pulsatile shear rate. CCA dilation during stroop was not associated with shear rates (data not 
shown), which may reflect differing sensitivity to shear in the common versus downstream, 
internal carotid artery [327]. Increases in mean pressure may also contribute to carotid dilation 
[327,347] by pushing against the once compliant CCA wall, mechanically distending (increasing 
diameter) and simultaneously stiffening the vessel during NVC. Although our data may suggest 
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pressure plays a prominent role in mediating CCA dilation, the importance of shear in this 
setting should not be completely dismissed. Pressure-mediated stiffening may additionally 
increase the sensitivity to shear forces [327] as we noted a positive association between CCA 
stiffness and mean shear during the incongruent Stroop task. This stiffness-mediated change in 
shear sensitivity may facilitate faster functional changes in blood flow to intracranial circulation, 
however additional research is required to test this hypothesis. Ultimately, CCA dilation during 
cognitive activity occurs contrary to mild hypocapnia and any myogenic response from 
increased pressure that would be expected to constrict the vessel. This may suggest that 
functional CCA dilation during NVC may override constrictor stimuli, akin to observations during 
exercise in extracranial vessels [346], to ensure adequate increases in flow.   
 CCA dilation contributed to increases in CCA mean flow during Stroop, as mean velocity 
was unchanged. The brunt of this increase in extracranial blood flow can be transmitted 
intracranially to the ICA and eventually MCA [102]. We noted increases in MCA mean blood 
velocity during the Stroop task, regardless of HTN status. Increases in pressure partially 
contributed to this increase in blood flow, as flow expressed relative to pressure (i.e 
conductance) was unaltered in the CCA and MCA during the Stroop task. Ultimately, increases 
in both extra- and intra-cranial blood flow would be expected to feed downstream active 
vascular beds.  
 We assessed PFC oxygenation during the Stroop task using NIRS. Both no-HTN and 
HTN achieved similar PFC oxygenation (measured by TSI) during the Stroop tasks, but 
achieved this by slightly different means. In no-HTN, TSI was driven primarily by reductions in 
HHb during the Stroop task. TSI in HTN individuals was achieved via similar reductions in HHb, 
supplemented with increases in O2Hb during the Stroop task. Increased O2Hb and decreased 
HHb at the PFC during cognitive activity likely reflects increased neuronal metabolic demand 
and neurotransmitter release from active neurons (in this case engaged by the cognitive 
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task)[348], thereby eliciting local vasodilation [349] and modulating PFC hemodynamics to 
support cognitive activity. These changes in NIRS signals during the Stroop task remained 
when expressed relative to MP, indicating this hemodynamic response was not solely 
dependent on the increases in pressure that contributed to upstream increases in blood flow. 
Taken together, these data indicate that the functional changes in oxygenation required to 
support neural activity is largely intact in our middle-aged sample of controlled-HTN compared 
to their counterparts without HTN.  
Neurovascular coupling and task performance 
 We conducted exploratory analyses on our combined HTN and no-HTN sample to 
identify associations between extracranial stiffness, cerebrovascular pulsatility, PFC 
oxygenation, and task performance. Our data suggest that adults who increased their PFC TSI 
performed better on the congruent task, and that those adults who had greater increases in 
carotid stiffness responded slower on the incongruent task. Moreover, individuals who were not 
able to reduce CCA blood velocity pulsatility during the Stroop task had greater decreases in 
PFC TSI. Interestingly, changes in TSI were not associated with MCA PI, perhaps indicating 
extracranial vessels play a larger role in optimal NVC than originally thought. Indeed, 
extracranial vessels are now being recognized as key players in the regulation of brain blood 
flow [320]. Our data propose that extracranial reductions in blood velocity pulsatility may help 
maintain brain oxygenation of active neural circuitry within the PFC during cognitive 
engagement. Taken together, extracranial modulation of hemodynamic pulsatility may be an 
important part of optimal NVC to support brain oxygenation and ultimately cognitive function.  
Limitations and considerations 
 We tested adults with medicated HTN in order to interrogate cerebrovascular NVC as it 
would typically be in their “free-living” state. As such, NVC during cognitive activity may differ in 
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untreated middle-aged adults with HTN. We did not perform an extensive scan for carotid 
stenosis, however average intima-media thickness (≈0.63 mm) was indicative of minimal 
stenosis. Cerebrovascular hemodynamics were assessed unilaterally, thus we cannot comment 
on potential differences in lateralization in HTN. Changes in CCA shear rate were not 
associated with changes in diameter during cognitive activity. This could reflect differential 
sensitivity to shear compared to other extracranial vessels [327], or may reflect experimental 
limitations. We assessed shear at a single time point (potentially missing the peak shear 
stimulus) during sustained cognitive activity, which may limit the ability to tease out shear-
mediated regulation of extracranial flow because of a growing influence of confounding factors 
(blood pressure, PCO2 etc.) [347]. Thus, future studies are needed with greater temporal 
resolution of changes in extracranial shear, stiffness, and flow (including the internal carotid) to 
understand their complex interplay during cognitive activity. The NIRS signal may respond to 
changes in skin blood flow. Changes in NIRS signals, however, remained significant when 
covarying for mean change in forehead skin temperature (a proxy of skin blood flow), thus we 
do not believe changes in skin blood flow can solely explain the PFC oxygenation responses 
observed herein.  
Conclusion 
 Our study is the first to investigate NVC during sustained cognitive activity using multi-
modal cerebrovascular imaging (Ultrasound, TCD, and NIRS) in middle-aged, medicated HTN. 
Our data indicates that extra- and intra-cranial cerebrovascular reactivity during cognitive 
activity was largely maintained in this cohort of generally well-controlled HTN. Individuals with 
and without HTN exhibited similar 1) increases in blood pressure, blood flow/velocity, and 
aortic/carotid stiffness during cognitive activity; and similar 2) reductions in CCA blood velocity 
PI, but not MCA PI, and similar PFC oxygenation during cognitive activity. Additionally, our data 
suggests that extracranial modulation of hemodynamic pulsatility may have effects on 
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intracranial oxygenation at the PFC. Together these data suggest that well-controlled middle-
aged adults with HTN have similar cerebrovascular NVC as their counterparts without HTN, and 
that extracranial hemodynamics may play an important role in optimizing the manner in which 
blood flow is delivered (i.e. non-pulsatile) during NVC. 
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Table 7.1: Descriptive characteristics for no-HTN and HTN groups (mean ± SD 
unless otherwise noted). 
  No-HTN HTN p-value 
Sex (male/female) 16/14 16/14 - 
Age (yrs) 56 ± 6 56 ± 6 0.93 
Anthropometrics    
Height (cm) 169.8 ± 11.3 171.3 ± 9.6 0.57 
Weight (kg) 82.0 ± 13.3 82.4 ± 12.5 0.91 
Body fat (%) 32.2 ± 8.4 31.4 ± 6.9 0.69 
Body mass index (kg/m2) 28.3 ± 2.6 28.0 ± 3.3 0.71 
Medications, %(n)    
Statin 6.7 (2) 40.0 (12) 0.005 
Birth control 3.3 (1) 0.0 (0) - 
Hormone replacement therapy 3.3 (1) 3.3 (1) - 
Hypothyroid 3.3 (1) 3.3 (1) - 
ACE inhibitor - 43.3 (13) - 
ARB - 33.3 (10) - 
Diuretic - 20 (6) - 
β-Blocker - 13.3 (4) - 
CCB - 13.3 (4) - 
Combination therapy (≥2) - 20.0 (6)  
Atherosclerosis    
Intima-media thickness (mm) 0.61 ± 0.10 0.65 ± 0.12 0.18 
Lipid profile    
Hemoglobin (g/dL) 14.2 ± 0.9 13.8 ± 1.3 0.12 
Total cholesterol (mg/dL) 202 ± 39 192 ± 36 0.28 
HDL (mg/dL) 58 ± 17 56 ± 20 0.56 
Triglycerides (mg/dL) 103 ± 61 116 ± 56 0.28 
LDL (mg/dL) 128 ± 41 114 ± 30 0.17 
Non-HDL (mg/dL) 144 ± 44 136 ± 32 0.43 
Total cholesterol:HDL  4 ± 2 4 ± 1 0.89 
Glucose (mg/dL) 94 ± 9 102 ± 16 0.03 
Questionnaires    
CESD 6 ± 5 7 ± 4 0.71 
PSQI 5 ± 3 5 ± 3 0.45 
Physical activity    
6-day average steps (count/d) 10913± 4572 8765 ± 3046 0.06 
6-day average MVPA (min/d) 40 ± 24 29 ± 20 0.03 
ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; CCB, 
calcium-channel blocker; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
CESD, Center for Epidemiologic Studies Depression questionnaire; PSQI, 
Pittsburgh Sleep Quality Index; MVPA, moderate-vigorous physical activity.  
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Table 7.2: Brachial blood pressure, heart rate, end-tidal CO2, skin temperature in 
response to cognitive activity in adults with and without hypertension (HTN) (mean ± 
SD). 
Measure Baseline 
Congruent 
Stroop 
Incongruent 
Stroop G T GxT 
Heart rate (b/min)      
No-HTN 59 ± 10 66 ± 11* 67 ± 11*# 0.43 0.001 0.70 
HTN 61 ± 8 68 ± 9* 69 ± 9*#    
Skin temperature (oC)      
No-HTN 34.00 ± 0.83 34.52 ± 0.64* 34.51 ± 0.65* 0.42 0.001 0.85 
HTN 34.12 ± 0.66 34.64 ± 0.49* 34.64 ± 0.49*    
End-tidal CO2 (mmHg)      
No-HTN 35 ± 3 34 ± 3* 34 ± 3* 0.68 0.001 0.71 
HTN 35 ± 3 34 ± 3* 34 ± 3*    
Respiration note (br/min)     
No-HTN 14 ± 4 19 ± 5* 20 ± 4* 0.35 0.001 0.84 
HTN 14 ± 3 18 ± 5* 18 ± 5*       
G, group effect; T, time effect; GxT, group by time interaction. †p<0.05 t-test vs No-
HTN; †p<0.05 baseline t-test vs No-HTN; *p<0.05 time effect vs baseline; # time 
effect vs Congruent. 
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Table 7.3: Brachial and carotid blood pressure responses to cognitive activity in 
adults with and without hypertension (HTN) (mean ± SD). 
Measure Baseline 
Congruent 
Stroop 
Incongruent 
Stroop G T GxT 
Brachial systolic pressure (mmHg)     
No-HTN 122 ± 14 132 ± 16* 134 ± 17*# 0.15 0.001 0.80 
HTN 127 ± 13 138 ± 14* 139 ± 14*#    
Brachial diastolic pressure (mmHg)     
No-HTN 76 ± 8 80 ± 9* 81 ± 10*# 0.03 0.001 0.61 
HTN 81 ± 9† 85 ± 9* 86 ± 9*#    
Brachial pulse pressure (mmHg)     
No-HTN 47 ± 11 52 ± 12* 52 ± 13* 0.81 0.001 0.54 
HTN 46 ± 8 53 ± 10* 53 ± 8*    
Brachial mean pressure (mmHg)     
No-HTN 91 ± 9 98 ± 10* 99 ± 11*# 0.05 0.001 0.91 
HTN 96 ± 10† 102 ± 10* 104 ± 10*#    
Systolic pressure (mmHg)      
No-HTN 113 ± 13 121 ± 14* 121 ± 15* 0.08 0.001 0.45 
HTN 118 ± 13 126 ± 13* 128 ± 14*    
Pulse pressure (mmHg)      
No-HTN 37 ± 10 41 ± 12* 40 ± 12* 0.73 0.001 0.20 
HTN 37 ± 7 41 ± 9* 43 ± 9*    
AIx (%)       
No-HTN 17 ± 19 19 ± 21 22 ± 17 0.42 0.102 0.48 
HTN 21 ± 15 24 ± 13 23 ± 13    
AIx75 (%)       
No-HTN 9 ± 19 15 ± 21* 18 ± 17* 0.52 0.001 0.61 
HTN 15 ± 15 21 ± 14* 21 ± 13*    
AIx, augmentation index; AIx75, augmentation index at 75 b/min; G, group effect; T, 
time effect; GxT, group by time interaction. †p<0.05 baseline t-test vs No-HTN; 
*p<0.05 time effect vs baseline; # time effect vs Congruent. 
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Table 7.4: Extracranial flow responses to cognitive activity in adults with and without 
hypertension (HTN) (mean ± SD). 
Measure Baseline 
Congruent 
Stroop 
Incongruent 
Stroop G T GxT 
Systolic velocity (cm/s)      
No-HTN 73.9 ± 16.9 70.2 ± 13.8* 70.2 ± 15.7 0.65 0.02 0.70 
HTN 74.5 ± 12.4 71.7 ± 11.6* 72.7 ± 14.9    
Diastolic velocity (cm/s)      
No-HTN 21.0 ± 5.5 20.6 ± 4.6 20.0 ± 4.3 0.26 0.65 0.37 
HTN 21.7 ± 4.1 21.3 ± 3.7 22.0 ± 5.0    
Mean velocity (cm/s)      
No-HTN 35.3 ± 5.2 35.4 ± 5.5 35.4 ± 5 0.08 0.53 0.71 
HTN 37.4 ± 5.8 37.8 ± 5.6 38.6 ± 7    
Velocity PI       
No-HTN 1.525 ± 0.369 1.42 ± 0.30* 1.42 ± 0.40* 0.24 
0.00
1 0.84 
HTN 1.418 ± 0.279 1.35 ± 0.26* 1.31 ± 0.20*    
Mean diameter (mm)      
No-HTN 5.67 ± 0.54 5.86 ± 0.58* 5.84 ± 0.57* 0.31 
0.00
1 0.18 
HTN 5.55 ± 0.66 5.67 ± 0.65* 5.71 ± 0.69*    
Mean flow (mL/min)      
No-HTN 530 ± 101 571 ± 129* 566 ± 116* 0.85 
0.00
1 0.72 
HTN 536 ± 92 563 ± 90* 577 ± 116*    
Conductance (mL/s/mmHg)      
No-HTN 5.89 ± 1.37 5.89 ± 1.37 5.79 ± 1.26 0.41 0.77 0.59 
HTN 5.63 ± 1.17 5.55 ± 1.05 5.62 ± 1.32    
Systolic shear rate (/s)      
No-HTN 504.5 ± 131.0 464.3 ± 106.3* 464.7 ± 119.8* 0.35 
0.00
1 0.67 
HTN 523.6 ± 117.6 495.3 ± 107.8* 501.4 ± 132.9*    
Diastolic shear rate (/s)      
Non-HTN 154.5 ± 48.5 145.9 ± 39.6* 143.0 ± 39.4* 0.22 0.04 0.45 
HTN 164.1 ± 44.2 156.4 ± 38.0* 161.9 ± 47.3*    
Mean shear rate (/s)      
Non-HTN 252.0 ± 51.0 244.8 ± 52.4 245.2 ± 50.9 0.12 0.21 0.87 
HTN 277.0 ± 68.0 272.3 ± 64.1 274.6 ± 74.3    
Shear rate PI      
No-HTN 1.40 ± 0.35 1.31 ± 0.28* 1.32 ± 0.38* 0.53 
0.00
1 0.39 
HTN 1.32 ± 0.27 1.26 ± 0.25* 1.23 ± 0.20*    
PWV, pulse wave velocity; cf, carotid-femoral; PI, pulsatility index; NA, negative area; RIx, 
reflection index. G, group effect; T, time effect; GxT, group by time interaction. †p<0.05 
baseline t-test vs No-HTN; *p<0.05 time effect vs baseline; # time effect vs Congruent. 
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Table 7.5: Extracranial vessel stiffness and hemodynamic pulsatility responses to cognitive 
activity in adults with and without hypertension (HTN) (mean ± SD). 
Measure Baseline 
Congruent 
Stroop 
Incongruent 
Stroop G T GxT 
cf PWV (m/s)       
No-HTN 7.8 ± 1.1 8.0 ± 1.1* 8.3 ± 1.3* 0.10 0.005 0.65 
HTN 8.3 ± 1.3 8.7 ± 1.6* 8.7 ± 1.4*    
PWVβ (m/s)      
No-HTN 6.3 ± 1.0 6.6 ± 1.0* 6.5 ± 1.0* 0.07 0.001 0.45 
HTN 6.6 ± 1.3 7.1 ± 1.3* 7.2 ± 1.2*    
W1  (mmHg/m/s3)      
No-HTN 6.3 ± 2.8 9.1 ± 4.2* 8.9 ± 4.7* 0.82 0.001 0.19 
HTN 6.8 ± 3.0 8.2 ± 3.6* 9.6 ± 5.6*    
NA (mmHg/m/s2)  
No-HTN 26.7 ± 19.0 29.8 ± 17.5 29.3 ± 17.9* 0.99 0.03 0.41 
HTN 23.4 ± 10.5 27.1 ± 14.2 32.2 ± 20.9*    
RIx (%)       
No-HTN 4.32 ± 2.48 3.37 ± 1.39 3.58 ± 1.85 0.83 0.11 0.46 
HTN 3.59 ± 1.35 3.55 ± 1.95 3.64 ± 1.58    
W2 (mmHg/m/s3)      
No-HTN 1.8 ± 0.7 2.1 ± 1.2* 2.2 ± 1.1 0.39 0.04 0.64 
HTN 1.9 ± 0.7 2.5 ± 1.7* 2.3 ± 1.1       
PWV, pulse wave velocity; cf, carotid-femoral; NA, negative area; RIx, reflection index. G, 
group effect; T, time effect; GxT, group by time interaction. †p<0.05 baseline t-test vs No-
HTN; *p<0.05 time effect vs baseline; # time effect vs Congruent. 
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Table 7.6: Intracranial (middle cerebral artery) hemodynamic responses to 
cognitive activity in adults with and without hypertension (HTN) (mean ± SD). 
Measure Baseline 
Congruent 
Stroop 
Incongruent 
Stroop Group Time GxT 
Mean velocity (cm/s)      
No-HTN 60 ± 15 64 ± 15 65 ± 15 0.48 0.001 0.54 
HTN 63 ± 11 66 ± 12 67 ± 12    
PI       
No-HTN 0.78 ± 0.12 0.77 ± 0.13 0.78 ± 0.13 0.39 0.17 0.85 
HTN 0.76 ± 0.11 0.74 ± 0.11 0.74 ± 0.1    
RI       
No-HTN 0.53 ± 0.04 0.53 ± 0.05 0.53 ± 0.05 0.33 0.72 0.66 
HTN 0.52 ± 0.05 0.52 ± 0.05 0.52 ± 0.04    
Conductance (cm/s/mmHg)     
No-HTN 0.67 ± 0.18 0.67 ± 0.15 0.67 ± 0.16 0.80 0.44 0.70 
HTN 0.66 ± 0.13 0.65 ± 0.14 0.65 ± 0.13    
Pulsatility dampening 
factor      
No-HTN 1.82 ± 0.29 1.74 ± 0.27 1.71 ± 0.29 0.52 0.001 0.90 
HTN 1.77 ± 0.29 1.71 ± 0.24 1.66 ± 0.23    
PI, pulsatility index; RI, resistance index; G, group effect; T, time effect; GxT, 
group by time interaction. †p<0.05 baseline t-test vs No-HTN; *p<0.05 time effect 
vs baseline; # time effect vs Congruent. 
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Table 7.7: Exploratory associations between extra- and intra-cranial hemodynamics and 
congruent Stroop performance. 
  %Hits RT 
ΔPFC 
TSI 
ΔMCA 
PI 
ΔCCA 
PI 
ΔCCA 
PP 
ΔCCA 
SR-PI 
ΔCCA 
SR 
ΔCCA 
PWVβ 
RT -0.52         
ΔTSI 0.27 -0.25        
ΔMCA PI 0.01 0.00 -0.15       
ΔCCA PI -0.18 0.07 -0.26 0.41      
ΔCCA PP 0.07 -0.20 -0.10 0.11 -0.07     
ΔCCA SR-PI -0.21 -0.05 -0.18 0.26 0.76 -0.05    
ΔCCA SR -0.14 0.06 -0.15 0.01 -0.02 0.03 0.03   
ΔCCA PWVβ -0.12 -0.06 -0.11 -0.07 -0.05 0.48 0.00 0.00  
ΔCF PWV -0.06 0.20 -0.05 -0.06 0.02 -0.02 0.11 0.03 -0.19 
RT, reaction time; PFC, prefrontal cortex; TSI, tissue saturation index; MCA, middle cerebral 
artery; PI, pulsatility index; CCA, common carotid artery; PP, pulse pressure; SR, shear rate; 
PWV, pulse wave velocity. Bold p<0.05 . 
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Table 7.8: Exploratory associations between extra- and intra-cranial hemodynamics and 
incongruent Stroop performance. 
  %Hits RT 
ΔPFC 
TSI 
ΔMCA 
PI 
ΔCCA 
PI 
ΔCCA 
PP 
ΔCCA 
SR-PI 
ΔCCA 
SR 
ΔCCA 
PWVβ 
RT -0.52         
ΔTSI 0.06 -0.21        
ΔMCA PI -0.02 0.13 -0.21       
ΔCCA PI 0.05 0.23 -0.33 0.42      
ΔCCA PP -0.07 0.12 -0.08 0.26 -0.09     
ΔCCA SR-PI 0.02 0.13 -0.33 0.33 0.79 0.04    
ΔCCA SR -0.07 -0.06 0.06 0.12 -0.13 0.28 -0.04   
ΔCCA PWVβ -0.13 0.30 -0.22 0.18 0.09 0.54 0.05 0.26  
ΔCF PWV 0.18 -0.09 -0.05 -0.15 -0.10 -0.03 -0.06 -0.01 0.01 
RT, reaction time; PFC, prefrontal cortex; TSI, tissue saturation index; MCA, middle cerebral 
artery; PI, pulsatility index; CCA, common carotid artery; PP, pulse pressure; SR, shear rate; 
PWV, pulse wave velocity. Bold p<0.05 . 
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Figure 7.1: Changes in prefrontal cortex oxygenation during congruent and incongruent 
Stroop tasks adults with and without hypertension (HTN) for a) tissue saturation index (TSI), 
b) total (THb), c) oxy- (O2Hb), and d) deoxyhemoglobin (HHb).  
Effects, ΔTSI (group 0.286; time 0.141; group x time 0.088), ΔTHb (group 0.182; time 0.001; 
group x time 0.066), ΔO2Hb (group 0.404; time 0.001; group x time 0.048), ΔHHb (group 
0.106; time 0.001; group x time 0.591). *p<0.05 vs baseline, # p<0.05 vs Congruent. 
No-HTN HTN 
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Chapter VIII: Summary, Future Directions, and Conclusions 
The presence of hypertension (HTN) in middle-age is important as this population is 
particularly vulnerable to later-life development of cognitive and cardiovascular disease [11,55]. 
Identifying means to attenuate the burden of cardiovascular and cognitive diseases in this at 
risk, middle-aged population is critical to improve quality of life, reduce healthcare costs, and 
reduce societal burden [241,242]. This study sought to investigate the effects of an acute bout 
of aerobic exercise of a recommended dose/intensity on arterial stiffness and cognitive function 
in middle-aged adults with and without HTN.  
Our initial hypotheses were largely unsupported by our findings (Figure 8.1). Acute 
exercise resulted in similar responses in adults with and without HTN, manifesting as increased 
aortic stiffness and cerebrovascular hemodynamic pulsatility, and accelerated reaction time on 
executive function and memory tasks in the absence of changes in accuracy. This suggests that 
Figure 8.1: Hypothesized and observed responses to acute exercise between adults with 
hypertension (red arrows) and adults without hypertension (green arrows). 
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improvements in post-exercise cognitive function occurred immediately following a time of 
increased arterial stiffness and cerebrovascular pulsatility. This is somewhat contradictory, as 
greater arterial stiffness and pulsatility are generally associated with reduced cognitive function 
at rest. These observations indicate that acute changes in vascular hemodynamics post-
exercise may not directly influence cognitive function. Rather, improvements in cognitive 
function, manifesting as accelerated reaction time, may stem from changes in brain-derived 
neurotrophic factor (BDNF) [350,351]. BDNF release appears dependent on cerebrovascular 
endothelium-derived nitric oxide [352], which may be released in response to shear stress 
and/or oxidative stress that occurs with exercise [353]. As such, facilitation of cognitive function 
post-exercise may be of indirect vascular origin by increasing BDNF release via shear stress. 
While were adequately powered to detect significant effects of exercise, we did not 
observe many HTN effects or HTN-by-exercise effects in our sample. This suggests that either 
1) we were not adequately powered to detect such effects, or 2) exercise did not result in 
meaningful differential responses between our sample of middle-aged adults with well-controlled 
HTN and those without HTN. Post-hoc power analyses (see Table 8.1) suggest that while an 
additional 16 subjects may have revealed differential responses to exercise for aortic stiffness 
between groups, the majority of remaining major outcomes would require a substantially larger 
sample. Thus, we do not believe we missed capturing any meaningful differences between 
groups based solely on sample size. As such, our data suggest the exercise responses 
between our groups were largely similar, giving way to small effect sizes for vascular and 
cognitive outcomes. It is possible, however, that a less well-matched sample, or group with 
more severe HTN might increase effects (discussed further below).  
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Table 8.1: Observed η2, effect sizes, and required sample size per group to detect significant 
main effects at a power of 0.8. 
  HTN effect Exercise effect HTN x exercise interaction 
  η2 
Effect 
Size f N/group η2 
Effect 
Size f N/group η2 
Effect 
Size f N/group 
  cf PWV 0.05 0.24 19 0.20 0.50 6 0.03 0.16 38 
Carotid artery         
  β-stiffness 0.02 0.14 52 0.02 0.15 47 0.02 0.13 62 
  Mean diameter 0.01 0.07 197 0.11 0.35 9 0.01 0.07 197 
  Blood velocity PI 0.02 0.12 66 0.16 0.44 7 0.01 0.09 123 
  W1 0.00 0.01 9812 0.28 0.62 4 0.00 0.03 982 
  Negative area 0.02 0.15 47 0.13 0.39 8 0.01 0.09 123 
MCA        
  Blood velocity PI 0.02 0.14 55 0.15 0.41 7 0.01 0.09 123 
  Mean velocity 0.00 0.05 491 0.00 0.01 9812 0.09 0.32 11 
Reaction times         
  Flanker 0.01 0.07 205 0.34 0.73 4 0.02 0.11 4920 
  N-Back 0.04 0.21 24 0.05 0.23 20 0.00 0.06 328 
  Memory  0.02 0.16 41 0.10 0.32 11 0.00 0.01 9812 
 
Based on findings from Aim 1 and 2, we examined an exploratory Aim 3 to probe 
additional vascular contributions to cognitive function using a novel experimental design by 
comparing vascular hemodynamic responses during cognitive activity (neurovascular coupling 
[NVC]) in middle-aged adults with and without HTN. Similar to Aims 1 and 2, our hypotheses 
were largely rejected (Figure 8.2). We noted both adults with and without HTN exhibited similar 
increases in arterial stiffness and reductions in extracranial (i.e. carotid) pulsatility, and cerebral 
oxygenation (although adults with HTN appeared to do so with greater reliance on oxy- rather 
than de-oxygenated hemoglobin) during cognitive activity. Additionally, our data propose that 
modulation of hemodynamic pulsatility outside of the brain (i.e. extracranially) may impact tissue 
oxygenation in the brain. In total, the findings from these aims indicate that compared to adults 
without HTN, well-controlled middle-aged adults with HTN have similar 1) vascular and cognitive 
responses to acute exercise, and 2) cerebrovascular NVC during cognitive activity. 
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Implications 
A major implication of our data is that middle-aged adults with HTN may not suffer from 
overt accelerated vascular aging, cognitive dysfunction, or cerebrovascular dysfunction at this 
stage of life compared to their counterparts free of HTN. Additionally adults with HTN appear to 
respond similarly to acute perturbations like exercise and cognitive activity. Of note, we believe 
the similar responses documented herein may largely stem from the general health status of our 
adults with controlled HTN compared to their counterparts without HTN. Our cohort of adults 
with controlled HTN had adequately controlled blood pressure and cholesterol, and achieved 
the recommended levels of physical activity on average. The pleiotropic benefits of certain anti-
HTN and cholesterol-lowering medications (such as ACE-inhibitors and statins) may extend 
beyond lowering blood pressure/cholesterol and helped contribute to preserved vascular 
function and reactivity in our sample. Ultimately, this combination of lifestyle and pharmaceutical 
Figure 8.2: Hypothesized and observed responses during cognitive activity (i.e. NVC) between 
adults with hypertension (red arrows) and adults without hypertension (green arrows). 
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control of cardiovascular risk factors likely ameliorated detrimental changes in vascular and 
cognitive function that have previously been observed in middle-aged adults with HTN. As such, 
our findings highlight the importance of lifestyle and pharmaceutical management and control of 
HTN. While HTN control and general health status may have helped attenuate differences in 
vascular and cognitive function between middle-aged adults with and without HTN in our study, 
it should be underscored adults with controlled-HTN still experience greater cardiovascular 
disease risk [354,355].   
Data indicates that blood pressure control may not ameliorate cardiovascular risk [355-
359]. Indeed, middle-aged individuals using anti-HTN medication still have ≈10% lower 
probability of survival compared to adults without HTN [357] and 46-75% greater risk of 
cardiovascular disease (cardiovascular death/events, coronary heart disease, and stroke) after 
adjustment for standard risk factors (i.e. age, blood pressure, cholesterol) [355]. Residual 
cardiovascular risk in this setting may stem from anti-HTN treatment’s inability to reverse 
underlying cardiovascular structural/functional changes induced by HTN [360]. Some anti-HTN 
medications may reduce brachial blood pressure without consistently reducing vessel stiffness 
[13,14,184], giving way to observations of greater vessel stiffness in HTN, regardless of blood 
pressure control [276]. Additionally, anti-HTN medication may exert differential effects on more 
clinically relevant central blood pressure compared to brachial (i.e. peripheral) blood pressure 
[361]. As such, controlled blood pressure in HTN may not necessarily restore vascular structure 
(vessel stiffness, central blood pressure) and function to normal levels, and thus cardiovascular 
risk may remain elevated. For this reason, research and lifestyle interventions intended to 
prevent the development of HTN are still critical in reducing the burden of HTN and 
cardiovascular disease. 
Aerobic fitness and physical activity are two important factors that contribute to blood 
pressure control and cardiovascular disease risk. Our adults without HTN were significantly 
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more fit (assessed via VO2peak), had higher levels of physical activity, and had slightly lower 
average blood pressure at home. This could suggest that this group of middle-aged adults relied 
on greater amounts of physical activity and aerobic fitness to “control” their blood pressure and 
prevent the development of HTN. If this was the case, there should be an inverse relationship 
between fitness/physical activity and blood pressure in our adults without HTN. We noted no 
such associations between mean pressure and average step count (r=0.076, p=0.69), average 
minutes of MVPA (r=0.22, p=0.23), or VO2peak (r=-0.20, p=0.28) in our adults without HTN. 
This suggests that differences in physical activity/fitness were not the sole determinants of lower 
blood pressure in our adults without HTN compared to those with HTN. Similar insignificant 
relationships were documented in our cohort of adults with HTN (mean pressure vs steps [r=     
-0.11, p=0.55], MVPA [r= -0.08, p=0.67], VO2peak [r= -0.01, p=0.96]). There was, however, a 
modest association (r= -0.23) between VO2peak and mean pressure in the group as a whole, 
however, that approached statistical significance (p=0.07), suggesting aerobic fitness may play 
some role in blood pressure control in middle-aged adults regardless of HTN status.  
AHA recognizes intervening in mid-life HTN is key for late-life cognitive function [129]. 
Blood pressure control is associated with slower progression of arterial stiffening [275] reduced 
cerebral small vessel disease and brain atrophy [123,362], and improved cognitive function 
[362,363]. While some evidence indicates certain anti-HTN medications are beneficial for 
cognitive health [180,364,365], AHA and others suggest the direct effects of anti-HTN treatment 
and cognitive function are unclear and require further scrutiny [11,129,179]. As such, adequate 
blood pressure control and anti-HTN therapy in middle-aged adults may help slow vascular and 
brain aging explain why we noted no differences in vascular or cognitive function between our 
groups. The generally well-controlled HTN seen in our study may have also reflected that we 
excluded individuals with depression, condition known to reduce adherence to cardiovascular 
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medication [366]. Thus, differences between adults with and without HTN may emerge with 
inclusion of this co-morbidity.  
Recent literature suggests that HTN severity and length of time exposed to HTN may be 
the predominant driver of differences between adults with and without HTN. Adults with more 
severe HTN (i.e. stage II) have higher arterial stiffness, and worse cerebrovascular reactivity 
and cognitive performance than adults with less severe HTN (i.e. stage I) or no HTN [367]. 
Similarly, cognitive impairment in this population appears related to HTN severity [302]. 
Univariate associations within our sample largely echo these observations (see Table 8.2). We 
noted that individuals with greater exposure to HTN (time since diagnosis) had stiffer arteries, 
greater pulsatile load and atherosclerotic burden, and lower cognitive performance. Additionally, 
those adults with more severe HTN (i.e. higher blood pressure) had stiffer arteries and lower 
memory recognition performance. These data further highlight the importance of early 
intervention and blood pressure control in slowing the detrimental cumulative effects of HTN.
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Table 8.2: Univariate associations between hypertension history, at-home blood pressure, vascular health, 
cognition, and fitness/activity in middle-aged adults with controlled hypertension (n=30). 
   HTN 7-day at home blood pressure Vascular health Cognition Fitness Activity 
  HX SP DP MP PP PL IMT MCA PI Cf PWV WM ATTN MEM VO2peak Avg steps 
SP 0.25              
DP 0.08 0.75             
MP 0.16 0.91 0.96            
PP 0.30 0.72 0.07 0.36           
PL 0.38 0.70 0.30 0.50 0.73          
IMT 0.51 0.16 0.04 0.10 0.20 0.31         
MCA PI -0.06 -0.08 -0.46 -0.32 0.37 -0.02 0.01        
Cf PWV 0.41 0.26 0.15 0.21 0.23 0.36 0.28 -0.03       
WM  -0.37 -0.24 -0.19 -0.23 -0.15 -0.22 -0.47 0.05 0.01      
ATTN  -0.48 -0.06 0.21 0.10 -0.31 -0.28 -0.47 -0.09 0.00 0.59     
MEM  -0.47 -0.45 -0.37 -0.43 -0.28 -0.40 -0.03 0.03 -0.07 0.37 0.27    
VO2peak -0.05 0.10 -0.08 -0.01 0.23 -0.02 -0.40 0.08 -0.17 -0.21 -0.17 -0.06   
Avg steps 0.43 0.02 -0.20 -0.11 0.24 0.20 0.00 0.14 0.11 -0.39 -0.41 -0.35 0.51  
Avg MVPA 0.44 0.02 -0.14 -0.08 0.18 0.10 -0.10 0.18 0.08 -0.31 -0.22 -0.30 0.51 0.86 
HTN HX, self-reported duration of hypertension; SP, systolic pressure; DP, diastolic pressure; MP, mean pressure; PP, pulse 
pressure; PL, pulsatile load; IMT, intima-media thickness; MCA, middle cerebral artery; PI, pulsatility index; cf PWV, carotid-
femoral pulse wave velocity; WM, working memory accuracy (n-back); ATTN, attention accuracy (Flanker); MEM, memory 
recognition accuracy. 
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In November of 2017, after conclusion of the current study, AHA and collaborating 
governing bodies released new guidelines for the diagnosis, treatment, and management of 
hypertension [368]. The new guidelines now classify individuals with blood pressure >130 
mmHg systolic and/or >80 mmHg diastolic, as hypertensive. With this shift, the number of 
American’s with HTN increased from 32% to nearly half of all adults (46%) [369]. The 
guidelines, however, now take cardiovascular risk scores (Pooling Cohort 10-yr Cardiovasuclar 
disease risk estimations ≥10%) and age (≥65 yrs) into account prior to initiating pharmaceutical 
treatment of individuals with stage I HTN (130-139 mmHg systolic, 80-89 mmHg diastolic) [368]. 
As such, nearly 68.7% of individuals with stage 1 HTN will not qualify for pharmaceutical 
treatment, but will be treated with non-pharmaceutical therapy (i.e. weight loss, low sodium/high 
potassium diet, exercise/physical activity, and moderation of alcohol intake) [369]. Within our 
sample of middle-aged adults, 10 individuals without HTN would be reclassified by the new 
guidelines as having HTN. All of our “new HTN” individuals were <65 yrs of age, and only 1 
would have qualified for pharmaceutical intervention according to the new guidelines (risk score 
≥10%). The new guidelines would not have drastically altered our comparison of adults with 
medically-controlled HTN versus individuals without HTN. Interestingly, under resting conditions, 
those “new HTN” individuals were more phenotypically similar to the HTN group, exhibiting 
comparable arterial stiffness and blood pressure (see Table 8.3). This observation echoes the 
new guidelines that suggest those with blood pressure between 130/80 mmHg and 139/89 
mmHg may be at similar risk as those >140/90 mmHg. Ultimately, all groups in our study 
(regardless of “new” or “old” HTN status) responded similarly to the perturbations of acute 
exercise and cognitive activity.  
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Table 8.3 Descriptive characteristics for normotensive (n=20), “≥130/80 HTN” (i.e. new 
2017 guidelines; n=10), and “≥140/90 HTN” (i.e. previous 2003 guidelines; n=30). 
  Normotensive “≥130/80” HTN “≥140/90” HTN p 
  Sex (male/female) 9/11 7/3 16/14 0.43 
  Age (yr) 56 ± 6 56 ± 6 56 ± 6 1.00 
  Body fat (%) 32.8 ± 9.1 31 ± 7.3 31.4 ± 6.9 0.77 
  Body mass index (kg/m2) 28.3 ± 2.3 28.3 ± 3.2 28.0 ± 3.3 0.94 
  VO2peak (ml/kg/min) 32.6 ± 9.5 32.1 ± 7.5 27.2 ± 5.6† 0.03 
  Avg steps (#) 10926 ± 4145 10885 ± 5574 8765 ± 3046 0.11 
  Avg MVPA (min) 38.7 ± 23 44 ± 28 29 ± 20 0.13 
At-home blood pressure   
  Systolic pressure (mmHg) 111 ± 6 126 ± 5† 126 ± 12† 0.01 
  Diastolic pressure (mmHg) 71 ± 5 78 ± 7 79 ± 8† 0.01 
  Mean pressure (mmHg) 85 ± 4 94 ± 5† 95 ± 9† 0.01 
  Pulse pressure (mmHg) 40 ± 7 48 ± 9† 47 ± 8† 0.01 
  Pulsatile load (mmHg/min) 2509 ± 298 2983 ± 470 3150 ± 602a 0.01 
Aortic stiffness    
  cf PWV (m/s) 7.6 ± 1.1 8.4 ± 0.9 8.2 ± 1.3 0.09 
Middle cerebral artery   
  Mean velocity (cm/s) 59 ± 16 63 ± 11 63 ± 11 0.55 
  Blood velocity PI 0.78 ± 0.11 0.78 ± 0.15 0.76 ± 0.11 0.74 
Common carotid artery   
  IMT (mm) 0.61 ± 0.09 0.63 ± 0.11 0.65 ± 0.12 0.38 
  Blood velocity PI 1.399 ± 0.341 1.48 ± 0.347 1.336 ± 0.261 0.42 
  β-Stiffness 7.7 ± 1.9 9.5 ± 2.8 8.7 ± 3 0.19 
Cognition    
  Working memory (%) 65.0 ± 20.0 71.0 ± 26.0 73.5 ± 15.6 0.32 
  Attention (%) 99.0 ± 1.5 98.5 ± 1.7 98.4 ± 2.5 0.60 
  Memory recognition (%) 49.8 ± 20.7 55.7 ± 22.1 54.5 ± 17.7 0.69 
MVPA, moderate-to-vigorous physical activity; cf PWV, carotid-femoral pulse wave 
velocity; PI, pulsatility index; cognition displayed as %accuracy from working memory (N-
back), attention (Flanker), and memory recognition tasks. †p<0.05 vs normotensive. 
 
The new HTN guidelines represent a purposeful attempt to slow the growing burden that 
results from cumulative exposure to high blood pressure. However, these new guidelines still 
may not account for a critical component of long-term cardiovascular and cognitive disease risk: 
arterial stiffness. Arterial stiffness may be an underlying cause of HTN that precedes changes in 
blood pressure [6,7,65-72]. There is considerable evidence that arterial stiffness and the 
accompanying pulsatile hemodynamics predicts target organ damage and cardiovascular/ 
cognitive disease risk [6,66,77,82,83,95-101]. Data suggests arterial stiffness, rather than blood 
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pressure per se, may account for residual cardiovascular disease risk among adults with and 
without HTN [276]. Standardization of measurement for arterial stiffness is improving and is 
used widely in Europe, but has not been adapted in the US despite substantial utility in 
predicting cardiovascular disease risk [55]. As such, future guidelines should begin to 
incorporate the growing evidence that arterial stiffness may serve as one of the earliest and 
most robust indicators of target-organ damage and future disease risk.   
Future Directions 
 Further studies investigating vascular and cognitive function following exercise in the 
setting of HTN should consider inclusion of additional groups to expand application of their 
findings to beyond those with well-controlled HTN. Comparing exercise effects in adults without 
HTN, with uncontrolled HTN, controlled HTN (medication and blood pressure <130/80), and 
inadequately controlled HTN (medication and blood pressure >130/80). While a substantial 
undertaking, this expansive group comparison would allow interrogation of multiple important 
aspects of HTN (severity, length of diagnosis, role of medication use) in all relevant subgroups 
of HTN (inadequately controlled, controlled, uncontrolled). This design would facilitate an 
intricate investigation of how HTN (in all of its major clinical forms) effects vascular and cognitive 
responses to exercise.  
 We investigated the effects of exercise on cognition using a pre/post design, repeating 
cognitive testing on a single day. While this reduces variability in responses introduced by 
testing on separate days, it does introduce the potential for order effects to effect cognitive 
testing. Despite this possibility, meta-analyses indicate that pre/post designs typically result in 
smaller effect sizes for changes in cognition, contrary to what would be expected if a large order 
effect was inherent in such study designs. We attempted to minimize order and learning effects 
by utilizing a thorough familiarization visit (including practicing each cognitive task in its entirety) 
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and by randomizing task order to the extent possible (order of Flanker/N-Back, and 
congruent/incongruent Stroop randomized, counter-balanced). Familiarization appeared 
successful, as there was a large increase in accuracy on tasks between the practice visit and 
pre-exercise testing.  Additionally, if there was a significant learning effect driving post-exercis 
changes in cognition, we would expect that learning effect to elicit changes in the decision 
making process itself (changes in strength of evidence etc.). Of note, all observed changes in 
post-exercise cognition in this study was isolated to outside of the decision making process 
(non-decision time component of RT via DDM). None the less, future studies should consider 
including an additional resting set of cognitive measures, after proper familiarization, to be able 
to compare to post exercise measures. This would allow researchers to examine the effects of 
exercise on cognition through two separate comparisons and identify potential differences 
between the two designs.  
Future research is necessary to better understand the intricate and complex 
relationships between HTN, exercise, and vascular and brain health. More research is 
recognizing that large conduit arteries may not be responsive to exercise training in HTN [34], 
however the reason for this remains elusive. To date, there is little data indicating aerobic 
fitness protects the brain from cognitive decline in HTN. A recent publication, however, from the 
1998-2002 NHANES database suggests that older adults with greater self-reported physical 
activity have better cognitive function [370]. It should be underscored that this is far from a 
definitive report, based on our experience with the 1998-2002 NHANES sample [253], along 
with the study’s limited sample of older adults, a single cognitive test, and self-reported physical 
activity. As such, future research is necessary to identify relationships between physical activity, 
fitness, and cognitive function in HTN through experimental research and stronger, more robust 
cross sectional analysis than recent publications.  
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 Understanding vascular contributors to NVC in humans is a surprisingly understudied 
area that could offer insight into vascular contributions to cognitive decline with age and disease 
[320,325]. While much of the literature has focused on changes in mean blood flow/volume as it 
pertains to optimal NVC, many have overlooked how changes in hemodynamic pulsatility 
influence oxygen delivery to working neurons. More detailed characterization of extracranial 
contributions to intracranial hemodynamics during NVC is necessary. Future investigations 
should include bilateral assessment of common and internal carotid artery, intracranial, and 
prefrontal cortex hemodynamics. Including insonation of the anterior cerebral artery may help 
directly link hemodynamic transmission from the common carotid artery to the level of the 
prefrontal cortex measured by near-infrared spectroscopy. Utilizing novel experimental 
manipulations to alter arterial stiffness and pulsatility independent of changes in pressure via 
lower-body negative pressure could introduce additional insight into the role of extracranial 
vessel stiffness and pulsatility in NVC. This experimental design would allow for a 
comprehensive view of pulsatile transmission from the large extracranial vessels to the 
microvasculature surrounding active neural circuitry. Additional measurement to assess 
changes in shear stress and circulating BDNF during NVC may help uncover the indirect 
influence of cerebrovascular hemodynamics on neurotrophic factors and ultimately cognitive 
function. 
Conclusions 
The presence of hypertension (HTN) in middle-age is a major risk factor for later-life 
development of cognitive and cardiovascular disease. Exercise is widely recommended to 
combat vascular and brain aging in HTN. Acute aerobic exercise results in similar increases in 
arterial stiffness and hemodynamic pulsatility in adults with and without HTN. Additionally, acute 
aerobic exercise beneficially effects cognitive function in adults with and without HTN, 
accelerating executive function and memory processing speeds following exercise. Finally, 
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adults with and without HTN exhibit similar increases in large artery stiffness and decreases in 
extracranial hemodynamic pulsatility during cognitive activity, indicating similar NVC between 
groups. The similar responses to exercise and cognitive perturbations seen between our adults 
with and without HTN underscores the importance of blood pressure control to attenuate 
detrimental effects of HTN in middle-aged adults. 
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INSTITUTIONAL REVIEW 
BOARD MEMORANDUM 
 
TO: Kevin Heffernan 
DATE: June 14, 2016 
SUBJECT: Expedited Protocol Review - Approval of Human Participants 
IRB #:  16-155 
TITLE: Effects of Aerobic Exercise on Cerebrovascular and Cognitive Function in 
Hypertensive Adults 
 
The above referenced protocol was reviewed by the Syracuse University 
Institutional Review Board for the Protection of Human Subjects (IRB) and has been 
given expedited approval. The protocol has been determined to be of no more 
than minimal risk and has been evaluated for the following: 
 
1. the rights and welfare of the individual(s) under investigation; 
2. appropriate methods to secure informed consent; and 
3. risks and potential benefits of the investigation. 
 
The approval period is June 13, 2016 through June 12, 2017. A continuing 
review of this protocol must be conducted before the end of this approval period. 
Although you will receive a request for a continuing renewal approximately 60 
days before that date, it is your responsibility to submit the information in 
sufficient time to allow for review before the approval period ends. 
 
Enclosed are the IRB approved date stamped consent and/or assent document/s related to this study 
that expire on June 12, 2017. The IRB approved date stamped copy must be duplicated and used 
when enrolling new participants during the approval period (may not be applicable for electronic 
consent or research projects conducted solely for data analysis). Federal regulations require that 
each participant indicate their willingness to participate through the informed consent process and 
be provided with a copy of the consent form. Regulations also require that you keep a copy of this 
document for a minimum of three years after your study is closed. 
 
Any changes to the protocol during the approval period cannot be initiated prior 
to IRB review and approval, except when such changes are essential to eliminate 
apparent immediate harm to the participants. In this instance, changes must be 
reported to the IRB within five days. Protocol changes must be submitted on an 
amendment request form available on the IRB web site. Any unanticipated 
problems involving risks to subjects or others must be reported to the IRB within 
10 working days of occurrence. 
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Thank you for your cooperation in our shared efforts to assure that the rights and 
welfare of people participating in research are protected. 
 
Katherine 
McDonald 
IRB Chair 
 
 
DEPT: Exercise Science, 820 Comstock Ave. – Rm. 207B 
STUDENTS: Wesley Lefferts, Jacqueline Augustine, Jacob DeBlois 
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Electronic Informed Consent 
Syracuse University  
School of Education 
Exercise Science 
820 Comstock Avenue 
201 Women's Building 
Syracuse, NY 13244 
(315)-443-2114 
 
Project Title: The effect of exercise on the heart, blood vessels, and brain.   
Dr. Kevin Heffernan and Mr. Wesley Lefferts of Syracuse University are collecting information to 
determine participant eligibility for a research study investigating how exercise affects the heart, 
blood vessels, and the brain. To determine your eligibility to participate in this study we will need 
some basic information regarding your health history, current health status and exercise habits.  
The survey will take no more than 10 minutes to complete and will ask you a series of questions 
regarding your health and exercise habits.   
THE INFORMATION THAT YOU PROVIDE IN THIS SURVEY WILL BE USED TO 
DETERMINE YOUR ELIGIBILITY FOR THE RESEARCH STUDY ONLY.  
You will not receive compensation for providing this information. 
If you are eligible for the upcoming exercise research, we will contact you with details.  If you 
are not eligible, we will also contact you to inform you that you do not qualify for this research 
study.   
Willingness to provide information on this survey does not imply willingness to serve as a future 
research participant.  If you are contacted based on eligibility we will provide you with detailed 
information on that study so that you can make an informed decision with regards to 
participation.  
The information provided here will be held as confidential and protected.  In this regard, the 
Qualtrics survey account is password protected and data from the survey will be stored on 
password protected computers in secure offices in the Department of Exercise Science, 
Syracuse University.  
Your participation is voluntary, you may withdraw from the survey at any time and you do not 
need to answer any questions you do not want to.  
Whenever one works with e-mail or the internet there is always the risk of compromising 
privacy, confidentiality and/or anonymity. Your confidentiality will be maintained to the degree 
permitted by the technology being used. It is important for you to understand that no guarantees 
can be made regarding the interception of data sent via the internet by third parties.  
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Risks and discomforts associated with this survey are minimal. There is the risk that 
confidentiality could be compromised but we have taken steps to minimize this risk as much as 
possible through password protection and data storage.   
Benefits associated with this survey: There are no direct benefits to you from participating in this 
survey but there are potential benefits if you are eligible for the upcoming research study.  
Eligible participants for our upcoming exercise study will have the opportunity to receive 
compensation and information regarding their fitness and health status.  Our overarching 
research goals are to understand how exercise improves heart and brain health and our ability 
to think. This survey is the first step in identifying participants for this line of research.  
If you have any questions, concerns, complaints about this survey, you may contact Dr. Kevin 
Heffernan (email: ksheffer@syr.edu, telephone: 315-443-9801) or Wesley Lefferts (email: 
wleffert@syr.edu, telephone: 503-804-4424). 
If you have any questions about your rights as a research participant, you have questions, 
concerns, or complaints that you wish to address to someone other than the investigator, if you 
cannot reach the investigator, or have experienced research related injuries, contact the 
Syracuse University Institutional Review Board at 315-443-3013. 
PLEASE PRINT A COPY OF THIS INFORMED CONSENT FOR YOUR RECORDS. 
By consenting below you indicate that you have read and fully understood this electronic 
informed consent form. You are fully aware of the purpose and procedures of this survey, as 
well as the risks, discomforts, and benefits associated with the survey and that you sign this 
electronic document freely and voluntarily. 
___ I am over the age of 18 and I wish to complete the survey in order to be considered for a 
future exercise and health study.   
___ I do not wish to complete the survey and would like to exit this survey.   
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EXERCISE SCIENCE 
820 COMSTOCK AVENUE 
201 WOMEN’S BUILDING 
SYRACUSE, NY 13210 
(315)-443-2114 
 
The Effect of Exercise on Blood Pressure and Cognitive Function  
 
Principal Investigator: Kevin Heffernan, Ph.D. 
Telephone: 315-443-9801 
Email: ksheffer@syr.edu 
IRB Protocol #:  
 
We are inviting you to participate in a research study run by Dr. Kevin Heffernan and Mr. Wesley 
Lefferts.  Involvement in the study is voluntary, so you may choose to participate or not to 
participate.  This sheet will explain the study to you and please feel free to ask questions about 
the research if you have any. We will be happy to explain anything in more detail if you wish.  
Purpose 
Blood pressure, which represents the pressure inside the blood vessels when the heart is 
contracting or relaxing, has direct effects on brain health.  High blood pressure, in particular, has 
negative effects on the brain and blood vessels.  High blood pressure is associated with greater 
risk of developing dementia and Alzheimer’s disease.  Therefore it has become increasingly 
important to treat high blood pressure through a combination of medication and lifestyle changes.   
Exercise is widely recommended to improve brain health and to treat high blood pressure.  
Despite exercise’s wide recommendations for use, the direct effect of exercise on the brain and 
blood vessels in adults with high blood pressure is largely unestablished. The purpose of this 
study is to investigate the effect of acute exercise on the blood vessels, blood pressure, and the 
brain in adults with normal and high blood pressure.  In this study, after determining if exercise is 
appropriate for you, we will test your blood vessel elasticity, blood pressure, and brain function 
before and after a 30-minute bout of cycling exercise.  This will be done over 3 visits that are 
described below (visit 1, health screening; visit 2, cardiorespiratory fitness test; visit 3, blood 
vessel/pressure and brain function testing before/after exercise).  Understanding how exercise 
effects the blood vessels, blood pressure, and the brain in adults with high blood pressure will 
help us understand the effectiveness of exercise in improving health among this population.   
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 Who can participate?  
• Men and women between the ages of 45-64.  
  
Do I have to participate? 
• Your participation in this study is voluntary, which means you get to decide whether or not you 
want to participate 
• Make sure that you read this entire form before making a decision and take as much time as 
you need.  
• Feel free to ask as many questions about the study as you want. If you do not understand a 
term in the form, ask, and a researcher will explain it for you. 
• If you decide to participate in the study you will be asked to sign a consent form. 
• Do not sign the consent form until all of your questions have been answered and you understand 
what will happen in the study. 
• Your signature means that you agree to participate in this study. 
• You can ask for a copy of this form whether or not you agree to take part in the study. 
• Your decision not to be in this research study will not result in any loss of benefits to which you 
are otherwise entitled. 
Can I Withdraw From The Study Once It Has Started? 
• At any time you may remove yourself from the study without giving any reason.  
• If you are a student, withdrawing from the study will not affect your grade in courses in any way.  
What Can I Expect From Participating?  
For this study, you will need to visit the Human Performance Laboratory, located in the Women’s 
Building at Syracuse University once for study health screening and twice for the exercise portions 
of the study.  The screening will take about 75 minutes, the first exercise visit will take 
approximately 50 minutes, and the final exercise visit will take approximately 100 minutes. 
Visit 1: Health Screening Visit 
• At the health screening visit we will ask you to arrive >10 hours fasted (i.e. no food, caffeine, 
or alcohol for the past 10 hours).  We ask this so that we can accurately measure your 
cholesterol and blood sugar (described further below).  A light snack will be provided after this 
visit.   
• You will be asked to fill out and sign this consent form, a detailed health history questionnaire, 
a sleep and physical activity questionnaire, and a depression questionnaire.  Additionally, we 
will measure your height and weight using a stadiometer and electronic scale, in the same 
manner typically done at the doctor’s office.   
• We will also have you perform a brief cognitive test to assess basic brain function. We will also 
have you practice some on the computer in order to become familiar with them.   
• We will ask you to give us a small urine sample so that we can check the function of your 
kidneys.  We will provide a small sample container and escort you to the restroom.   
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• We will then estimate your body composition (percent body fat) using a BodPod and 3-D body 
scanner that will require you to wear tight fitting, minimal clothing for greatest accuracy in 
estimations.  You will be asked to sit quietly in a chamber that resembles a giant egg for 
approximately two, 60-second intervals. This machine measures your body volume to estimate 
body fat.  For the 3-D body scanner we will have you stand in the middle of the scanner in the 
same outfit you wear for the BodPod and 3 laser-guided cameras will scan down your body 
from head to toe.  These lasers are not dangerous and will not damage your eyes, if your eyes 
are sensitive however we will invite you to close your eyes for the scan. The scan takes 
approximately 10 seconds for the cameras to move from your head to your toes.  
• We will measure your blood pressure in both arms.  We will place a blood pressure cuff around 
both your left and right upper arms (bicep) and they will inflate and deflate slowly. This is the 
same measurement that is often done at the Doctors office during a routine visit. We will take 
this measurement both while you are sitting, and while you are lying down. 
• We will also measure your hemoglobin/hematocrit, cholesterol, glucose, and whole-body 
inflammation by obtaining a few small drops of blood from your fingertip (finger prick).  These 
tests require that you arrive >10 hours fasted. 
• As you leave the screening visit we will send you home with a small physical activity monitor 
and at-home blood pressure monitor.  The physical activity monitor is less than 2 inches in 
length and will measure how much you move throughout the week.  You will be instructed to 
attach it to the middle of your thigh using a special tape that we provide.  We ask that you wear 
the monitor for a full 7 days, only removing it when involved in water activities such as 
showering/bathing and swimming.  We will also ask you to measure your blood pressure twice 
a day, once in the morning, and once at night over the same 7 day span.   
• Depending on your health status determined from the answers you provide on health 
questionnaires along with your home blood pressure measurements, we may ask you to contact 
your physician and receive permission to continue with the exercise portion of the study on 
subsequent visits. 
• In total, the screening visit will take approximately 75 minutes. 
Visit 2: Cardiorespiratory Fitness (exercise) Test 
• For the first exercise visit we will ask you to arrive not having eaten within the past 3 hours.  
Intense exercise may upset your stomach if you have recently eaten.  Therefore, we will please 
ask you to refrain from exercising or consuming alcohol or caffeine (including caffeinated coffee, 
tea, soda or energy drinks) on the day that you will come into the lab.   
• We will have you practice some brain/cognitive tasks on the computer that we will have you 
perform in the third visit (described further under Visit 3).  We have you practice them at the 
second visit so that you can become familiar with them.   
• We will then prepare you for the cardiorespiratory fitness test.  We will have you sit on a cycle 
ergometer (stationary bicycle) and rest for 5 minutes while we measure your blood pressure. 
During this time we will explain the exercise protocol to you.  
• The cardiorespiratory fitness test will consist of cycling exercise, starting at a very low intensity 
for warm-up, and increasing exercise intensity with time.  We will increase the intensity of 
exercise by increasing the resistance that you are pedaling against (i.e. making it harder to 
pedal).  The goal of this test is to measure how much oxygen your body can consume during 
exercise.  The more oxygen you can take in, the more fit you are.  We will instruct you to continue 
exercising as long as you can.  The test will end whenever you believe you cannot exercise any 
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harder.  If you are ever uncomfortable or concerned you may end the test at any time.  If your 
cycling speed decreases too much we may also stop the test.  The exercise test will usually last 
somewhere between 6-12 minutes.   
• During the exercise test we will measure the following… 
o Your blood pressure on the upper arm. 
o The oxygen delivery to your calf muscle using a small sensor 
enclosed in a compressive stocking. 
o Your heart rate using a thin strap that will be placed directly on the 
skin around your chest. 
o The amount of oxygen you are consuming using a small device that 
is worn like a small backpack with a facemask (see image on the left). 
o How hard you think you are working using a scale ranging from 6 
(no work) to 20 (working as hard as I can). 
• After ending the test we will have you cool down and recover briefly 
by exercising at a very low intensity for 3-5 minutes before dismissing you. 
• The cardiorespiratory fitness test visit will take approximately 50 minutes. 
Visit 3: Acute exercise  
• For the second exercise visit we will ask you to arrive >4 hours fasted (i.e. no food, caffeine, 
or alcohol for the past 4 hours) and to wear shorts and a T-shirt.  At this visit we will measure 
your blood vessels, blood pressure, and brain function both before, and after, 30-minutes of 
moderate-intensity cycling exercise.   
• First we will measure your blood pressure in the same manner as the previous visits. This is the 
same measurement that is often done at the Doctors office during a routine visit. We will take 
this measurement both while you are sitting, and while you are lying down. 
• Next we will measure blood pressure at specific blood vessels in the body.  To do so, we will 
take a small tonometer (a small pen-like device that senses pressure) and press it gently against 
the carotid artery (neck), radial artery (wrist), and femoral artery (upper leg/hip). We will do this 
while simultaneously measuring your heart rate from electrodes placed on your ribs and 
shoulder. We can use these pressure waves to calculate how stiff your blood vessels are.  
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• Next we will measure your neck blood flow and brain blood flow using two non-invasive (no 
needles, no blood) techniques, Doppler ultrasound and blood flow sensors. Ultrasound probes 
will be placed on your neck and on the side of your face (near your temple, between your eye 
and ear) to assess neck artery stiffness and blood flow and brain blood flow. Additionally a blood 
flow sensors will be placed on the forehead and secured with a headband to assess brain blood 
flow.  
 
• We will also measure the amount of carbon dioxide you exhale with each breath.  This is done 
by placing small sampling lines directly under your nostrils and having you relax and breathe 
normally through your nose.   
• After completion of the resting measures, you will begin a series of cognitive tasks that will be 
projected from a laptop to a screen above you.  You will use a hand clicker to respond to 
questions on the monitor for ≈15 minutes. During these cognitive tasks we will continue to 
measure brain blood flow using the ultrasound probes and blood flow sensors previously 
described. This test will give us information about how the arteries in your brain react to the 
thinking required to answer the cognitive test. These cognitive tasks will be the same ones that 
you practiced at visit 2 and are designed to test your attention, reflexes, and memory.   
• Once you have completed the cognitive tests we will remove our instruments and you will begin 
the 30-minute cycling exercise bout. The cycling intensity will be set at a workload to 
approximate 50-60% of your peak oxygen consumption (determined from visit 2). 
• During the 30-minute cycling exercise bout we will measure blood pressure, heart rate, how 
hard you think you are working, and how much oxygen you are breathing in using the same 
techniques from the cardiorespiratory fitness test.   
• After completing the exercise bout we will have you return to the testing table and let you recover 
for approximately 10 minutes while we set our instruments back up.  After that we will repeat 
the same measures from before exercise (blood pressure, blood flow, cognitive function).   
• Once the cognitive tasks are complete, we will remove our instruments and you will be permitted 
to leave.  
• This exercise visits will take approximately 100 minutes to complete (25 minutes pre-testing, 30 
minutes exercise, 35 minutes post-exercise).   
• If you wish to withdraw from the study at any time you are free to do so.   
  
Ultrasound probes 
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Table 3 (Summary): Estimate timeline for participants across the 3 laboratory visits  
Visit 1 (≈1.25 hr)  Visit 2 (≈0.83 hr)  Visit 3 (≈1.66 hr)  
Item Time (min) Item 
Time 
(min) Item 
Time 
(min) 
Consent 15 Cognitive task practice 15 Rest/instrumentation 10 
Height/weight 5 Instrumentation 5 Blood pressure  
Blood lipids 5 Warm-up 5 Artery stiffness 10 
Body composition 10 cardiorespiratory fitness test 15 Blood flow   
Kidney function 5 Cool-down 5 Cognitive testing 15 
Blood pressure 15 Post-exercise monitoring 5 Acute exercise 30 
Questionnaires 10   Rest/instrumentation 10 
Dementia/depression 10   Blood pressure  
    Artery stiffness 10 
    Blood flow   
        Cognitive testing 15 
Total 
75 
min   
50 
min   100 
Total time burden ≈ 3.75 hr     
 
Can I be excluded from participation for any reason? 
• Exercise is not appropriate for all individuals based on their health status.  This study has a 
multi-stage process where we may exclude you from participating in the exercise portions of 
the study.  An online eligibility survey is the first step, which you have already completed, 
followed by the health screening visit and at-home blood pressure measurements. Throughout 
this process, you may be excluded from the study based on answers to the eligibility survey, 
the questionnaires administered in the screening visit, if you have low kidney function 
(determined from the urine test), very low cognitive function (determined from the basic 
cognitive function test on visit 1), high depressive symptomology (determined from a 
questionnaire), and very high cholesterol or blood sugar (determined from blood tests).  We 
may also exclude you if…  
o We find that you regularly experience any signs or symptoms that suggest you may have 
a medical condition and your health care provider is not aware that you are experiencing 
these symptoms.  We will exclude you from the study and ask that you contact your health 
care provider.   
o You have recently sustained a concussion.   
o You have high blood pressure (systolic pressure >140, diastolic pressure >90 mmHg) and 
are not undergoing medical treatment for it. We will exclude you and ask that you follow 
up with your health care provider.   
o You have an abnormal blood pressure response to exercise during visit 2.   
o You have >2 cardiovascular risk factors and your physician does not give you, or you do 
not obtain, clearance to exercise.    
• If you are experiencing any signs or symptoms of a serious/significant health condition at the 
time of consent (i.e. severe chest pain, leg pain, dizziness, feelings of heart palpitations) we will 
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contact emergency medical services immediately and you will not be able to participate in the 
study. 
What Benefits Can I Expect From Participating?  
• You may feel good about helping others with their research study by participating in this 
research study. 
• You will receive information on your blood pressure, cholesterol levels, body composition, 
aerobic fitness, and cognitive function. 
• These tests are not being used to diagnose a problem (NOT for medical/clinical 
purposes). These tests are for research purposes only.  If you have high blood pressure 
we will inform you to go the university health center or go see your health care provider.   
Are There Any Potential Risks From Participating In This Study? 
• There are some risks associated with portions of this study. 
• We will use a small amount of gel to help us measure your brain blood flow. There is minimal 
risk of gel getting into your eye when we measure brain blood flow due to the small amount of 
gel used in this technique.  None the less, we will remind you to remain still as we take these 
measures to ensure that the gel does not come into contact with your eye. The gel is water-
based and is designed for eye exams so in the event some comes in contact with your eye the 
discomfort should be minimal and temporary and can be rinsed out easily.  We will escort you 
quickly to a sink to rinse out your eye if discomfort occurs.  
• You may experience discomfort from the finger stick to test your blood lipids, hematocrit and 
hemoglobin. This will only be done two or three times and no more than that. We will use 
different fingers each time to reduce discomfort. If desired we can also place ice on the finger 
prior to the finger stick to reduce discomfort from the pinch. 
• There is a small risk of infection associated with the finger stick. However, we will reduce this 
risk by ensuring that equipment is clean and sterile and the finger stick technician will wear lab 
coat, gloves, will clean the finger with alcohol swabs and will clean the area with a disinfectant 
wipe afterwards.     
• There are inherent risks associated with exercise.   
o There is a small risk of losing consciousness following intense exercise. We will 
minimize this risk by having you “cool-down” following the cardiorespiratory fitness test 
at visit 2.  This will prevent the blood from staying down in your legs and will reduce the 
risk of light-headedness or dizziness after exercise.  Additionally we will ask you 
communicate directly with us if you feel any light-headedness so that we can take 
appropriate precautions.  
o Any type of exercise may, in rare instances, lead to heart attack, stroke or death; 
however, this is unusual, especially in adults free of known cardiovascular disease, free 
of any signs or symptoms of cardiovascular disease, and with few major risk factors of 
cardiovascular disease.  Thus, risks associated with exercise are low in healthy, middle-
aged adults.  Our multi-stage screening process will help us ensure that exercise is 
appropriate and saafe for you.  The multi-stage screening process will let us identify any 
pre-existing conditions or abnormalities that might limit exercise. By design, our 
exclusion criteria and extensive health screening priot to the exercise visits (visit 2 and 
3) will remove you from participating if you are a high-risk individual.   
o Based on our criteria however, you may be a moderate-risk individuals (i.e. you have >2 
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cardiovascular risk factors).  The odds are, if you have high blood pressure you will fall 
into this moderate-risk group.  As mentioned previously, we will require you to obtain 
clearance from your physician to participate in the exercise portion of the study if you are 
in this moderate-risk group (>2 cardiovascular risk factors).  If you are unable to obtain 
clearance from your physician you will not be allowed to participate in the exercise visits.  
o It should be noted that exercise is widely recommeneded by health organizations as a 
lifestyle modification to reduce the negative effects of cardiovascular disease, even in 
moderate-risk populations with high blood pressure.  Our multi-stage screening process 
and physican clearance steps will ensure that you will only engage in exercise if it is 
appropriate and safe for you, thus these risks should be minimal should you be cleared 
for the exercise portions of the study. 
• Communicating with the researcher throughout the protocol will reduce risks.  
• If at any point you are uncomfortable or feel pain anywhere, please tell us immediately.   
• In the event of illness or physical injury resulting from taking part in this research study, 
medical treatment will not be compensated for.  You will be responsible for any costs not paid 
by your insurance company.  No other compensation is offered by Syracuse University.  You 
have not waived any of your legal rights by signing this form. 
Are There Any Costs? 
• There will be no costs to you for participating in this study. 
Is There Any Compensation? 
• Yes, you may receive monetary compensation for your time.  You may receive $5 for 
completing the health screening visit, $5 for completing the physical activity and at-home 
blood pressure monitoring, $15 for completing the cardiorespiratory fitness test, and $20 for 
completing the final exercise visit. If you remove yourself, or are excluded, from the study prior 
to completing all visits, you will only be compensated for the trials that were completed.  If you 
withdraw or are excluded from the study at visit 2 or 3 your compensation will be pro-rated 
depending on what stage of the visit you had completed.  For visit 2, you will receive $5 for 
completing the cognitive practice tests, and $10 for undergoing the cardiorespiratory fitness 
test.  For visit 3, you will be compensated with $5 for completing the resting measures, $5 for 
completing the 30-min exercise bout, and $10 for completing the post-measures.    
Who Can See Information About This Study? 
• The research records from this study will be confidential. Confidentiality means that it is 
our responsibility to keep any information you provide private and safe. Although we have 
taken steps in order to maximize and maintain confidentiality, it is important to understand that 
confidentiality cannot be guaranteed in lab settings.  
• Only members of the trained research staff for this study with training in research ethics may 
look over your research records.  
• The paperwork, results and records will be kept in a locked filing cabinet that only the 
researchers with training in research ethics will have access to.  
• You will be given a study identification number (coded numbers, known only by primary 
researchers) and this will be entered into all research computers used to collect your blood 
pressure and blood flow.  Your name will not appear anywhere on these computers or the 
data output from these computers.   
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• All information stored on computers requires a password access it.  Only members of the 
research team with training in research ethics will have this password.  
• The data and research record will be stored for up to 10 years.  
• Your individual results will not be used in any way (we will average all results and 
display group averages only when presenting findings in papers and presentations) 
What Are My Rights In This Study? 
• If at any point you wish to withdraw yourself from the study you may.  
• You do not give up any of your legal rights by participating in this study. 
Who Can I Contact For Questions Or More Information? 
• If there are research related injuries or if you have any questions, concerns, or complaints 
about this study at any time, please feel free to contact:  
o Dr. Kevin Heffernan at ksheffer@syr.edu or call his office at 315-443-9801.  
• If you have any questions about your rights as a research participant, you have questions, 
concerns, or complaints that you wish to address to someone other than the investigator, if 
you cannot reach the investigator, or have experienced research related injuries, contact the 
Syracuse University Institutional Review Board at 315-443-3013.  
 
By signing below you indicate that you have read and fully understood this informed consent 
form.  You are fully aware of the purpose and procedures of this study as well as the risks, 
discomforts, and benefits associated with the experimental protocol and that you sign this 
document freely and voluntarily.  
All of my questions have been answered, I am 18 years of age or older, and I wish to 
participate in this research study.  I have received a copy of this consent form.  
 
_________________________________________    _________________________ 
Signature of participant                                                                    Date  
 
_______________________________________     
Printed name of participant     
                                                                    
_________________________________________    _________________________ 
Signature of researcher                                                             Date  
 
_________________________________________    
Printed name of researcher           
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Human Performance Lab Health Screening Form                       Date__________  
Age _______  
Gender ______                       
 
Please answer the following questions as honestly as you can. Your patterns of responses will determine whether 
you may participate in the study. 
Known Diseases (Medical Conditions) 
1. List the medications and dietary supplements you take on a regular basis. (Include prescription and non-
prescription, aspirin, vitamins/minerals, nutrition supplements [Ensure, Boost, etc.])  
______________________________________________________________________________________________ 
_______________________________________________________________________________ 
_______________________________________________________________________________ 
_______________________________________________________________________________ 
 
2. Has your health care provider ever told you have diabetes?            No Yes 
3. Do you have acute or terminal illness (if so, please explain below)?    No   Yes 
 ____________________________________________________________________________ 
4.   Have you ever had a stroke, heart attack or heart trouble?     No   Yes 
5.  Has your health care provider ever told you that you have a heart murmur?   No  Yes  
6.  Have you had a head injury in the past 3 months?                                                      No   Yes 
7.   Do you have asthma /take asthma medication?       No  Yes 
8.   Has your health care provider ever told you that you have  
      kidney or liver disease?          No  Yes 
9.  Has your health care provider ever told you that you have  
      chronic pulmonary or respiratory disease?                                                   No  Yes 
     10.  Has your health care provider ever told you that you have  
            peripheral artery disease?         No  Yes 
     11.  Has your health care provider ever told you that you have  
            high blood pressure?           No  Yes 
     12.  Has your health care provider ever told you that you have  
     high cholesterol?                                                  No       Yes 
     13.  Do you smoke cigarettes on a daily basis?                             No  Yes  
      If yes to #13, how many packs per day _________________ 
      If yes to #13, how long have you been smoking _________________ 
 
Study ID:__________________ 
141 
 
 
     14.  Have you lost or gained weight in the previous 6 months?     No   Yes 
If yes, how much weight? _______  
     15.  Has a first degree relative (e.g. father, mother, sister, brother, or child)  
        suffered from a heart attack or diagnosed cardiovascular disease?    No   Yes 
 
Relative Age Did they pass away? 
   
   
 
16. Do you often have pains in your heart, chest, neck, jaw, arms or other areas           No Yes 
 especially during exercise?         
17. Do you regularly get pains in you calves or lower legs during exercise 
 which are not due to soreness or stiffness?      No Yes 
18. Do you experience swelling or accumulation of fluid in or around your ankles?  No Yes 
19. Do you often feel faint or have spells of severe dizziness during exercise?  No Yes 
20. Do you often get the feeling that your heart is beating faster, racing, 
  or skipping beats, either at rest or during exercise?     No Yes 
21. If you answered YES to question(s) 17-21, does your health care provider  
       know that you have this/these symptom(s)?                No       Yes  
22. If you answered YES to question(s) 16-20, are you currently experiencing this/these  
      symptom(s) RIGHT NOW?                              No        Yes 
23.  With which hand do you write?                                                                              Left       Right 
 
24. How do you define your race/ethnicity? ___________________________________ 
 
25.   What is the highest grade/level of schooling/education completed? 
 
       8th Grade            Some HS              HS              some college          college            graduate school 
 
26.  Have you ever lost consciousness before during any daily activity?   No  Yes 
 If you answered YES to question 31, please explain below. 
 
27.  On a scale of 1-5 (1= not anxious at all; 5= very anxious) how anxious do you feel during a typical Doctor’s office 
visit?  1 2 3 4 5 
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28.  Additional:   
 
Please circle all that apply 
Allergies Fibromyalgia Polio Flu 
Anemia Attention Deficit 
Hyperactivity Disorder 
Reflux or Ulcers Seizures 
 
Anxiety Glaucoma Liver Disease Concussion 
Arthritis Lupus Bone Disease Eczema 
Asthma Meningitis Leg/foot Ulcers Epilepsy 
Cataracts Chronic Lyme Disease Diverticulitis  Headaches/Migraine 
Chronic Bronchitis Gout Infection Urinary Tract Infection 
Lung Disease Thyroid 
(underactive/overactive) 
Cold Kidney Stones 
 
Continued on back. 
143 
 
Blood pressure history 
 
3. Have you ever been told you have high blood pressure (i.e. hypertension)?   No Yes 
 
4. Have you ever been diagnosed with high blood pressure by your physician?   No Yes 
 
If yes, how long have you been living with high blood pressure? _____________ 
 
5. Are you currently taking prescription medication to treat/control your blood pressure? No Yes 
 
If yes, what kind of medication are you taking? ___________ 
 
What dose? ____________ 
 
Approximately how long have you been taking this medication? ____________ 
 
Has your medication or your dose changed in the past 4-6 weeks?   No Yes 
 
6. Have you had trouble medically controlling your blood pressure (i.e. been on multiple medications)?  
          No Yes 
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Exercise history 
 
1. Do you currently exercise on a regular basis?      No Yes 
 
2. Please rate your exercise level on a scale of 1 to 5 (5 indicating very strenuous) for each age range to your present 
age: 
 
15-20  _______     21-30  _______    31- 40  _______   41-50  _______    50 & older  _______ 
 
3. Were you a high school and/or college athlete? 
 
If yes, please specify:  ___________________________________________________________ 
 
4. Approximately how much time per week do you engage in exercise?   No Yes 
 
Minutes/day:  ______________   Days/week:  _______________ 
 
5. Are you currently involved in regular endurance (cardiovascular) exercise?  No Yes 
 
If yes, specify the type of exercise(s): _______________________________________________ 
 
Days/week: ___________        Minutes/day: ___________ 
 
Rate your perception of the exertion during your endurance/cardiovascular exercise (circle the number): 
 
(1) Light                    (2) Fairly Light                   (3) Somewhat Hard                  (4) Hard 
 
6. Are you currently involved in regular strength building (weight lifting) exercise? 
 
If yes, specify the type of exercise(s): _______________________________________________ 
 
Days/week: ___________        Minutes/day: ___________ 
 
Rate your perception of the exertion during your strength building exercise (circle the number): 
 
(1) Light                    (2) Fairly Light                   (3) Somewhat Hard                  (4) Hard 
 
7. How long have you been exercising regularly?     _________ months       ________ years 
 
8. Do you participate in any sport, or recreational activities? 
 
If yes, please specify the sports/activities 
____________________________________________________________ 
 
____________________________________________________________ 
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Menstrual Status (answer these questions only if you are a female) 
1. Do you currently experience a regular menstrual cycle (i.e. period)?    No Yes 
If no, approximately how many years ago did you have a regular menstrual cycle 
(10-12 a year)?_________ 
 
If yes, approximately how many periods in a year do you have? _______  
 
Approximately how many days between periods? _______ 
 
What was the approximate date of your last menstrual period?______________ 
 
2. Has the time between your menstrual cycles changed at all recently?    No Yes 
Has the length differed by >7 days?       No Yes 
 
Has the length between cycles been >60 days (2 months)?     No Yes 
 
3. Have you ever experienced menstrual irregularity?      No Yes 
 
Please describe (i.e. number of skipped menses, or prolonged menses): _____________________  
 
Approximately how long did this occur? Are you experiencing this currently?________________ 
 
4. Are you currently ammenhoreic?        No Yes 
 
5. Have you gone through menopause (defined as no menstrual cycle/period for more than 12 months without any 
other possible causes)?         No Yes 
 
6. Do you currently experience any of the following? Circle all that apply   No Yes 
 
7. Hot flashes 8. Irregular menstrual cycles 9. Night sweats 10. Sleep problems 
11. Mood changes 12. Frequent urination 13. Urinary tract infections 14. Uncomfortable genital dryness 
 
15. Do you use oral contraceptives?         No Yes 
If yes, for how long have you been using? ____________ 
Which kind? ____________________  
What dose?______  
Do you take the withdrawal/Placebo pills?___________     
 
16. Do you use Depo-Provera for birth control?       No Yes 
If yes, for how long have you used this method?_________ 
 
17. Do you use hormone replacement therapy?     No Yes 
If yes, for how long have you been using? ____________ 
 
Which kind? ____________________  
 
What dose?______  
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PITTSBURGH SLEEP QUALITY INDEX 
INSTRUCTIONS: 
The following questions relate to your usual sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in the past 
month. 
Please answer all questions. 
 
1. During the past month, what time have you usually gone to bed at night? 
BED TIME ___________ 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each 
night? 
NUMBER OF MINUTES ___________ 
3. During the past month, what time have you usually gotten up in the morning? 
GETTING UP TIME ___________ 
4. During the past month, how many hours of actual sleep did you get at night? (This may be 
different than the number of hours you spent in bed.) 
HOURS OF SLEEP PER NIGHT ___________ 
For each of the remaining questions, check the one best response. Please answer all 
questions. 
5. During the past month, how often have you had trouble sleeping because you . . . 
a) Cannot get to sleep within 30 minutes 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
b) Wake up in the middle of the night or early morning 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
c) Have to get up to use the bathroom 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
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d) Cannot breathe comfortably 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
e) Cough or snore loudly 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
f) Feel too cold 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
g) Feel too hot 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
h) Had bad dreams 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
i) Have pain 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
j) Other reason(s), please describe__________________________________________ 
__________________________________________________________________________ 
How often during the past month have you had trouble sleeping because of this? 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
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6. During the past month, how would you rate your sleep quality overall? 
Very good ___________ 
Fairly good ___________ 
Fairly bad ___________ 
Very bad ___________ 
7. During the past month, how often have you taken medicine to help you sleep (prescribed or 
"over the counter")? 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
8. During the past month, how often have you had trouble staying awake while driving, eating 
meals, or engaging in social activity? 
 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____  times a week_____ 
 
 
9. During the past month, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done? 
 
No problem at all __________ 
Only a very slight problem __________ 
Somewhat of a problem __________ 
A very big problem __________ 
10. Do you have a bed partner or room mate? 
No bed partner or room mate __________ 
Partner/room mate in other room __________ 
Partner in same room, but not same bed __________ 
Partner in same bed __________ 
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If you have a room mate or bed partner, ask him/her how often in the past month you 
have had . . . 
 
a) Loud snoring 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
b) Long pauses between breaths while asleep 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
 
c) Legs twitching or jerking while you sleep 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
d) Episodes of disorientation or confusion during sleep 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
e) Other restlessness while you sleep; please describe__________________________________ 
___________________________________________________________________________ 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____ a week_____   times a week_____ 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
(August 2002) 
 
SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 questionnaires. 
Long (5 activity domains asked independently) and short (4 generic items) versions for use by 
either telephone or self-administered methods are available. The purpose of the questionnaires 
is to provide common instruments that can be used to obtain internationally comparable data on 
health–related physical activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in Geneva in 
1998 and was followed by extensive reliability and validity testing undertaken across 12 
countries (14 sites) during 2000.  The final results suggest that these measures have acceptable 
measurement properties for use in many settings and in different languages, and are suitable for 
national population-based prevalence studies of participation in physical activity. 
 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as this will 
affect the psychometric properties of the instruments.  
 
Translation from English and Cultural Adaptation 
Translation from English is supported to facilitate worldwide use of IPAQ. Information on the 
availability of IPAQ in different languages can be obtained at  www.ipaq.ki.se. If a new 
translation is undertaken we highly recommend using the prescribed back translation methods 
available on the IPAQ website. If possible please consider making your translated version of 
IPAQ available to others by contributing it to the IPAQ website. Further details on translation 
and cultural adaptation can be downloaded from the website. 
 
Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical Activity 
Prevalence Study is in progress. For further information see the IPAQ website.  
 
More Information 
More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. (2000).  
Assessment of Physical Activity: An International Perspective.  Research Quarterly for Exercise 
and Sport, 71 (2): s114-20.  Other scientific publications and presentations on the use of IPAQ 
are summarized on the website. 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part of 
their everyday lives.  The questions will ask you about the time you spent being physically active 
in the last 7 days.  Please answer each question even if you do not consider yourself to be an 
active person.  Please think about the activities you do at work, as part of your house and yard 
work, to get from place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much harder than 
normal.  Think only about those physical activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities like 
heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of those 
days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities refer 
to activities that take moderate physical effort and make you breathe somewhat harder than 
normal.  Think only about those physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads, bicycling at a regular pace, or doubles tennis?  Do not include 
walking. 
 
_____ days per week 
 
   No moderate physical activities  Skip to question 5 
 
 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
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Think about the time you spent walking in the last 7 days.  This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for 
recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  This may 
include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to watch 
television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
This is the end of the questionnaire, thank you for participating. 
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CES-D Depression Inventory 
 
INSTRUCTIONS: For each statement, please circle the number in the column 
that best describes how you have been feeling in the past week. 
 
 
  Rarely or none 
of the time  
(less than 1 day) 
 
Some or a little 
of the time  
(1-2days) 
 
Occasionally or a 
moderate amount 
of the time 
(3-4 days) 
Most or all 
of the time 
(5-7 days) 
 
1. 
I was bothered by things that 
usually don’t bother me. 0 1 2 3 
2. 
I did not feel like eating; my 
appetite was poor. 0 1 2 3 
3. 
I felt that I could not shake 
off the blues, even with the 
help from family or friends. 
0 1 2 3 
4. 
I felt that I was just as good 
as other people. 3 2 1 0 
5. 
I had trouble keeping my 
mind on what I was doing. 0 1 2 3 
6. I felt depressed. 0 1 2 3 
7. 
I felt that everything I did 
was an effort. 0 1 2 3 
8. 
I felt hopeful about the 
future. 3 2 1 0 
9. I thought my life had been a failure. 0 1 2 3 
10. I felt fearful. 0 1 2 3 
11. My sleep was restless. 0 1 2 3 
12. I was happy. 3 2 1 0 
13. I talked less than usual. 0 1 2 3 
14. I felt lonely. 0 1 2 3 
15. People were unfriendly. 0 1 2 3 
16. I enjoyed life. 3 2 1 0 
17. I had crying spells. 0 1 2 3 
18. I felt sad. 0 1 2 3 
19. I felt that people dislike me. 0 1 2 3 
20. I could not get “going”. 0 1 2 3 
 
 
Anyone with suicidal urges should seek immediate consultation with a qualified psychiatrist or psychologist. 
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Tri-fold recruiting pamphlet 
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Please wear the physical activity monitor taped to the middle part of your thigh. Please wear 
this monitor during all waking and sleeping hours. Remove the monitor before any water 
activity (i.e. swimming, bathing, showering) and document the time and duration that it 
was off of your body. 
 
EXAMPLE DAILY LOG 
Monday Woke up at: 6:30AM Went to bed at: 10:30PM 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
6:45-7:00AM - shower - 
5:30-5:40PM - shower after exercise - 
- - 
- - 
- - 
 
 
Monday Woke up at: Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
  
  
  
  
  
 
Tuesday Woke up at: Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
  
  
  
  
  
 
Wednesday Woke up at: Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
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Thursday Woke up at: Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
  
  
  
  
  
 
 
Friday 
 
 
Woke up at: 
 
 
Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
  
  
  
  
  
 
 
Saturday 
 
 
Woke up at: 
 
 
Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
  
  
  
  
  
 
 
Sunday 
 
 
Woke up at: 
 
 
Went to bed at: 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower) 
  
  
  
  
  
Other notes: 
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Meeting, Indianapolis, ID, May 28-June 1, 2013. 
 
29. † Lefferts WK, Hultquist EM, Barr DA, Storer TW, Cooper CB, Fehling PC, Smith DL. 
“Cardiovascular and metabolic responses during Maximal Incremental Exercise in Firefighter’s 
Personal Protective Equipment.”  Presented at the American College of Sports Medicine’s 59th 
Annual Meeting, San Francisco, CA, May 29-June 2, 2012. 
 
30. Smith DL, Barr DA, Hultquist EM, Lefferts WK, Haller JM, Fehling PC, Storer TW, Cooper CB. Does 
“Exercise Mode or Protocol Alter the Chronotropic Index?”  Presented at the American College 
of Sports Medicine’s 59th Annual Meeting, San Francisco, CA, May 29-June 2, 2012. 
 
31. Haller JM, Hultquist EM, Lefferts WK, Smith DL, Fehling PC. “Influence of Clothing Layers Under 
Firefighting Protective Clothing on Physiological/Perceptual Responses to Intermittent Work.” 
Presented at the American College of Sports Medicine’s 59th Annual Meeting, San Francisco, CA, 
May 29-June 2, 2012. 
 
32. Hultquist EM, Arena L, Lefferts WK, Storer TW, Cooper CB, Fehling PC, Smith DL. “The Effect of 
Pre-cooling on Cardiovascular and Metabolic Strain During Incremental Exercise.” Presented at 
the American College of Sports Medicine’s 59th Annual Meeting, San Francisco, CA, May 29-June 
2, 2012. 
 
33. Smith DL, Hultquist E, Arena L, Lefferts WK, Fehling PC “Effect of Heat Acclimation on Cardiac 
and Vascular Function, Oxygen Consumption, and Body Fluids.” Presented at the American 
College of Sports Medicine’s 58th Annual Meeting, Denver, CO, May 31-June 4, 2011. 
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Regional Presentations  *Slide presentation, ⱡ Invited symposium, †Award recipient 
1. *Lefferts WK, DeBlois JP, Mammolito GL, Dressel EA, Receno CN, Heffernan KS. “Effect of 
Aerobic Exercise on Artery Stiffness and Cerebrovascular Pulsatility in Hypertensive and Non-
Hypertensive Adults. Presented at the Mid-Atlantic Regional Conference American College of 
Sports Medicine, Harrisburgh, PA, November 3-4, 2017. 
 
2. DeBlois JP, Lefferts WK, Heffernan KS. “Influence of High-Intensity Exercise on Aortic Stiffness 
and Femoral Artery Shear Patterns. Presented at the Mid-Atlantic Regional Conference 
American College of Sports Medicine, Harrisburgh, PA, November 3-4, 2017. 
 
3. Keller AP, Lefferts WK, Augustine JA, DeBlois JD, Heffernan KS. “Muscular Strength is Inversely 
Associated with Central Hemodynamic Load in Young Women.” Presented at the Mid-Atlantic 
Regional Conference American College of Sports Medicine, Harrisburgh, PA, November 3-4, 
2017. 
 
4. Augustine JA, Lefferts WK, DeBlois JP, Barreira TV, Liu K, Taylor B, Heffernan KS. “Sex Differences 
in Aortic Stiffness, 24-hour Aortic Blood Pressure and Cardiac Deformation in Marathon 
Runners.” Presented at the Mid-Atlantic Regional Conference American College of Sports 
Medicine, Harrisburgh, PA, November 3-4, 2017. 
 
5. Pagan P, Palamar AJ, DeBlois JP, Lefferts WK, Heffernan KS. “Retrograde Shear in the Superficial 
Femoral Artery in Recreationally Active and Exercise-Trained Men.” Presented at the Mid-
Atlantic Regional Conference American College of Sports Medicine, Harrisburgh, PA, November 
3-4, 2017. 
 
6. *ⱡ Lefferts WK. “The Consequences of Increased Pulsatility on the Brain and Cognitive Function.” 
Presented at the Mid-Atlantic Regional Conference American College of Sports Medicine, 
Harrisburgh, PA, November 4-5, 2016. 
 
7. DeBlois JP, Lefferts WK, Augustine JA, Nunemacher KN, Heffernan KS. “Effect of Sitting Time on 
Measures of Subclinical Atherosclerosis in Older Adults.” Presented at the Mid-Atlantic Regional 
Conference American College of Sports Medicine, Harrisburgh, PA, November 4-5, 2016. 
 
8. *Lefferts WK, Babcock MC, Tiss M, White CN, Brutsaert TD, Heffernan KS. “Effect of Hypoxia on 
Cerebrovascular and Cognitive Function During Exercise.” Presented at the Mid-Atlantic 
Regional Conference American College of Sports Medicine, Harrisburgh, PA, November 6-7, 
2015. 
 
9. Nunemacher K, Augustine JA, Lefferts WK, Barreira T, Heffernan KS. “Physical Activity Mediates 
the Relationship Between Sleep Quality and Vascular Health in Older Adults.” Presented at the 
Mid-Atlantic Regional Conference American College of Sports Medicine, Harrisburgh, PA, 
November 6-7, 2015. 
 
10. Wade M, Lefferts WK, Heffernan KS. “The Effects of Acute Resistance Exercise on Vascular and 
Cognitive Function.” Presented at the Mid-Atlantic Regional Conference American College of 
Sports Medicine, Harrisburgh, PA, November 6-7, 2015. 
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11. Babcock MC, Lefferts WK, Heffernan KS. “Acute Effects of High-Intensity Exercise on Femoral 
Artery Stiffness and Shear Patterns.” Presented at for the Mid-Atlantic Regional Conference 
American College of Sports Medicine, Harrisburgh, PA, November 6-7, 2015. 
 
12. *† Lefferts WK, Hughes WE, White CN, Brutsaert TD, Heffernan KS. “Effect of Nitrate on 
Cognitive Function and Neurovascular Coupling at High Altitude” Presented at the Mid-Atlantic 
Regional Conference American College of Sports Medicine, Harrisburgh, PA, October 31-
November 1, 2014. 
 
13. Babcock MC, Lefferts WK, Heffernan KS. “Relation Between Exercise Central Hemodynamic Load 
and Resting Cardiac Structure and Function in Young Men” Presented at the Mid-Atlantic 
Regional Conference American College of Sports Medicine, Harrisburgh, PA, October 31-
November 1, 2014. 
 
14. Augustine JA, Lefferts WK, Spartano NL, Hughes WE, Gump BB, Heffernan KS. “Physical 
Function, Cognitive Function, and Aortic Stiffness in Older Adults” Presented at the Mid-Atlantic 
Regional Conference American College of Sports Medicine, Harrisburgh, PA, October 31-
November 1, 2014. 
 
15. Martin E, Augustine JA, Spartano NL, Lefferts WK, Heffernan KS. “No Association between Body 
Fat and Arterial Stiffness in Non-obese Women” Presented at the Mid-Atlantic Regional 
Conference American College of Sports Medicine, Harrisburgh, PA, November 1-2, 2013. 
 
16. Augustine JA, Lefferts WK, Martin E, Spartano NL, Heffernan KS. “Vascular Function in Exercise-
Trained Women.” Presented at the Mid-Atlantic Regional Conference American College of 
Sports Medicine, Harrisburgh, PA, November 1-2, 2013. 
 
17. Spartano NL, Augustine JA, Lefferts WK, Hughes W, Morse B, Martin E, Bill K, Gump B, Heffernan 
KS. “Carotid blood pressure reactivity is associated with carotid intima-media thickness 
independent of central adiposity.”  Presented at the Mid-Atlantic Regional Conference American 
College of Sports Medicine, Harrisburgh, PA, November 1-2, 2013. 
 
18. Hughes WE, Spartano NL, Lefferts WK, Augustine JA, Heffernan KS. “Sex differences in arterial 
stiffness and left ventricular pressure energetics.”  Presented at the Mid-Atlantic Regional 
Conference American College of Sports Medicine, Harrisburgh, PA, November 1-2, 2013. 
 
19. *Lefferts WK, Augustine J, Heffernan K.  “Resistance exercise, carotid artery stiffness, and 
cerebral blood flow pulsatility” Presented at the Mid-Atlantic Regional Conference American 
College of Sports Medicine, Harrisburgh, PA, November 1-2, 2013. 
 
20. *Lefferts WK, Hultquist E, Heffernan K, Fehling P, Smith D. “Vascular changes following exercise-
induced hyperthermia.” Presented at the Mid-Atlantic Regional Conference American College of 
Sports Medicine, Harrisburgh, PA, November 2-3, 2012. 
 
21. Tarzia BJ, Kasprowicz AG, Lefferts WK, Heffernan KS. “Physical Activity, Sedentary Behavior and 
Blood Pressure in Young Adults.” Presented at the Mid-Atlantic Regional Conference American 
College of Sports Medicine, Harrisburgh, PA, November 2-3, 2012. 
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22. *† Lefferts WK, Hultquist E, Arena L, DeBlois J, Fehling PC, Smith DL. “Effect of Base Layers on 
Physiological and Perceptual Strain during Exercise in Personal Protective Equipment.”  
Presented at the Mid-Atlantic Regional Conference American College of Sports Medicine, 
Harrisburgh, PA, November 5-6, 2010.   
 
23. Hultquist E, Arena L, DeBlois J, Lefferts WK, Fehling PC, Smith DL. “Effect of Heat Acclimation on 
Cardiac and Vascular Function, Oxygen Consumption, and Body Fluids.”  Presented at the Mid-
Atlantic Regional Conference American College of Sports Medicine, Harrisburgh, PA, November 
5-6, 2010.  
 
Other Publications and Reports 
• DeBlois JP, Lefferts WK, Heffernan KS. Don’t Let the Pressure Get to You. New York State 
Association for Health, Physical Education, Recreation and Dance Winter Newsletter 2017. 
 
• Smith DL, Haller JM, Lefferts WK, Hultquist EM, Fehling PC. Heat Stress, Dehydration, Cardiac 
Strain and Personal Protective Equipment. Fire Engineering 2015. 
 
• Smith DL, DeBlois JP, Haller JM, Lefferts WK, Fehling PC. Effect of Heat Stress and Dehydration 
on Cardiovascular Function. First Responder Health and Safety Laboratory, Health and Exercise 
Sciences, Skidmore College 2014. 
 
• Smith DL, Haller JM, Hultquist EM, Lefferts WK, Fehling PC. The Station Uniform Shirt: Does it 
Play a Role Beyond Appearance? Firehouse 2013; 38(1):74, 76-78.  
 
Grants/Support 
Funded 
1. American Heart Association Pre-Doctoral Fellowship ($51,900) – Effects of aerobic exercise on 
cerebrovascular and cognitive function in hypertensive adults (2016). PI-Lefferts; Sponsor-
Heffernan 
2. American College of Sports Medicine Foundation Research Grant ($4,998.37) – Effects of aerobic 
exercise on cerebrovascular and cognitive function in hypertensive adults (2016). PI-Lefferts; 
Sponsor-Heffernan  
3. Joan N. Burstyn Endowed Fund for Collaborative Research ($2,470) – Effects of Exercise on 
Markers of Brain Function at High Altitude (2015). PI-Lefferts; Sponsor-Heffernan 
4. American College of Sports Medicine Foundation Research Grant ($4,983.93) – The effect of 
Dietary Nitrate on Cognitive and Cerebrovascular Function in Hypoxia (2014). PI-Lefferts; 
Sponsor-Heffernan  
5. Syracuse University Department of Neuroscience Travel Grant – ($500, 2016) 
6. Syracuse University School of Education Travel Grant – ($400, 2014, 2017; $348, 2015) 
7. Syracuse University Graduate School Organization Travel Grant ($200, 2014; $250, 2015; $450, 
2017) 
 
Unfunded 
1. American Heart Association Pre-Doctoral Fellowship ($46,000) – PI 
The effect of high-intensity interval exercise on cerebrovascular and cognitive function in middle-
aged adults (2015)  
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Professional Organizations 
American College of Sports Medicine (ACSM), 2010 – present. 
Mid-Atlantic Regional Chapter (MARC) of ACSM, 2010 – present. 
American Heart Association (AHA), 2015 – present.  
North American Artery (NAA), 2015 – present.  
American Physiological Society (APS), 2016 – present. 
 
Service Activities 
   Internal Service 
• Syracuse University Vice President for Research Search Committee, 2017 
• Skidmore College’s Science/Math Open House, Alumni Panel, 2016 
• School of Education graduate student Q&A panel, 2016 
• Planning Committee for the Syracuse University Exercise Science Games, 2016-2018 
• Syracuse University Learning Community information session on research in Exercise Science, 
2013-2017 
• Prospective Exercise Science student information sessions on laboratory skills and research, 
2012-2017 
• Fitness testing/consulting for Syracuse University D-I Women’s field hockey (2013-2016), soccer 
(2018) 
 
   External Service 
• East Syracuse Minoa Central Schools PEAK program, 2012-2018 
• Central blood pressure assessment, Loving Myself Loving My Sisters, Heart Month event 
organized by the Syracuse American Heart Association, 2017  
• Heart-to-Heart panel member, community talk sponsored by the Syracuse Downtown YMCA, 
2017 
• Reviewer for MS/PhD student research awards, MARC-ACSM conference, 2016 
 
Invited Lectures 
• Lefferts WK, Schroeder EC. How Does Your Body Respond to Exercise? Presented to 4th grade 
students, University Preparatory School, Denver, CO, May 30, 2017.   
 
• Lefferts WK, Cardiovascular Disease, Arterial Stiffness, and the Brain. Presented to EX 361: 
Clinical Aspects of Cardiovascular Disease, Skidmore College, Saratoga Springs, NY, April 8, 2016. 
 
• Lefferts WK, Principles and Measures of Assessing Body Composition. Presented to HES 1823: 
Scientific Principles of Health and Disease, Oklahoma University, Norman, OK, November 23, 
2015.   
 
• Lefferts WK, Perspectives on Atherosclerosis. Presented to HES 1823: Scientific Principles of 
Health and Disease, Oklahoma University, Norman, OK, September 4, 2015.   
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• Lefferts WK, Novel Measures of Body Composition. Presented to PPE 500: Obesity and Body 
Composition, Syracuse University, Syracuse, NY, April 22, 2014. 
 
   Invited Talks 
• Lefferts WK, Heffernan KS. “Premature vascular aging.” Presented at the Aging Studies Institute, 
Syracuse University, April 20, 2018. 
  
• Lefferts WK, Spartano N, Augustine J. "Cardiovascular function and health implications: research 
and application." Presented to the Syracuse University School of Education Board of Visitors, 
Syracuse, NY, September 21, 2013. 
 
• Lefferts WK “Summer Collaborative Research Experience.” Presented at the Skidmore College 
Board of Trustees Reception and Dinner, Saratoga Springs, NY, February 24, 2011.   
 
   Local Presentations *Slide presentation, †Award recipient 
• *† Lefferts WK, DeBlois JD, White CN, Heffernan KS. “Effects of Acute Aerobic Exercise on 
Cognition and Constructs of Decision-Making in Adults with and without Hypertension.” 
Presented at Neuroscience Research Day, Syracuse, NY, April 6, 2018. 
 
• *Lefferts WK, Figueroa A, Sperry SD, Jorgensen RS, Heffernan KS. “Relationships between 
Carotid Stiffness, Extra-Medial Thickness, and Central Adiposity in Young Adults” Presented at 
Neuroscience Research Day, Syracuse, NY, April 7, 2017. 
 
• Lefferts WK, Babcock MC, Tiss M, White CN, Brutsaert TD, Heffernan KS. “Effect of Hypoxia on 
Cognition and Neurovascular Coupling during Exercise.” Presented at Neuroscience Research 
Day, Syracuse, NY, April 15, 2016. 
 
• Lefferts WK, Hughes WE, White CN, Brutsaert TD, Heffernan KS. “Effect of Nitrate 
Supplementation on Cognitive Function and Neurovascular Coupling in Hypoxia” Presented at 
Neuroscience Research Day, Syracuse, NY, April 3, 2015. 
 
• *Lefferts WK, Hultquist E, Arena L, Fehling, PC, Smith, DL.  Effects of Altered Core Temperature 
on Cardiovascular Strain, Thermal Strain and Performance. Presented at Undergraduate 
Research Conference, Saratoga Springs, NY, October 1, 2011.  
 
• *Lefferts WK, Hultquist E, Arena L, Fehling PC, Smith, DL.  Effects of Altered Core Temperature 
on Cardiovascular Strain, Thermal Strain and Performance. Presented at Skidmore College 
Academic Festival, Saratoga Springs, NY, May 4, 2011.   
 
 
• *Lefferts WK, Hultquist E, Arena L, DeBlois J, Fehling PC, Smith DL.  Effect of Base Layers on 
Physiological and Perceptual Strain during Exercise in Personal Protective Equipment.  Presented 
at Skidmore College Celebration Weekend Spotlight on Collaborative Research, Saratoga 
Springs, NY, October 15, 2010. 
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• *Lefferts WK, Hultquist E, Arena L, DeBlois J, Fehling PC, Smith DL.  Effect of Base Layers on 
Physiological and Perceptual Strain during Exercise in Personal Protective Equipment.  Presented 
at Summer Collaborative Research Meeting, Saratoga Springs, NY, August 6, 2010.   
 
Honors/Awards 
• Syracuse University Neuroscience Research Day, Graduate Research Award, 2018 
• Okanagan Cardiovascular & Respiratory Symposium, The Dr. Chris Willie Graduate Research 
Award, 2018 
• The American Physiology Society, Caroline tum Suden/Frances Hellebrandt Professional 
Opportunity Award, Experimental Biology, 2017 
• North American Artery, Program Committee’s Choice, Best Abstract Award, 2015 
• American College of Sports Medicine Environmental and Occupational Physiology Interest Group 
MS Research Award, 2015 
• Mid-Atlantic Regional Chapter, American College of Sports Medicine, MS Research Award, 2014 
• American College of Sports Medicine Environmental and Occupational Physiology Interest Group 
BS Research Award, 2012 
• Graduated Magna Cum Laude, Skidmore College, Health and Exercise Sciences, 2011 
• Margaret Paulding Award in Exercise Science, Skidmore College, 2011  
• Mid-Atlantic Regional Chapter, American College of Sports Medicine, Matthew Kerner 
Undergraduate Research Award, 2010  
 
Invited Journal Reviewer 
Journal of Physiology 
American Journal of Physiology: Heart and Circulatory Physiology 
Biological Psychology 
Physiology & Behavior 
Journal of Human Hypertension 
Vascular Medicine 
Nutrients 
Physiological Reports 
International Journal of Chronic Obstructive Pulmonary Disease 
International Journal of Sports Medicine 
 
 
